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Virus Schmallenberg : Pathogenèse de l’infection chez les ruminants domestiques et 
circulation chez les ruminants sauvages  
 
Le virus Schmallenberg (SBV) appartient au genre Orthobunyavirus, au sein de la famille des 
Bunyaviridae. Ce nouveau virus, découvert en 2011 au nord-ouest de l’Europe, affecte les 
ruminants domestiques. Il est responsable de signes cliniques discrets chez les adultes et de 
malformations congénitales chez les nouveau-nés. Ces travaux de thèse s’inscrivent dans les 
projets d’étude de la pathogenèse de l’infection à SBV et de l’épidémiologie de la maladie, 
dans le cadre d’un programme de recherche européen sur le virus. Ce manuscrit inclut de 
nouvelles données, telles les cinétiques de la virémie et de la séroconversion chez les ovins et 
caprins, après infection expérimentale par SBV. La possibilité d’infection par SBV par voie 
vaginale est démontrée expérimentalement chez la chèvre. Après infection expérimentale de 
chèvres gestantes entre 28 et 42 jours de gestation, une mortalité fœtale ou des lésions du 
système nerveux central des fœtus peuvent survenir. Enfin, la sensibilité de plusieurs espèces 
de ruminants sauvages et exotiques de parcs zoologiques vis-à-vis de SBV est démontrée pour 
la première fois.  
 
 
Mots clés : Virologie ; Arbovirus ; Orthobunyavirus ; Virus Schmallenberg ; Infection 
expérimentale ; Reproduction ; Caprins ; Ovins ; Faune sauvage ; Ruminants exotiques ; Parc 
zoologique.  
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Schmallenberg virus: Pathogenesis of the infection in domestic ruminants and 
circulation in wild ruminants 
 
Schmallenberg virus (SBV) belongs to the genus Orthobunyavirus in the family 
Bunyaviridae. This new virus was discovered in 2011 in Northwestern Europe in domestic 
ruminants. Infection by SBV is associated with mild clinical signs in adult and congenital 
malformations in the progeny. In the scope of the European research program on SBV in the 
pathogenesis and epidemiology areas, the works included in this thesis provide new data 
about SBV infection in livestock and wild and exotic ruminants. The kinetics of viremia and 
seroconversion after experimental SBV infection are described in sheep and goats. This 
manuscript includes evidence of SBV infection via vaginal route in goats. Experimental SBV 
infection in pregnant goats between 28 and 42 days of gestation can lead to death or central 
nervous system lesions in fetuses. Evidence of susceptibility to SBV in several species of wild 
and exotic ruminants kept in zoos is described for the first time. 
 
 
Keywords : Virology; Arbovirus; Orthobunyavirus; Schmallenberg virus; Experimental 
infection; Reproduction; Caprine; Ovine; Wildlife; Exotic ruminants; Zoological park.  
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1 INTRODUCTION 
 
Schmallenberg virus (SBV), belonging to the genus Orthobunyavirus in the family 
Bunyaviridae, was discovered in 2011 in Northwestern Europe (Hoffmann et al., 2012b), five 
years after the emergence of Bluetongue Virus serotype 8 (BTV-8) in the same area (Wilson 
and Mellor, 2009). Similarly to BTV, SBV is an arbovirus transmitted by midges of the genus 
Culicoides (De Regge et al., 2012) and cause clinical disease in domestic ruminants (van den 
Brom et al., 2012; Hoffmann et al., 2012b). 
 
The disease associated with SBV is an example of an emerging disease, as defined by the 
World Organization for Animal Health (OIE): ‘a new occurrence in an animal of a disease, 
infection or infestation, causing a significant impact on animal or public health resulting from: 
(i) a change of a known pathogenic agent or its spread to a new geographic area or species; or 
(ii) a previously unrecognized pathogenic agent or disease diagnosed for the first time’ (OIE, 
2015). As a reaction to this emerging disease, the European Commission identified in 
February 2012 the major areas for which research was needed prior to decision making about 
regulation and control. These areas were the pathogenesis, the epidemiology and the 
diagnostic of SBV-associated disease. A consortium gathering laboratories from Belgium, 
Germany, France, the Netherlands and the United Kingdom has performed a large part of the 
corresponding studies. 
 
The studies presented in this PhD thesis have been carried out in the scope of the consortium 
research program in the pathogenesis and epidemiology areas. I was involved in pathogenesis 
studies focusing on small domestic ruminants, especially the goat - as determined by the task 
allocation planned by the Consortium. The epidemiologic studies included in this thesis deal 
with exposure of wild and exotic ruminants to SBV. 
 
In chapter 2, a review about SBV will provide general knowledge about the virus, a state of 
the art about epidemiology of the disease as well as work hypotheses about pathogenesis of 
the lesions associated with SBV. The objectives of the thesis will be detailed in chapter 3, 
followed by the corresponding works in chapter 4. A general discussion and future directions 
will be provided in chapter 5 and chapter 6, respectively. 
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2 STATE OF THE ART 
 
2.1 Discovery of a new virus 
 
2.1.1 History 
 
In summer and fall 2011, an unidentified disease was reported in dairy cattle in Germany and 
in the Netherlands. The clinical signs were not specific, including fever, decreased milk 
production and diarrhea. No known agent could be identified in the affected cattle. Sequences 
of a new virus were then detected after metagenomic analysis on blood samples. This virus 
was named “Schmallenberg virus” after the city of Schmallenberg from where the first 
positive samples came. Phylogenetic analyses showed that the virus belonged to the Simbu 
serogroup in the genus Orthobunyavirus. Viruses of this serogroup had not been identified 
previously in Europe (Hoffmann et al., 2012b).  
 
A retrospective study on ruminant brain tissues archived from 1961 to 2010 in Germany 
showed no SBV RNA or antigen in these tissues by in situ hybridization (ISH) and 
immunohistochemistry (IHC), respectively (Gerhauser et al., 2014). Thus, SBV was probably 
not present in northwestern Europe before 2011. The way it was introduced remains 
unknown. One hypothesis is transport by aircraft of infected midges, e.g. on flowers or on 
exotic animals from as yet unrecognized areas where SBV would be enzootic (Gale et al., 
2015). 
 
 
2.1.2 Structure  
 
Viruses from the family Bunyaviridae are enveloped viruses with a segmented RNA genome. 
SBV-virions are about 100 nm in diameter (Figure 1). 
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The genome of viruses in the Orthobunyavirus genus is made of three segments of negative-
sense single-stranded RNA: L (large), M (medium) and S (small). These segments encode 
four structural proteins and two non-structural proteins: 
- The S segment encodes the nucleoprotein N and the non-structural protein NSs; 
- The M segment encodes a polyprotein, which is cleaved into two surface 
glycoproteins (Gn and Gc) and the non-structural protein NSm; 
- The L segment encodes the RNA-dependent RNA polymerase (RdRp or L protein). 
- In the virion, the genome is included in a ribonucleoprotein: each segment is 
associated to many copies of the nucleoprotein N and a few copies of the polymerase 
(Briese et al., 2013; Doceul et al., 2013; Wernike et al., 2014a). 
 
 
 
Figure 1. Morphology of SBV: schematic drawing on the left, electronic microscopy on the right (bar = 100 
nm). 
RNA segments are associated with N nucleoproteins (not shown) and L proteins (in purple on the schematic 
drawing). Courtesy of Dr H. Granzow and M. Jörn, FLI. 
 
The surface glycoproteins Gn and Gc are type I integral membrane proteins that are 
embedded in the envelope. Their C-terminal parts, also known as cytoplasmic tails, are 
towards the intraviral space while the N-terminal parts are in contact with the outer 
environment. Their functions have not been fully elucidated but they are necessary for 
budding of viruses of the genus Orthobunyavirus. They may be involved in virus fusion and 
entry into the cells as well (Strandin et al., 2013). 
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The nucleoprotein N is the most abundant protein in the virion and in infected cells. Its major 
role is encapsidation of the genome but it may be involved in transcription and replication of 
the viral RNA (Wernike et al., 2014a). 
In viruses from the genus Orthobunyavirus, the NSs protein is not essential for virus growth 
in vitro but is involved in viral pathogenesis. Functions of the NSm protein are still unknown, 
yet it may be participate in viral assembly (Eifan et al., 2013), probably in the Golgi apparatus 
(Doceul et al., 2013). 
 
The L protein of bunyaviruses has a double activity: it acts both as an RNA polymerase and as 
an endonuclease. As an endonuclease, the L protein cleaves cellular messenger RNAs, leading 
to capped primers that initiate transcription of viral messenger RNAs; this process is known 
as ‘cap-snatching’ (Briese et al., 2013). 
 
2.1.3 Phylogeny 
 
The Orthobunyavirus genus belongs to the Bunyaviridae family. This family encompasses 
350 viruses that are divided into 5 genera: Orthobunyavirus, Hantavirus, Nairovirus, 
Phlebovirus and Tospovirus. Viruses from the latter genus infect plants whereas viruses from 
the other genera infect vertebrates (Doceul et al., 2013).  
 
The Orthobunyavirus genus is made of more than 170 viruses allocated to 18 serogroups 
(Doceul et al., 2013). The Orthobunyavirus genus includes viruses responsible for disease in 
humans, as Oropouche virus (Simbu serogroup), or Jamestown Canyon virus and La Crosse 
virus (California serogroup), and viruses responsible for disease in ruminants, as Aino virus 
and Akabane virus (Simbu serogroup) or Cache Valley virus (Bunyamwera serogroup) 
(Briese et al., 2013; Hoffmann et al., 2012a). 
SBV was found to be closely related to viruses of the Simbu serogroup when it was 
discovered. The most similar sequences were from Shamonda virus, Aino virus and Akabane 
virus (AKAV), three viruses that can be found in cattle (Hoffmann et al., 2012b). None of 
these viruses has been detected in continental Europe: Shamonda virus has been detected in 
Nigeria, Japan and Korea; AKAV has been found in Australia, Japan, Korea, Israel, Saudi 
Arabia, Kenya, Sudan, Cyprus and Turkey; Aino virus has been found in Japan, Korea and 
Australia (Lievaart-Peterson et al., 2012). 
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Later, a phylogenetic study found the M segment was derived from Sathuperi virus (another 
virus of the Simbu serogroup) while the S and L segments were derived from Shamonda 
virus, suggesting SBV could be a reassortant between Sathuperi virus and Shamonda virus 
(Yanase et al., 2012). However, a subsequent study found SBV may be instead an ancestor of 
Shamonda virus, based on phylogenetic and serologic analyses (Goller et al., 2012). Part of 
the results of the latter phylogenetic analyses are reproduced in Figure 2.  
 
 
 
Figure 2. Phylogenetic relationships of Simbu serogroup viruses for the M (A), L (B), and S (C) coding regions. 
 Maximum-likelihood trees (numbers at nodes: percentage of 1,000 bootstrap replicates, when >50). Scale bars: 
nucleotide substitutions per site. GenBank accession numbers are shown in brackets. DOUV, Douglas virus; 
SATV, Sathuperi virus; SBV, Schmallenberg virus; SHUV, Shuni virus; AINOV, Aino virus; SIMV, Simbu virus; PEAV, 
Peaton virus;  SANV, Sango virus; AKAV, Akabane virus; SABOV, Sabo virus; SHAV, Shamonda virus; OROV, 
Oropouche virus. ND, not determined. Adapted from (Goller et al., 2012). 
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In addition to reassortment (genetic shift), bunyaviruses can evolve via point mutation 
(genetic drift) (Briese et al., 2013). Genetic variability has been shown in SBV, with a 
hypervariable region in the M segment corresponding to the glycoprotein Gc (Coupeau et al., 
2013; Fischer et al., 2013a; Hofmann et al., 2015; Rosseel et al., 2012). However, as yet, this 
variability does not correlate with the time of collection, the geographical location, or the host 
of the SBV strains (Fischer et al., 2013a; Hofmann et al., 2015). 
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2.2 Epidemiology 
 
2.2.1 Susceptible species  
 
EFSA has defined the species susceptible to SBV as the species in which SBV can replicate, 
with or without clinical signs (EFSA, 2014). ‘Receptive species’ means the same. According 
to EFSA, there are three categories of susceptible species to SBV:  
- Species in which SBV has been detected in association with clinical signs; 
- Species in which SBV has been detected (direct detection); 
- Species in which antibodies against SBV have been detected (indirect detection) 
(EFSA, 2014). 
 
2.2.1.1 Ruminants 
 
In this manuscript, ‘ruminant’ is used in a broad sense, meaning any artiodactyl from the 
Ruminantia taxon or from the Tylopoda taxon (Camelidae). 
 
2.2.1.1.1 Domestic ruminants 
 
Herein are considered the usual domestic ruminants in Europe: cattle, sheep, and goats.  
In all these species, direct and indirect detection of SBV and clinical signs in adults or in their 
offspring have been identified (van den Brom et al., 2012; Garigliany et al., 2012; Herder et 
al., 2012; Wernike et al., 2014a). The clinical signs will be detailed later in the manuscript 
(part 2.3). 
 
2.2.1.1.2 Wild and exotic ruminants 
 
SBV-infection has been detected in several species among wild and exotic ruminants.  
Species in which SBV-RNA or antibodies have been detected are summarized in Table 1. 
 
 
10 
 
Table 1. Detection of SBV infection in wild and exotic ruminants from the wild or kept in captivity. 
Species 
Antibodies 
against SBV 
SBV 
RNA 
Country Context Reference 
Alpaca 
(Vicugna pacos) 
x  UK, Austria Captive animals 
(Jack et al., 2012) 
(Steinrigl et al., 2014) 
Alpaca 
(Vicugna pacos) 
x x Germany 
Experimental infection on 
captive adult animals 
(Schulz et al., 2013) 
European bison 
(Bison bonasus) 
x  Poland Free-ranging animals 
(Larska et al., 2013a) 
(Larska et al., 2014) 
Water buffalo 
(Bubalus bubalis) 
x  Turkey Captive animals (farm) (Azkur et al., 2013) 
Red deer 
(Cervus elaphus) 
x  
Belgium, Italy,  
Poland , Austria, 
UK 
Free-ranging wild animals 
(Linden et al., 2012) 
(Chiari et al., 2014) 
(Larska et al., 2013a) 
(Steinrigl et al., 2014) 
(Barlow et al., 2013) 
(Larska et al., 2014) 
Sika deer 
(Cervus Nippon) 
x  Austria Not specified (Steinrigl et al., 2014) 
Chamois 
(Rupicapra 
rupicapra) 
x  
Italy,  Austria, 
Spain 
Free-ranging wild animals 
(Chiari et al., 2014) 
(Steinrigl et al., 2014) 
(Fernández-Aguilar et al., 
2014) 
Roe deer 
(Capreolus 
capreolus) 
x  
Austria, Belgium, 
Spain, Poland 
Free-ranging wild animals 
(Steinrigl et al., 2014) 
(Linden et al., 2012) 
(Fernández-Aguilar et al., 
2014) (Larska et al., 2014) 
Fallow deer 
(Dama dama) 
x  
Austria, UK, 
Poland 
Free-ranging wild animals 
(Steinrigl et al., 2014) 
(Barlow et al., 2013) 
(Larska et al., 2014) 
Elk 
(Alces alces) 
 x Poland 
A free-ranging 6 month-old 
calf 
(Larska et al., 2013a) 
Mouflon 
(Ovis aries 
musimon) 
x  Poland Not specified (Larska et al., 2014) 
Llama 
(Lama glama) 
x x Germany 
Experimental infection on 
captive adult animals 
(Schulz et al., 2013) 
Llama 
(Lama glama) 
x  Austria Not specified (Steinrigl et al., 2014) 
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In addition, in two zoological parks in the United Kindgom, antibodies against SBV have 
been detected in the following ruminant species: Bongo (Tragelaphus eurycerus), Banteng 
(Bos javanicus), Congo buffalo (Syncerus caffer), European bison (Bison bonasus), Gaur (Bos 
gaurus), Gemsbok (Oryx gazelle), Greater kudu (Tragelaphus strepsiceros), Moose (Alces 
americanus), Nile lechwe  (Kobus megaceros), Pere David’s deer (Elaphurus davidianus), 
Reindeer (Rangifer tarandus), Roan antelope (Hippotragus equinus), Scimitar-horned oryx 
(Oryx dammah), Sitatunga (Tragelaphus spekii), and Yak (Bos mutus) (EFSA, 2014). 
 
In spite of detection of SBV antibodies and RNA, clinical signs related to SBV infection have 
not been described in these wild and exotic species. 
After experimental inoculation, alpacas and llamas showed a SBV RNAemia in the 9 days 
post infection (dpi) without clinical signs. SBV antibodies were first detected between 9 and 
21 dpi (Schulz et al., 2013). In a field study in Germany, llamas and alpacas owners did not 
reported clinical signs or congenital malformations (Schulz et al., 2013). 
A 6 month-old elk, found alone in a national park in Poland, showed weakness, hyperthermia 
hyperventilation, muscle tremors, and hind limb paresis: acute pneumonia was diagnosed. It 
died 5 days later despite treatment. Suppurative bronchopneumonia was found at necropsy 
and SBV RNA was detected in the serum. Bronchopneumonia and SBV infection were 
probably unrelated, yet the authors speculate SBV infection could have impaired the immune 
response in the elk, facilitating the pneumonia (Larska et al., 2013a). However, they did not 
report hematological or histological abnormalities to support the latter hypothesis. 
 
2.2.1.2 Non-ruminants 
 
As several viruses from the genus Orthobunyavirus can cause disease in humans, the 
possibility of SBV transmission from animals to humans was one of the most important 
question to answer at the beginning of the epizootics. Molecular and serological testing have 
been performed on exposed populations in Germany and in the Netherlands. SBV RNA and 
antibodies against SBV were not detected (Ducomble et al., 2012; Reusken et al., 2012). The 
Reindeer 
(Rangifer 
tarandus) 
x  Austria Not specified (Steinrigl et al., 2014) 
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public health risk for SBV was concluded to be ‘absent or extremely low’ (Reusken et al., 
2012). 
 
In two zoological parks in the United Kingdom, antibodies against SBV have been detected in 
Onager (Equus hemionus) and Grevy’s zebra (Equus grevyi). However, SBV RNA has not 
been detected in samples from horse (Equus caballus) offspring tested in the Netherlands 
(EFSA, 2013). 
Antibodies against SBV have been found in free-ranging wild boar (Sus scrofa) in Belgium 
(Desmecht et al., 2013). After SBV experimental infection, domestic pigs seroconverted but 
did not show clinical signs or SBV RNAemia (Poskin et al., 2014a), suggesting they are 
receptive to SBV though they do not develop disease. 
SBV infection can occur in dogs, albeit few cases have been reported. In Sweden, antibodies 
against SBV have been found in one dog (Wensman et al., 2013). In France, SBV RNA was 
found in the brain of a puppy showing torticollis and degenerative encephalopathy while 
antibodies against SBV were detected in the mother (Sailleau et al., 2013a) (cf. appendix). 
Nevertheless, in Belgium, a serologic survey did not detect any positive sample in 132 dogs 
(Garigliany et al., 2013). SBV infection is probably a rare event in dogs. 
Finally, a mouse model of infection has been developed with the type I Interferon receptor 
knock-out (IFNAR
-/-
) mice. After experimental subcutaneous inoculation, SBV RNA was 
found in blood and organs; the mice lose weight and some died. Thus, this mouse strain is 
susceptible to SBV infection (Wernike et al., 2012a). 
 
2.2.2 Transmission 
 
2.2.2.1 Vectors 
 
SBV is an arbovirus, which is “a virus which in nature can infect hematophagous arthropods 
by their ingestion of infected vertebrate blood. It multiplies in the arthropod’s tissues and is 
transmitted by bite to other susceptible vertebrates” (Mellor, 2000). 
 
Biting midges, small blood-sucking insects of the genus Culicoides, are the putative vectors 
for SBV. Their life cycle include eggs, larvae (four larval instars), pupa and adults (Carpenter 
et al., 2013). The midges are usually active from April to October in the United Kingdom 
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(Tarlinton et al., 2012). The species in which SBV RNA has been found in Europe are C. 
obsoletus complex (i.e. C. obsoletus sensu stricto and C. scoticus), C. dewulﬁ and C. 
chiopterus (Elbers et al., 2013a, 2013b; Goffredo et al., 2013; Rasmussen et al., 2012, 2014; 
De Regge et al., 2012). C. punctatus and C. nubeculosus may be involved as well (Balenghien 
et al., 2014; Larska et al., 2013b).  
Vector competence has not been established under laboratory conditions for any of the 
aforementioned species, except for C. scoticus, because these species are hard to feed and to 
breed in the laboratory (Balenghien et al., 2014; Veronesi et al., 2013). Nevertheless, 
competence may be inferred from field data by two methods: 
- By dissecting midges and performing SBV RT-qPCR on heads only: detection of SBV 
RNA in the head means the salivary glands are infected (De Regge et al., 2012);  
- By analysis of the distribution of Cq-values after SBV RT-qPCR: a recent study 
showed a bimodal distribution of Cq-values indicated the ability for a species to be a 
vector (Veronesi et al., 2013). 
Both methods have confirmed the vector competence of midges of the C. obsoletus complex, 
C. dewulﬁ and C. chiopterus (De Regge et al., 2012, 2014). These species belong to the 
subgenus Avaritia, known to breed on dung (Lühken et al., 2014) and bog land (Koenraadt et 
al., 2014). 
 
A few studies have been carried out to elucidate the role of mosquitoes in SBV transmission. 
No SBV RNA was found in 50,000 mosquitoes trapped in Germany in 2011 (Wernike et al., 
2014b). Experimental oral infection of Aedes albopictus and Culex pipiens mosquitoes did not 
result in SBV replication to transmissible levels, suggesting these two species are unlikely to 
be true vectors of SBV (Balenghien et al., 2014). 
The role of other arthropods as SBV vectors has not been explored. 
 
2.2.2.2 Vertical transmission in ruminants 
 
SBV can be transmitted vertically from the pregnant female to its offspring. Congenital 
malformations associated to SBV RNA have been found in newborns, stillborn or aborted 
animals in sheep, cattle, and goats (van den Brom et al., 2012; Garigliany et al., 2012; Herder 
et al., 2012). Vertical transmission in other species has not been reported. 
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2.2.2.3 Horizontal transmission in ruminants 
 
SBV RNA has been detected in fecal, oral and nasal swabs in subcutaneously-inoculated 
cows (Wernike et al., 2013a). Nevertheless, direct transmission of SBV from an infected 
ruminant to a naïve one by contact or by oral or nasal route is unlikely. Indeed, oral 
inoculation to cattle and nasal inoculation to sheep failed to produce RNAemia (Martinelle et 
al., 2015; Wernike et al., 2013a). Moreover, naïve cows in contact with viremic cows for 24 
days did not show RNAemia and remained seronegative, as determined by SBV-specific 
ELISA (Wernike et al., 2012b). 
 
Whether SBV can be sexually transmitted is still unknown. Bulls can excrete SBV in their 
semen, as shown by detection of infectious SBV in a few bovine semen samples from the 
field (Hoffmann et al., 2013; Ponsart et al., 2014; Schulz et al., 2014). However, the ability of 
the female to be infected by the vaginal route during artificial insemination or natural service 
has not been assessed. This topic deserves interest, as cows have been successfully infected 
with AKAV by uterine route at the time of artificial insemination (Parsonson et al., 1981a). 
  
2.2.2.4 Overwintering 
 
In May 2012 in France, eight months after the likely introduction date of SBV in the country 
(Zanella et al., 2013), evidence of acute infection was found in cows in France, suggesting 
SBV could overwinter or was reintroduced (Sailleau et al., 2013b). SBV overwintering was 
confirmed in Germany after acute infections that occurred in summer and fall 2012 (Conraths 
et al., 2013). SBV has then overwintered in 2013 and 2014, with new cases or SBV RNA 
detection being reported each vector season (Wernike et al., 2015). 
Several mechanisms could account for SBV overwintering. First, SBV may persist in its host: 
it seems unlikely at least in domestic ruminants, because viremia appeared to be short-lasting 
in adults (Hoffmann et al., 2012b) and SBV RNA is not often detected in malformed 
newborns (Bouwstra et al., 2013; De Regge et al., 2013). Characteristics of viremia in most of 
the susceptible wild or exotic ruminants remain unknown. Second, transovarial transmission 
of the virus in the vector might be involved in overwintering: one study reported SBV RNA in 
nulliparous females of C. obsoletus complex and C. punctatus (Larska et al., 2013b). Third, 
SBV may persist in adult midges during winter, as postulated for African Horse Sickness 
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Virus (Mellor, 2000). Adult midges of the C. obsoletus complex are able to survive, without 
blood meal, for 10 days at 4°C and up to 92 days at temperatures between 17°C and 25°C 
(Goffredo et al., 2004). As C. obsoletus midges have the ability to live indoors (endophagy) 
(Koenraadt et al., 2014), infected midges could thus survive in the coldest months in barns 
and infect vertebrates once the temperature rise. This hypothesis is supported by evidence of 
transmission of SBV to cattle in winter 2013 in Germany, after a rise in temperature above 
5°C for a few days (Wernike et al., 2013b). Finally, as yet unidentified vectors could play a 
role in SBV transmission and overwintering. 
 
2.2.3 Geographical repartition  
 
From Germany, the Netherlands, and Belgium, where it was initially detected in 2011, SBV 
has then spread quickly to other European countries along the four cardinal directions (Figure 
3) (Afonso et al., 2014), up to 320 km from the northern polar circle in Sweden (Chenais et 
al., 2013). 
 
 
Figure 3. Regions (NUTS2) with at least one SBV herd confirmed by direct detection by period of first report 
(Afonso et al., 2014).  
NUTS: Nomenclature of territorial units for statistics 
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In addition, antibodies against SBV have been found in 2013 in cows in Lithuania (Lazutka et 
al., 2014), and in cows and sheep in Greece (Chaintoutis et al., 2014), demonstrating presence 
of SBV in these countries. 
 
Outside of Europe, in Turkey, SBV RNA was detected in aborted cattle and sheep fetuses in 
June 2012 (Yilmaz et al., 2014), suggesting a spread from northern Europe to Turkey. In this 
country antibodies to SBV have been found by ELISA in samples collected before 2011 
(Azkur et al., 2013); however viral neutralization was not performed, thus cross-reactivity 
with other viruses from the Simbu serogroup cannot be excluded. 
 
Finally, SBV might be circulating in Africa. Antibodies to SBV have been detected by ELISA 
in cattle, sheep and goats in Mozambique, in 2013; yet, the possibility of cross-reactivity with 
other viruses from the Simbu serogroup precludes a definitive conclusion (Blomström et al., 
2014). Lesions retrospectively consistent with SBV infection have been found in sheep 
offspring in South Africa in 2006 and 2008, but tests specific for SBV detection were not 
available at this time (Leask et al., 2013). 
 
2.2.4 Risk factors 
 
The risk of SBV infection seems to differ among ruminant species. In wildlife, SBV 
seroprevalence was higher in heavy wild ruminants than in light wild ruminants in Poland in 
2013 (Larska et al., 2014). Regarding domestic ruminants, within-herd prevalence was found 
to be lower in sheep than in cattle, in Germany (Helmer et al., 2015). In addition, goats have 
been shown to have a lower risk of SBV infection than sheep in Germany (Helmer et al., 
2015). 
These differences can be a consequence of intrinsic differences in susceptibility of these 
species to SBV. Experimentally, cattle needs a lower SBV infectious dose than sheep to be 
successfully infected (Poskin et al., 2014b; Wernike et al., 2012b). 
Alternatively, the differences between species may depend on their difference of exposure to 
midges. Culicoides spp. find their hosts after their odor (Koenraadt et al., 2014) and have 
developed host preferences. Cattle was found to be more attractive than sheep for midges of 
the C. obsoletus complex in Germany (Ayllón et al., 2014). Housing conditions may also 
facilitate exposure of some species to midges. Indeed, the moist cesspool under slatted floors 
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in cow barns may offer breeding sites for Culicoides spp. while sheep barns display most 
often deep litter, which may not favor midges larval development (Helmer et al., 2015). 
 
For a given species, breeding conditions are also a risk factor for SBV infection. Indoor dairy 
cow herds showed lower SBV seroprevalence of SBV than outdoor herds, probably due lower 
midge exposure of cattle kept indoors (Tarlinton and Daly, 2013; Veldhuis et al., 2014a). The 
housing conditions were also found to influence seroprevalence in goats, with the outdoor 
herds tending to have a higher within-herd seroprevalence in France and in Germany (Helmer 
et al., 2013; Valas et al., 2014). 
 
Other factors have been found to influence the probability of domestic ruminants from a farm 
to be infected by SBV. According to a study in the Netherlands, presence of one or more dogs 
in the farm, on the one hand, and purchase of silage, on the other hand, were found to be 
associated with an increased odd of malformations in newborn lambs (Luttikholt et al., 2014). 
As shown previously, dogs may be infected by SBV but viremia in this species has not been 
characterized, thus their role in SBV dissemination is still unknown. The biological link 
between the purchase of silage and SBV-associated malformations remains unclear. 
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2.3 Clinical signs and lesions in affected animals 
 
In this section, the clinical signs and lesions associated with SBV infection in domestic 
ruminants will be described and compared with those involving two other members of the 
genus Orthobunyavirus that infect domestic ruminants: AKAV and Cache Valley virus 
(CVV). 
 
2.3.1 Non-pregnant adults 
 
2.3.1.1 Clinical signs 
 
At first, SBV infection was discovered in non-pregnant dairy cows in Germany. It was 
responsible for short-lasting non-specific clinical signs, namely fever, decreased milk 
production, and diarrhea (Hoffmann et al., 2012b). One report suggests that goats infected by 
SBV may also experience diarrhea and reduction in milk yield (Helmer et al., 2013). Fever, 
diarrhea and decreased milk production have been sometimes reported in sheep from the field, 
without an obvious causal link with SBV infection (Lievaart-Peterson et al., 2012; Luttikholt 
et al., 2014). 
 
Likewise, AKAV infection can result in subclinical disease in adult ruminants (Spickler, 
2009) and in a drop of milk production in dairy cows (Horikita et al., 2005). However, more 
severe clinical signs have been reported in adult cattle. In 2000 and 2010 in Korea, outbreaks 
of neurological signs associated with AKAV infection occurred in 2 to 7 years-old and in 4 to 
72 months-old cows, respectively. The clinical signs included hypersensitivity, tremors, 
locomotor ataxia, and lameness (Lee et al., 2002; Oem et al., 2012). No clinical signs have 
been reported in association with CVV infection in adult ruminants. 
 
2.3.1.2 Lesions 
 
No lesions have been described in association with SBV infection in non-pregnant adult 
ruminants in the field. 
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During the outbreak of neurological signs associated with AKAV infection in Korea in 2000 
in adult cows, 5 affected cows were slaughtered and submitted to post-mortem examination. 
They were devoid of gross lesions, but histological examination revealed similar lesions in 
their brains and spinal cords. The brain, especially the pons and medulla oblongata, was 
characterized by moderate to severe perivascular infiltrations of lymphocytes, macrophages, 
and plasma cells with multifocal gliosis and neuronal necrosis. In the spinal cord, similar 
lesions were found in the ventral horns with lymphohistiocytic perivascular cuffing, gliosis, 
and neuronal necrosis and loss. Overall, these lesions corresponded to a non-suppurative 
encephalomyelitis (Lee et al., 2002). 
 
Phylogenetic analyses showed the AKAV strain responsible for this Korean outbreak was 
closely related to Iriki strain, an AKAV strain that has been associated earlier with  
encephalitis in adult cattle in Japan (Oem et al., 2012). Despite the absence of lesions in adults 
associated with SBV infection, up to now, we cannot exclude that new strains with the ability 
to trigger encephalitis in adults may emerge in the future. 
 
 
2.3.2 Pregnant females and their offspring 
 
After discovery of SBV in non-pregnant adult cows in Germany, epizootics of congenital 
malformations were reported in sheep in the Netherlands. They were associated in about half 
of the cases with detection of SBV RNA in the brains from the affected newborns (van den 
Brom et al., 2012), showing the ability of SBV to cross the placenta in pregnant ewes and to 
cause lesions in the growing embryo or fetus. 
 
2.3.2.1 Clinical signs in pregnant females and in newborns 
 
At parturition, pregnant females infected by SBV can show clinical signs of dystocia when 
their offspring is malformed (van den Brom et al., 2012). During pregnancy, there are several 
lines of evidence SBV could be associated with embryonic or fetal death and abortion. In 
flocks affected by SBV, increased numbers of repeat breeders and increased rate of abortions 
suggest early embryonic or fetal loss and abortions in ewes (Dominguez et al., 2014; Lievaart-
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Peterson et al., 2012; Luttikholt et al., 2014; Saegerman et al., 2014) and goats (Dominguez et 
al., 2014; Helmer et al., 2013). In cattle flocks affected by SBV, increased numbers of repeat 
breeders and of early embryonic deaths have been reported as well (Dominguez et al., 2014). 
All the aforementioned data come from retrospective studies. In addition, one report describes 
an association between early fetal death (around 60 days of gestation (dg)) in two cows and 
SBV genome in the corresponding allantoic fluids (Steinrigl et al., 2014). 
The birth of both one malformed and one healthy offspring has been described in SBV-
infected cattle (Wernike et al., 2014c) and sheep (van den Brom et al., 2012). In the affected 
sheep flocks, the lambs were either malformed, dummy with inability to suckle or normal 
(van den Brom et al., 2012).  Neurological signs have also been described in a newborn calf 
infected in utero by SBV: hypertonicity, hyperreflexia, depression, blindness, ventrolateral 
strabismus, and inability to stand (Garigliany et al., 2012). These neurological signs are 
suggestive of SBV-induced lesions in the central nervous system (CNS). 
 
During an outbreak of AKAV infection of pregnant cows in Japan in 1973-1974, a succession 
of different clinical signs were noticed. Abortions, stillbirths, premature births and neonatal 
deaths were seen at the beginning of the outbreak. Then, the newborn calves were alive but 
displayed musculoskeletal malformations as torticollis and arthrogryposis. At the end of the 
outbreak, the newborn calves showed blindness or tongue paralysis (Konno et al., 1982). 
 
Similarly, infection of sheep with CVV in the field was associated with stillbirths, mummified 
fetuses, malformed fetuses or newborns, and weak lambs as well (Edwards et al., 1989). 
 
2.3.2.2 Lesions in fetuses and newborns  
 
A wide range of lesions have been described in fetuses and newborns with proven or 
presumptive infection by SBV during gestation (Table 2). The most common lesions affect 
the skeletal muscle, the CNS and the axial skeleton; they can occur together in combination 
(Herder et al., 2012; Peperkamp et al., 2014; Seehusen et al., 2014). The animals may show 
arthrogryposis (Figure 4) associated with histological evidence of muscular hypoplasia 
(Figure 4), characterized by a reduction in number and diameter of the myofibrils, with or 
without loss of cross-striation in myofibrils and fatty replacement (Herder et al., 2012; 
Seehusen et al., 2014). In the CNS, the most common lesions are hydranencephaly, 
porencephaly, hydrocephalus, cerebellar hypoplasia and micromyelia (Figure 4); they are 
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sometimes associated with nonsuppurative inflammation and neuronal degeneration and 
necrosis (Figure 4). The animals often display vertebral malformations, including lordosis, 
kyphosis, scoliosis, and torticollis, and may show brachygnathism inferior (Figure 4) (Herder 
et al., 2012). 
 
 
Table 2. Lesions in fetuses and newborns associated with spontaneous SBV infection in domestic ruminants. 
 Gross lesions Histological  lesions Ref. 
Bovine Porencephaly, hydrocephalus, hydranencephaly, 
brain stem hypoplasia, cerebellar hypoplasia, 
cerebellar dysplasia, micromyelia, arthrogryposis, 
torticollis, lordosis, scoliosis, kyphosis, cranial 
malformations, brachygnathism inferior, 
prognathism, ectopia cordis, lung hypoplasia, 
ventricular septal defect 
Non-suppurative 
meningoencephalitis, non-
suppurative poliomyelitis, 
skeletal muscle hypoplasia, 
lymphoid depletion in thymus 
and lymph node, chronic 
hepatitis 
(Garigliany 
et al., 2012) 
(Peperkamp 
et al., 2012) 
(Herder et 
al., 2012) 
(Seehusen 
et al., 2014) 
(Peperkamp 
et al., 2014) 
(Bayrou et 
al., 2014) 
Ovine Arthrogryposis, torticollis, lordosis, scoliosis, 
kyphosis, brachygnathism inferior, domed skull, 
flattened skull, hydranencephaly, hydrocephalus, 
micrencephaly, macrocephaly, brainstem hypoplasia, 
cerebral hypoplasia, cerebellar hypoplasia, cerebellar 
dysplasia, micromyelia, cardiac ventricular septal 
defect, unilateral hydronephrosis, colonic atresia 
Non-suppurative 
meningoencephalitis, skeletal 
muscle hypoplasia, lymphoid 
depletion in spleen or lymph 
node, cataract, decreased 
hematopoietic cellularity in 
bone marrow 
(van den 
Brom et al., 
2012) 
(Herder et 
al., 2012) 
(Peperkamp 
et al., 2014) 
Caprine Arthrogryposis, vertebral deformities, 
brachygnathism inferior, hydrocephalus, 
porencephaly, cerebellar hypoplasia, lung hypoplasia 
Non-suppurative 
meningoencephalitis, non-
suppurative poliomyelitis 
(Herder et 
al., 2012) 
(Wagner et 
al., 2014) 
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Figure 4. Gross and histological lesions from SBV-infected fetuses (Herder et al., 2012). 
(1) Aborted ovine fetus with arthrogryposis, torticollis, and brachygnathism inferior. (2) Cerebellar hypoplasia in 
a bovine fetus. (3) Brain from a bovine fetus. Hydrocephalus and porencephaly (arrow) in the adjacent cerebral 
parenchyma. (4) Brain; goat. Perivascular lymphocytes and macrophages. Hematoxylin-Eosin (HE). (5) Brain; 
goat. Glial nodule of microglia/macrophages. HE. (6) Brain; sheep. Chromatolysis, with dispersion of Nissl 
substance, swelling, and homogeneous cytoplasmic eosinophilia of a neuron. HE. (7) Brain; calf. 
Hypereosinophilic, necrotic neuron. HE. (8) Cervical spinal cord; calf. Micromyelia with severe reduction of gray 
matter and few neurons in one ventral horn (arrow). Ventral meningeal fibrosis (asterisk). HE. (9) Skeletal 
muscle; sheep. Myofibrillar hypoplasia with few residual normal muscle fibers (asterisk). HE. 
 
The nature of the musculoskeletal and nervous lesions associated with SBV are similar in 
cattle and sheep. Still, the severity of the CNS lesions may be higher in lambs than in calves 
 
23 
 
(Peperkamp et al., 2014). The lesions have not been as extensively described in goats as in 
cattle and sheep. 
 
Gross and histological lesions associated with AKAV infection in domestic ruminants are 
very similar to those described above for SBV. They are detailed in Table 3.  The CNS, the 
skeletal muscle and the axial skeleton are again the most affected systems. 
 
Table 3. Lesions in fetuses and newborns associated with AKAV infection in domestic ruminants. 
 Context Gross lesions Histological  lesions Ref. 
Bovine Spontaneous 
infection 
Arthrogryposis, scoliosis, 
kyphosis, lordosis, torticollis, 
porencephaly, 
hydranencephaly 
Muscle hypoplasia or atrophy, 
decrease in the number of neurons in 
the ventral horns in the spinal cord, 
nonsuppurative encephalomyelitis, 
retinal atrophy 
(Konno et 
al., 1982) 
(Ushigusa 
et al., 2000) 
 Experimental 
infection 
Same as above (normal 
fetuses were also found) 
Muscle degeneration and atrophy, 
decrease in the number of neurons in 
the ventral horns in the spinal cord, 
suppurative meningoencephalitis, 
cerebellar dysplasia 
(Kirkland et 
al., 1988) 
Ovine Experimental 
infection 
Arthrogryposis, scoliosis, 
kyphosis, lordosis, torticollis, 
porencephaly, 
hydranencephaly, dwarfism, 
brachygnathism inferior, 
micrencephaly, lung 
hypoplasia (normal fetuses 
were also found) 
Muscle atrophy and degeneration, 
myelitis and/or neuronal loss in the 
ventral horns in the spinal cord, 
meningoencephalitis and/or cysts 
and malacia in the brain, 
subependymal rosettes in the brain, 
thymic depletion 
(Hashiguchi 
et al., 1979) 
(Parsonson 
et al., 1977) 
(Parsonson 
et al., 
1981b) 
(Narita et 
al., 1979) 
Caprine Experimental 
infection 
Arthrogryposis, scoliosis, 
torticollis, hydranencephaly 
Degeneration and necrosis in skeletal 
muscle and/or myositis, non-
suppurative encephalitis 
(Kurogi et 
al., 1977) 
(Konno and 
Nakagawa, 
1982) 
 
Likewise, the lesions described in the offspring of SBV-infected sheep in the field include 
lesions of the skeletal muscle (arthrogryposis with skeletal muscle hypoplasia), of the CNS 
(hydrocephalus, hydranencephaly, micrencephaly, cerebellar hypoplasia, micromyelia with 
loss of motor neurons, porencephaly), and spinal column deformities (Edwards et al., 1989). 
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In addition, oligohydramnios, i.e. the close apposition of the amniotic membrane to the fetal 
body, was described after experimental in utero inoculation of CVV to pregnant ewes at 35 dg 
(Hoffmann et al., 2012a). The latter lesion may however rely upon the route of inoculation. 
 
2.3.3 Hypotheses on the pathogenesis of the lesions in fetuses and newborns 
 
Previous works on CVV and AKAV have brought pieces of information about the 
pathogenesis of the viral-induced lesions. Given that SBV is phylogenetically close to these 
viruses and causes very similar clinical signs and lesions, it is likely they are involved in 
common mechanisms of disease. By analogy with these virus, it is thus possible to formulate 
hypotheses regarding the pathogenesis of the lesions induced by SBV. 
  
2.3.3.1 Factors influencing the development of lesions in fetuses and 
newborns 
 
From the literature, both the age of the conceptus (i.e., the embryo or fetus with its placenta) 
and the inoculum have an impact on the development of lesions in fetuses and newborns. 
 
2.3.3.1.1 Influence of the age of the conceptus at the time of infection 
 
In cattle, an experimental infection with AKAV showed a sequential development of lesions 
depending on the stage of pregnancy at which the cow was infected. Hydranencephaly and 
porencephaly developed in fetuses after infection between 76 and 104 dg. Arthrogryposis 
developed in fetuses infected later, when infection took place between 103 and 174 dg. No 
lesions were found in fetuses born from cows infected before 76 dg (Kirkland et al., 1988). As 
the authors suggested, the absence of fetal lesions before 76 dg may be explained by 
immaturity of the placentomes until this day, with subsequent isolation and protection of the 
conceptus from the virus (Kirkland et al., 1988). However, they could not monitor the early 
embryonic development, thus they could not exclude embryonic mortality when infection 
took place before 76 dg (Kirkland et al., 1988). 
 
Similarly, in sheep, the lesions that developed seem to depend on the age of the conceptus at 
the time of infection with AKAV. A study from Japan showed that, when experimental 
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infection occurred between 29 and 45 dg, newborns displayed arthrogryposis and 
hydranencephaly. After inoculation between 30 and 70 dg, abnormal newborns were either 
weak, with or without porencephaly, or dwarf; there were also stillborn lambs. However, if 
the inoculation took place between 90 and 100 dg, all the newborns were normal (Hashiguchi 
et al., 1979). Another experimental infection of pregnant ewes with AKAV showed that brain 
lesions (necrosis and gliosis) could still occur after inoculation at 90 dg (Narita et al., 1979). 
 
One study showed that the ovine fetuses infected transplacentally could produce neutralizing 
antibodies against AKAV as soon as 64 dg (Hashiguchi et al., 1979). The development of the 
immune system in the fetus may inhibit viral progression and subsequent lesions; therefore it 
may be one reason for the lack of lesions at late stages of gestation. However, the immune 
system activity may not be the only factor responsible for this lack of lesions. An 
experimental inoculation of AKAV intraperitoneally in ovine fetuses at 120 dg resulted in a 
strong immune response, yet the fetuses showed damage in brain and skeletal muscle 
(McClure et al., 1988). The authors suggested that the stage of maturity of the target-organs 
may be of greater importance in determining its susceptibility to virus-induced damage than 
the fetal immune response (McClure et al., 1988).  
 
The susceptibility window of goat fetuses to AKAV infection has been partially described. An 
experimental infection of a pregnant goat by AKAV at 40 dg resulted in one malformed fetus 
but a normal twin fetus. The malformed fetus displayed hydranencephaly, arthrogryposis, 
scoliosis, and torticollis (Kurogi et al., 1977). Another experimental infection at 30 and 60 dg 
led to degeneration and necrosis in the skeletal muscle and/or myositis in all fetuses at 10 dpi. 
Only the fetuses infected at 60 dg showed also non-suppurative encephalitis (Konno and 
Nakagawa, 1982). 
 
In summary, the susceptibility of the growing embryo or fetus to AKAV infection may 
depend on: 
- The maturity of the placentomes: if the infection of the pregnant female takes place 
before maturity; the conceptus may be protected from viral invasion; 
- The stage of maturity of the target-organs: with increasing maturity, the target organs 
may be no more susceptible to the virus; 
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- The stage of development of the fetal immune system: with increasing development, 
the immune system could inhibit the progression of the virus and the virus-induced 
damage. 
By analogy with AKAV, hypotheses can be drawn on the effects of SBV infection in pregnant 
females depending on the stage of gestation. Figure 5 shows the putative consequences of 
SBV infection in pregnant ewes and goats. 
 
 
 
Figure 5. Hypothetic consequences of SBV infection in pregnant goats and ewes depending on the stage of 
gestation.  
By analogy with data from experimental infection with AKAV (Hashiguchi et al., 1979; Konno and Nakagawa, 
1982; Narita et al., 1979). AI: artificial insemination; CNS: central nervous system; dg: day of gestation; SKM: 
skeletal muscle. 
 
 
2.3.3.1.2 Influence of the inoculum 
 
Several teams have performed AKAV inoculations in pregnant ewes and their results 
sometimes differed. As an example, one study showed that lesions in fetuses occurred only if 
the inoculation had taken place between 30 and 36 dg but not between 38 and 82 dg 
(Parsonson et al., 1977), while another study showed fetal lesions after inoculation between 
29 and 70 dg (Hashiguchi et al., 1979). In these cases, the protocols were similar regarding 
the route of inoculation (intravenous), but they differed in the strains used as well as in the 
number of passages and the host species used for passage. The authors of the second study 
hypothesize that the difference in results could rely upon the difference in virulence between 
the two inocula, depending on the viral strain and the history of passages (Hashiguchi et al., 
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1979). Moreover, the viral load of the inoculum could also exert an influence on the severity 
of the damage in fetal tissues. 
 
 
2.3.3.2 Mechanisms involved in the development of lesions at the tissue level 
 
2.3.3.2.1 Microscopic lesions and correlation with tissular and cellular tropism 
 
In one study, pregnant ewes were inoculated at 35 dg with CVV and were sequentially 
slaughtered between 42 and 63 dg. The results suggest two hypotheses about the mechanism 
of lesion formation. 
First, this study shows a progression of the microscopic lesions in the fetuses along with the 
course of infection between 7 and 28 dpi. Between 7 and 10 dpi, the brain displayed necrosis 
in matrix and intermediate zones of the cerebral cortex and brainstem; necrosis was also 
noticed in the dorsal horns of the spinal cord and in the skeletal muscle, without vascular 
lesions. At 14 dpi, hydrocephalus ex vacuo was noticed, and myositis with mononuclear cells 
and granulocytes was seen in skeletal muscle. Then, between 21 dpi and 28 dpi, the 
histological lesions were hydrocephalus ex vacuo, myositis with muscle hypoplasia, and 
micromyelia (Hoffmann et al., 2012a). This sequential progression suggests that 
hydrocephalus ex vacuo, and probably hydranencephaly, proceed from necrosis of progenitor 
cells in the brain. 
Second, the microscopic lesions were associated with the presence of CVV in the affected 
tissues, i.e. the skeletal muscle and the CNS. Viral RNA and antigen, as determined by ISH 
and IHC, were associated with necrotic foci in muscle, brain and spinal cord. The target cells 
were progenitor cells in the periventricular area in the brain, and myofibers in the muscle; 
positive cells were also found in the spinal cord but their nature was not identified (Hoffmann 
et al., 2012a). This association between lesions, viral RNA and viral antigen are suggestive of 
a direct effect of the virus in the aforementioned tissues.  
 
The pathogenesis of skeletal muscle hypoplasia (and the associated arthrogryposis) is a matter 
of debate. In calves with arthrogryposis, a relationship has been described between the lesions 
observed in spinal cord and the side(s) affected by arthrogryposis: bilateral depletion of the 
ventral horn neurons was associated to bilateral arthrogryposis while unilateral depletion of 
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these neurons was associated to unilateral arthrogryposis (Kirkland et al., 1988). Depletion of 
ventral horn neurons has also been described in SBV-infected animals (Herder et al., 2012); 
as a consequence denervation may occur in skeletal muscle, followed by failure of muscle 
development (Seehusen et al., 2014). 
However, muscular lesions have been found in fetuses devoid of spinal cord lesions. Ten days 
after intravenous inoculation of AKAV to pregnant goats at 60 dg, fetuses displayed 
degeneration and necrosis in skeletal muscle, but no lesions were observed in spinal cord 
(Konno and Nakagawa, 1982). These results suggests that AKAV may directly damage 
skeletal muscle.  
Finally, the muscular hypoplasia could result both from damage to the myofibers as well as 
from motor neuron loss, as hypothesized for CVV (Hoffmann et al., 2012a). 
 
 
2.3.3.2.2 Insights in cellular and molecular consequences of SBV infection 
 
To study the pathogenesis of SBV in the brain, a mouse model of SBV infection was 
developed with NIH-Swiss mice. Intracerebral inoculation resulted in death and severe brain 
lesions with malacia and hemorrhage in the cerebral cortex, multifocal vacuolation in the 
white matter of the cerebrum, as well as lymphocytic perivascular cuffing in the grey matter. 
These lesions were associated with SBV antigen in neurons (Varela et al., 2013), which is in 
favor of a direct role for SBV in inducing this range of lesions. In addition, activated caspase-
3 staining in the brain has been later associated with SBV intracerebral infection of NIH-
Swiss mice (Barry et al., 2014), suggesting apoptosis may be one mechanism leading to the 
SBV-induced degenerative lesions in the brain. 
 
 To explore whether the viral protein NSs of SBV was a virulence factor, a NSs deletion 
mutant (SBVΔNSs) was produced by reverse genetics. Its virulence was then tested in NIH-
Swiss mice by intracerebral inoculation. The SBVΔNSs showed an attenuated phenotype, 
characterized by a delay in the time of mice death in comparison to the wild type SBV. This 
defined SBV NSs as virulence factor (Varela et al., 2013). 
In vitro, SBVΔNSs was able to induce the production of IFN in several cell lines while wild 
type SBV was not, showing that SBV NSs inhibits the IFN response of the host (Varela et al., 
2013). SBV NSs has also the ability to induce the degradation of the RPB1 subunit of RNA 
polymerase II in vitro, thus inhibiting transcription and protein synthesis. The inhibition of the 
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IFN response may be a consequence of this global inhibition of transcription (Barry et al., 
2014). Besides, a transcriptomic study showed that, in vitro, SBV NSs elicits a shutdown in 
the expression of genes involved in innate immunity. Nevertheless, this shutdown is 
incomplete as a few antiviral genes were still induced during SBV infection (Blomström et 
al., 2015). 
SBV NSs is also able to enhance the rate of apoptotic cell death in vitro (Barry et al., 2014). 
 
 
 
 
In domestic ruminants, SBV is responsible for a range of clinical signs and lesions that are 
similar to those found in association with CVV and AKAV. By analogy with these 
extensively-studied viruses, we could develop working hypotheses on the pathogenesis of the 
lesions that will be discussed along with the corresponding experiments later in the 
manuscript. Results from recent in vitro and in vivo studies of SBV brought additional pieces 
of information on the consequences of SBV infection at the cellular and molecular level. 
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2.4 Impact on livestock farming, on wild ruminants 
 
The impact of SBV epizootics on livestock have been evaluated through several studies. A 
SBV-affected herd was defined as a herd with malformed offspring with laboratory 
confirmation of SBV infection (Dominguez et al., 2014; Harris et al., 2014; Saegerman et al., 
2014); or as a herd with clinical signs in adult cattle or malformed newborns consistent with 
SBV infection (Veldhuis et al., 2014a); or as a herd with clinical signs in adult cattle or 
malformed newborns and laboratory confirmation of SBV infection (Afonso et al., 2014). One 
study compared farms which had sent samples to laboratories for SBV testing versus farms 
which had not send samples for SBV testing (Poskin et al., 2015). 
 
SBV impact in infected herds originated mainly from stillbirth or malformations in fetuses 
and neonates (Dominguez et al., 2014; Poskin et al., 2015; Raboisson et al., 2014). This 
affected offspring could not be bred and sold, leading to money loss. As an example, in beef 
suckler farms, SBV impact has been estimated to reach 26€ to 43€ per cow per year in France 
and 29€ to 36€ per cow per year in the United Kingdom (Raboisson et al., 2014). Besides, 
emotional impact has been reported in sheep farmers, due to the sight of malformations and to 
the stress raised by this new disease (Harris et al., 2014).  
 
The impact on adults was evaluated as limited, resulting mainly from dystocia in sheep and 
cattle (Poskin et al., 2015) and from milk loss in dairy cattle (Veldhuis et al., 2014a). In the 
Netherlands, in dairy cattle from SBV-affected herds, the average milk loss was 1.71kg per 
day per cow in the four weeks defined as SBV-infection period in August and September 
2011 (Veldhuis et al., 2014a). Impact on fertility was not evaluated in every study. In dairy 
cattle, fertility parameters showed a slight reduction in SBV-affected herds in Germany and 
the Netherlands in 2011 (Veldhuis et al., 2014b). In 2012, in SBV-affected farms, a 2-fold 
reduction in prolificacy was observed in ewes in Belgium (Saegerman et al., 2014) while goat 
and sheep farmers reported more frequent repeated estrus or early embryonic deaths in France 
(Dominguez et al., 2014). 
 
Between species, morbidity and malformation rates associated to SBV infection differed, as 
shown in Table 4. In SBV-affected herds in France in 2012-2013, the median frequency of 
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offspring morbidity (stillbirth or malformation) was significantly higher in lambs than in 
calves or kids (Dominguez et al., 2014). Considering SBV impact as resulting mainly of 
affected offspring, SBV impact has therefore been higher in sheep farms than in goat or cattle 
farms. 
 
 
Table 4. Impact of SBV infection in domestic ruminants in Europe and France, by species. 
Context of the study Reference  Cattle Goats Sheep 
Europe, August 
2011- April 2013 
(Afonso et al., 
2014) 
Confirmed herds 5,281 136 2,917 
  Herds with AHS observed 89% 91% 93% 
  Herds with AHS observed > 1 0.34% 0.00% 5.15% 
  
Herds with acute infection in 
adults 
6% 1% 3% 
France, 2012-2013 
(Dominguez 
et al., 2014) 
Dead or deformed offspring in 
affected herds (mean ± std dev) 
7.1% 
±18.4% 
4.8% 
±27.5% 
15.7% 
±30.4% 
  
AHS in affected herds (mean ± 
std dev) 
2.9% 
±13.0% 
1.7% 
±2.6% 
7.8% 
±11.8% 
AHS: arthrogryposis-hydranencephaly syndrome 
 
 
In addition to its impact on livestock and farming, SBV had an economic impact on European 
trade due to trade restrictions. The United States of America have banned importation of 
ruminant semen and embryos collected before June 1, 2011 in Europe since February 2012 
(USDA APHIS, 2015). Other countries outside Europe restricted cattle semen trade, leading 
overall to a drop of 11 to 26% in the number of semen doses exported outside Europe in 2012 
(EFSA, 2014).  
 
Although the impact on livestock has been evaluated, the impact on wild and exotic ruminants 
remains unknown. 
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2.5  Diagnostics and preventive measures  
 
2.5.1 Diagnostics 
 
Clinical disease in adults is mild or absent, hence SBV diagnostics cannot rely upon clinical 
signs. In addition, malformations in the offspring are not specific of SBV infection: in Europe, 
similar malformations can be found after infection of the pregnant female by other viruses 
(Border disease virus (BDV), BTV, and Bovine viral diarrhea virus (BVDV)) or after 
ingestion of lupine by the pregnant female. Outside Europe, possible causes would include 
AKAV (Spickler, 2009) and Aino virus (Tsuda et al., 2004). 
Diagnostics of SBV infection can be achieved by isolation of SBV or detection of SBV 
genome in samples from the animal (direct diagnosis) or by detection of the serological 
reaction of the animal following SBV infection (indirect diagnosis). 
 
2.5.1.1 Direct diagnosis 
 
2.5.1.1.1.1 Detection of infectious virus  
 
Virus isolation is one technique that allows detection of infectious virus. Virus isolation of 
SBV can be performed on several types of cells: KC cells (Culicoides variipennis larvae 
cells), BHK-21 cells (baby hamster kidney cells), and Vero cells with a cytopathic effect on 
the latter two (Hoffmann et al., 2012b; Van Der Poel et al., 2013). In addition, SBV has been 
reported to grow efficiently in other cell lines, especially in CPT-Tert cells, which are sheep 
choroid plexus cells immortalized with the simian virus 40 (SV40) T antigen and human 
telomerase reverse transcriptase (hTERT) (Arnaud et al., 2010; Elliott et al., 2013; Varela et 
al., 2013). 
 
Alternatively, infectious virus can be detected after inoculation on IFN
-/- 
mice. After 
inoculation with infectious SBV, these mice can lose weight and even die (Wernike et al., 
2012a) or only show viremia and seroconversion (Sailleau et al., 2013b; Ponsart et al., 2014). 
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2.5.1.1.1.2 Detection of viral genome by RT-qPCR 
 
Protocols for RT-qPCR have been developed at the same time the virus was discovered 
(Hoffmann et al., 2012b). The most widely used protocol is the SBV-S3 assay targeting the S 
segment (Bilk et al., 2012). A comparison between several RT-qPCR assays showed that this 
SBV-S3 assay is the most sensitive while another assay targeting the M segment (SBV-M1) is 
the most specific for detection of SBV RNA (Fischer et al., 2013b). New methods are being 
developed to allow for PCR testing outside the laboratory, via transportable devices 
(Aebischer et al., 2014) 
 
Viral genome can be detected in blood or serum samples, but RNAemia seems to be short-
lasting in cattle: about a week (Hoffmann et al., 2012b; Wernike et al., 2013a). Nevertheless, 
SBV RNA has been found at two-week intervals in blood samples from lambs in the field in 
2012, suggesting a longer viremia in sheep than in cattle (Claine et al., 2013). 
In malformed fetuses or newborns, SBV RNA is mostly found in placental fluids, the 
umbilical cord and the CNS (Bilk et al., 2012). According to one study on sheep and cattle, in 
the CNS, the brain stem is the sample in which SBV RNA is most likely to be detected (De 
Regge et al., 2013).  
However, SBV RNA is not so often found in malformed offspring. After testing of 348 lambs 
showing arthrogryposis and hydranencephaly in 2011-2012 in the Netherlands, SBV RNA 
was found in only 40% of lambs while antibodies against SBV were detected in 90%, and in 
58% of 111 calves (van Maanen et al., 2012). Similar results were obtained in Belgium; the 
absence of SBV RNA associated with presence of antibodies against SBV was interpreted by 
the authors as a viral clearance, maybe via the humoral response (De Regge et al., 2013). 
Therefore, in malformed fetuses or newborns, diagnostic of SBV infection would be best 
achieved through serological testing together with genome detection.  
 
2.5.1.1.1.3 Detection of viral antigen in tissue slices by immunohistochemistry 
 
SBV immunohistochemistry (IHC) aims at revealing SBV antigens in tissue slices. Protocols 
have been performed on paraffin-embedded, formalin-fixed tissue samples. In one protocol, 
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the primary antibody was a monoclonal antibody raised against Tinaroo virus (Peperkamp et 
al., 2012). Later, a polyclonal antibody raised against SBV nucleoprotein was employed in 
another protocol (Varela et al., 2013). The resulting staining was cytoplasmic, as expected for 
a virus with cytoplasmic replication. In SBV-infected calves and lambs, target cells were 
neurons in the cerebral cortex, brainstem and spinal cord (Peperkamp et al., 2012; Varela et 
al., 2013). 
 
 
2.5.1.1.1.4 Detection of viral genome in tissue slices by in situ hybridization 
 
In situ hybridization (ISH) allows visualization of SBV genome in tissue slices. One protocol 
has been developed on paraffin-embedded, formalin-fixed tissue samples, with a probe 
detecting a part of the S segment (Hahn et al., 2013). Positive cells in the CNS of SBV-
infected young ruminants appeared as randomly distributed clusters of neurons in cerebrum, 
cerebellum, brain stem, medulla oblongata, and spinal cord (Hahn et al., 2013). However, this 
technique has a low sensitivity: only 10 out of 82 SBV RT-qPCR positive animals were ISH-
positive  (Hahn et al., 2013). 
 
2.5.1.2 Indirect diagnosis: Serology 
 
2.5.1.2.1 Humoral immune response to SBV 
 
2.5.1.2.1.1 In the adult 
 
The immune response to SBV has been described mostly in cattle. After SBV inoculation to 
naïve cows, antibodies against SBV were detected between 14 and 21 dpi (Wernike et al., 
2013a). The effect on lymphoid populations in blood has been characterized in the same 
study. The absolute number of IgM +B lymphocytes, but not of CD8+T lymphocytes, 
increased in peripheral blood for 10 days after infection, suggesting humoral response, but not 
T-cell-mediated cytotoxicity, is involved in virus clearance after first infection in adult cows 
(Wernike et al., 2013a).  
As yet, antibody persistence has not been fully characterized. In cattle in the field, specific 
antibodies have been shown to persist at least 2 years (Elbers et al., 2014).  
35 
 
Via colostrum intake, the offspring of ruminants absorb the maternal antibodies and acquire 
passive immunity for a limited amount of time. In calves, maternal antibodies against SBV 
are lost 5 to 6 months after birth (Elbers et al., 2014). Therefore, in cattle, vaccination should 
not be done before the calves are 6 months-old. 
 
2.5.1.2.1.2 In the fetus  
 
Ruminants have a synepitheliochorial placenta that blocks any exchange of antibody from the 
mother to the fetus. The newborn gains access to maternal antibodies via colostrum intake 
only. Therefore, if the fetus mounts a humoral response during pregnancy, this response can 
be detected in newborns before colostrum intake. 
SBV infection in a ruminant fetus during pregnancy can elicit a humoral response from the 
fetus. Antibodies against SBV have been detected in 90% of 348 lambs and in 58% of 111 
calves showing arthrogryposis and hydranencephaly in 2011-2012 in the Netherlands (van 
Maanen et al., 2012). 
The window in which SBV infection would trigger antibody production in the fetus is not 
known. Nevertheless, data from experimental infection with the closely related AKAV 
indicate this window may be large: neutralizing antibodies were detected from the serum in 
newborn lambs after inoculation between 28 and 101 dg (Hashiguchi et al., 1979), and in 
newborn goats after inoculation between 40 and 115 dg (Kurogi et al., 1977).  
 
2.5.1.2.2 Detection of antibodies against SBV 
 
Several techniques are available to look for antibodies against SBV in a serum sample. 
Reference sera from seropositive sheep and cattle have been validated through an 
interlaboratory trial and are now available (van der Poel et al., 2014). 
 
2.5.1.2.2.1 Indirect immunofluorescence assay 
 
Indirect immunofluorescence assays can be performed on plates containing SBV-infected 
BHK-21 cells (clone BRS5) as antigen matrix (Bréard et al., 2013). However, this technique 
may be the least sensitive for detection of antibodies to SBV (Bréard et al., 2013). 
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2.5.1.2.2.2 Viral neutralization 
 
Several protocols of viral neutralization have been described (Bréard et al., 2013; Loeffen et 
al., 2012; Mansfield et al., 2013). They are based on the ability of neutralizing antibodies to 
prevent the cytopathic effect SBV can elicit in Vero or BHK cells. Viral neutralization is 
often considered as a gold standard for detection of SBV antibodies (Bréard et al., 2013; van 
der Heijden et al., 2013). Viral neutralization combines two advantages as a serological tool. 
First, it can be performed on samples from all kind of animal species, because it is not 
species-specific. Second, it provides a quantitative result, allowing to follow the evolution of 
antibody titers in time for a given animal (Mansfield et al., 2013). However, viral 
neutralization has disadvantages: each test is time-consuming (it lasts about 6 days) and 
cannot be automated (Bréard et al., 2013).  
 
2.5.1.2.2.3 ELISA 
 
ELISA testing is a faster method than viral neutralization, allowing for testing a larger number 
of samples in the same amount of time. First, indirect ELISA assays were available: one based 
on a recombinant SBV nucleoprotein antigen (Bréard et al., 2013), the other based on whole 
SBV virus (van der Heijden et al., 2013). A competitive ELISA was later commercialized (ID 
Screen® Schmallenberg virus Competition Multi-species, IDvet Laboratories, Montpellier, 
France). 
Albeit more practical, ELISA may be slightly less sensitive than VNT to detect SBV 
antibodies, especially SBV nucleoprotein antigen-based indirect ELISA (van der Poel et al., 
2014; Poskin et al., 2014b). 
 
In addition to serum, milk samples can be submitted to ELISA testing (but not to viral 
neutralization because of the milk toxicity on cells). ELISA can be performed on milk 
samples either from bulk tank to evaluate the exposure of dairy cattle at the farm level 
(Balmer et al., 2014; Humphries and Burr, 2012; Johnson et al., 2014; Tarlinton and Daly, 
2013), or from individuals to identify which cows have been exposed to SBV (Daly et al., 
2015). 
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2.5.2 Preventive measures 
 
Contrary to what happened with BTV-8, animal movements have not been restricted in 
Europe during the SBV outbreak. Retrospectively, modelling of SBV spread in the United 
Kingdom indicates that a movement ban would have had a very limited influence on virus 
spread (Gubbins et al., 2014a). Indeed, midge dispersal is considered as the main transmission 
route of SBV (Gubbins et al., 2014a, 2014b; Sedda and Rogers, 2013).  
Suitable measures include defense against midges and early acquisition of anti-SBV 
immunity. Preventive measures have been developed for livestock animals, but could also 
apply to wild and exotic ruminants kept in captivity. 
 
 
2.5.2.1 Protection against midges 
 
A topic treatment against external parasites may be used during the period of maximal activity 
of Culicoides spp., i.e. summer months (Helmer et al., 2013) and during the window of 
susceptibility of pregnant females. Deltamethrin, a pyrethroid, has been shown to decrease 
Culicoides feeding rates for 35 days in sheep (Weiher et al., 2014). 
Permanent housing may limit the exposure to midges (Helmer et al., 2013). If grazing is 
required, then the animals should be back indoors before sunset, because midges’ activity is 
greatest around sunset (Koenraadt et al., 2014). 
Insect traps may help to reduce the number of midges in barns (Helmer et al., 2013). As the 
Culicoides species implicated in SBV transmission breed on dung (Lühken et al., 2014), 
frequent dung removal may also limit the number of midges that develop in barns. 
In sheep, mating after August decreased the odds of malformations in lambs in 2011 
(Luttikholt et al., 2014), probably due to decreased exposure to midges during the window of 
susceptibility of pregnant ewes. Therefore, in order to protect pregnant females, the mating 
period can be scheduled to coincide with the months of decreased abundance of Culicoides 
spp. Thus, the insemination would be planned in October or November for goats (Helmer et 
al., 2013) and sheep. 
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Protection against midges can decrease the risk of exposure to SBV, however contact between 
ruminants and midges cannot be totally avoided. It is safer to make the animals gain immunity 
against SBV. 
 
 
 
2.5.2.2 Protection by development of acquired immunity against SBV 
 
Given the impact of SBV is mostly due to offspring morbidity, the individuals to be protected 
are the naïve females that are going to breed. In sheep, natural immunity seems to protect 
pregnant ewes against SBV reinfection (Rodríguez-Prieto et al., 2014). If vaccines are not 
available, the farmer should move naïve females to an area where SBV is known to circulate 
before mating time, as advised for AKAV (Anonymous, 2013). Vaccination is however more 
convenient and reliable. 
 
Inactivated SBV vaccines candidates have been produced after growth on baby hamster 
kidney (BHK-21) and monkey kidney (MA-104) cell lines, with saponine and aluminium 
hydroxide as adjuvants. After two consecutive administrations in sheep and cattle, followed 
by challenge infection, several candidates elicited a neutralizing antibody response and were 
able to prevent RNAemia (Wernike et al., 2013c). One of the MA-104 based candidates has 
been showed to work as well with a single injection in sheep (Hechinger et al., 2014). Two 
inactivated vaccines have been available with a Market Authorization for cattle and sheep 
since 2013 (British Veterinary Association, 2013; Merial, 2013). The length of immunity after 
vaccination remains unknown in cattle and sheep. As yet, no vaccine is available for goats.  
Furthermore, pilot studies on deletion mutants of SBV showed promising for production of 
live attenuated vaccines in the future. A double deletion mutant lacking NSs and NSm was 
able to induce seroconversion in cattle and to protect them after SBV challenge. Live 
attenuated vaccines are of interest because they are often more efficacious than inactivated 
vaccines (Kraatz et al., 2015). 
 
Vaccination combines two advantages: it protects the individuals and it can also be used to 
break the SBV transmission chain. Modelling studies revealed this tactical approach could be 
beneficial to reduce SBV spread even if only cattle are vaccinated (Bessell et al., 2014). 
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3 AIMS OF THE THESIS 
 
The studies presented in this document were carried out to describe and understand the 
consequences of SBV infection in domestic ruminants, on the one hand, and to explore the 
exposure of free-ranging or captive wild and exotic ruminants to SBV, on the other hand. 
 
As to SBV infection in domestic ruminants, the specific objectives were: 
- In non-pregnant adult ruminants: 
 To describe the clinical signs, the kinetics of viremia and seroconversion, 
the distribution of the virus and the lesions after SBV infection in non-
pregnant adult sheep and goats; to formulate hypotheses on the 
pathogenesis of these lesions; 
 To establish a reliable goat model of SBV infection. 
- In pregnant goats: 
 To identify the window of susceptibility of the growing embryo or fetus; 
 After SBV inoculation in this window: to describe the outcome of 
pregnancy, the distribution of the virus in fetuses, and the lesions in 
fetuses; to formulate hypotheses on the pathogenesis of these lesions. 
- In goats around the time of insemination: 
 To evaluate the effects of SBV infection on the hypothalamic-pituitary-
ovarian axis and on the outcome of the fecundation; 
 To determinate the consequences of intravaginal inoculation of SBV. 
 
Regarding exposure of wild and exotic ruminants to SBV, the specific objectives were: 
- In free-ranging wild ruminants: to evaluate the spread of SBV in France in 2011-2012 
; 
- In captive wild and exotic ruminants, in France and in the Netherlands: 
 To identify the species susceptible to SBV infection; 
 In these species, to describe the clinical signs and lesions associated to 
SBV infection. 
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4 EXPERIMENTS 
 
4.1 Pathogenesis in domestic ruminants 
 
 
4.1.1 Infection of adult sheep  
 
Experimental inoculation of adult sheep with SBV was performed in several laboratories in 
order to describe the clinical signs, the kinetics of viremia and seroconversion, and the 
distribution of the virus and the lesions. The results have been gathered in the following 
paper, published in Veterinary Microbiology (Wernike et al., 2013d).  
 
I participated in necropsies, sample collection, histological analyses, and RT-qPCR assays. 
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1. Introduction
In late 2011 a novel orthobunyavirus of the Simbu
serogroup, referred to as ‘‘Schmallenberg virus’’ (SBV), was
discovered near the German-Dutch border and thereafter
spread rapidly to other European countries (European Food
Safety Authority, 2012; Hoffmann et al., 2012). Recently, it
has been shown that SBV is most related to Douglas and
Sathuperi virus (Goller et al., 2012). Affected adult cattle
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A B S T R A C T
Since late 2011, a novel orthobunyavirus, named Schmallenberg virus (SBV), has been
implicated in many cases of severely malformed bovine and ovine offspring in Europe. In
adult cattle, SBV is known to cause a mild transient disease; clinical signs include short
febrile episodes, decreased milk production and diarrhoea for a few days. However, the
knowledge about clinical signs and pathogenesis in adult sheep is limited.
In the present study, adult sheep of European domestic breeds were inoculated with
SBV either as cell culture grown virus or as virus with no history of passage in cell cultures.
Various experimental set-ups were used. Sampling included blood collection at different
time points during the experimental period and selected organ material at autopsy.
Data from this study showed, that the RNAemic period in sheep was as short as
reported for cattle; viral genome was detectable for about 3–5 days by real-time RT-PCR. In
total, 13 out of 30 inoculated sheep became RNAemic, with the highest viral load in
animals inoculated with virus from low cell culture passaged or the animal passaged
material. Contact animals remained negative throughout the study. One RNAemic sheep
showed diarrhoea for several days, but fever was not recorded in any of the animals.
Antibodies were ﬁrst detectable 10–14 days post inoculation. Viral RNA was detectable in
spleen and lymph nodes up to day 44 post inoculation.
In conclusion, as described for cattle, SBV-infection in adult sheep predominantly results
in subclinical infection, transient RNAemia and a speciﬁc antibody response. Maintenance of
viral RNA in the lymphoreticular system is observed for an extended period.
 2013 Elsevier B.V. All rights reserved.
* Corresponding author. Tel.: +49 38351 71200; fax: +4938351 7 275.
E-mail address: martin.beer@ﬂi.bund.de (M. Beer).
1 Present address: Institute of Veterinary Pathology, Department of
Veterinary Medicine, Freie Universita¨t Berlin, Oertzenweg 19b, 14163
Berlin, Germany.
Contents lists available at ScienceDirect
Veterinary Microbiology
jo u rn al ho m epag e: ww w.els evier .c o m/lo cat e/vetmic
0378-1135/$ – see front matter  2013 Elsevier B.V. All rights reserved.
http://dx.doi.org/10.1016/j.vetmic.2013.06.030
show none or only mild clinical signs, however, an
infection of SBV-naı¨ve cows and ewes during a critical
period of pregnancy may lead to severe foetal malforma-
tions (Garigliany et al., 2012; Herder et al., 2012); reviewed
in (Beer et al., 2013; Wernike et al., 2013b). Insect vectors
play an essential role in the spread of SBV; viral genome
has been detected in different ﬁeld collected Culicoides spp.
(De Regge et al., 2012; Rasmussen et al., 2012).
Based on an experimental infection study with calves,
the viraemic period in cattle seems to be short (Hoffmann
et al., 2012). However, very little is known about the
duration of viraemia as well as the progress of the disease
and development of antibodies to SBV in adult sheep. In the
present study, two different types of inoculum were
compared regarding the ability to induce RNaemia and
humoral immunity in sheep: culture-grown virus and an
SBV ﬁeld strain that was passaged in cattle only (delivered
as infectious serum). In addition, to investigate the tissue
tropism and potential persistence in any of the organ
systems, the animals were euthanized at different time
points after infection and analyzed for the presence of SBV.
2. Materials and methods
All experimental protocols were reviewed by a state
ethics commission and have been approved by the
competent authority (Denmark: Danish Animal Experi-
mentation Inspectorate, licence no. 2008/561-1541; France:
‘‘Secre´tariat Permanent du Comite´ d’Ethique en Expe´ri-
mentation Animale Val de Loire’’ C 37-175-3, 21 of June
2012; Germany: State Ofﬁce for Agriculture, Food Safety and
Fisheries of Mecklenburg-Vorpommern, Rostock, Germany,
ref. LALLF M-V TSD/7221.3-1.1-004/12).
2.1. Inocula
Two different types of inoculum were used in the
different experiments: (1) cell culture-grown SBV, and (2)
cattle serum containing SBV.
Cell culture grown SBV was produced as follows: For
group A and B, virus was isolated from cow blood on KC
cells (cell line L1062, Collection of Cell Lines in Veterinary
Medicine, Friedrich-Loefﬂer-Institut, Insel Riems,
Germany; derived from Culicoides variipennis midges
(Wechsler et al., 1991)). After initial isolation on KC cells as
previously described (Hoffmann et al., 2012) the virus was
passaged ﬁve times in baby hamster kidney (BHK) cells
(cell line L0164) (inoculum I: KC/BHK5), alternatively once
in BHK cells, again in KC cells and again in BHK cells
(inoculum II: KC/BHK/KC/BHK). For group C, virus was
isolated from lamb brain and passaged 3 times on Vero
cells (inoculum III: Vero). Inoculum I contained 106.2 tissue
culture infectious doses per ml (TCID50/ml), inoculum II
107 TCID50/ml and inoculum III contained 10
8 TCID50/ml,
as determined by end-point titration on the respective
cells.
Cattle serum containing SBV was collected for group E
and F. Brieﬂy, a whole blood sample of a SBV-positive cow
was injected into another heifer, two and three days after
inoculation serum was taken, tested in further cattle
regarding infectivity and stored at 70 8C until use
(Wernike et al., 2012).
2.2. Sheep and experimental design
The animal experiments were conducted at different
time points in the BSL-3 facilities of the National
Veterinary Institute, Lindholm, Denmark, of the Plate-
Forme d’Infectiologie Expe´rimentale, Institut National de
la Recherche Agronomique, Tours, France and of the
Friedrich-Loefﬂer-Institut, Insel Riems, Germany.
An overview of the experimental setup is shown in
Fig. 1. In total 37 SBV-naı¨ve adult sheep of European
domestic breeds were assigned to 7 groups. Male and
female animals were distributed equally. Twenty-three
sheep in 3 groups were inoculated with culture-grown
virus: 4 sheep received 1 ml of inoculum I subcutaneously
(s.c.) (group A), 3 animals received 1 ml of inoculum II s.c.
Fig. 1. Experimental design. Animal groups highlighted in the same colour were housed together. (For interpretation of the references to color in this ﬁgure
legend, the reader is referred to the web version of the article.)
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(group B) and 16 were intramuscularly inoculated with
2.5 ml of inoculum III (group C). Two groups (E, F) of 4 and 3
animals respectively received 1 ml of the infectious cattle
serum s.c. Seven sheep in two groups (D, G) were injected
with 1 ml phosphate-buffered saline s.c. and kept as
controls. Groups B, F and G were housed together and
group C was kept together with group D.
All animals were monitored for clinical signs every day,
rectal body temperatures were measured daily and serum
samples were taken at regular intervals. Sequential killing
was performed (see Fig. 1) and a large panel of organ
materials was collected at autopsy, including ﬁne dissec-
tion of genital tracts (Table 1).
2.3. Real-time PCR and serology
RNA from serum samples was extracted using the
MagAttract Virus Mini M48 Kit for automated extraction
(Qiagen, Germany) or MagNA Pure LC Total Nucleic Acid
Isolation Kit (Roche, Denmark) or QiaAmp Viral RNA Kit
(Qiagen, France) according to the manufacturer’s recom-
mendations.
SBV genome load was determined in all laboratories by
the S segment-speciﬁc real-time reverse transcription PCR
(RT-qPCR) as described previously (Bilk et al., 2012). The
tissue samples collected at autopsy were homogenized;
RNA was extracted and tested by RT-qPCR as well.
Serum samples were analyzed with a commercially
available SBV antibody ELISA (ID Screen1 Schmallenberg
virus Indirect, IDvet, France) (Breard et al., 2013).
3. Results
3.1. Clinical observation and pathology
One sheep (S03; see Fig. 1) had diarrhoea for 4 days (days
8 to 11 after inoculation [dpi]), and 2 sheep (S03 and S04)
had a snotty nose for about 1 week (starting at dpi 15 and dpi
8, respectively); well being and appetite were never
depressed in any animal. Body temperatures were within
a normal range for all animals, and no fever peak was seen.
Apart from slightly enlarged mesenteric lymph nodes of
S06 and S32-S34 autopsy did not reveal any signiﬁcant
gross lesions.
3.2. Real-time PCR and serology
In all sheep of group A, viral RNA was detected in serum
for 4 or 5 days, starting at dpi 1, 2 and 4, respectively
(Fig. 2). Antibodies were found in S02 from dpi 10, S03 from
day 14 and S04 from dpi 22 onwards by ELISA. In S01,
which was euthanized one week after infection, no
antibodies could be detected (Fig. 3A).
In 2 out of 3 animals of group B, SBV genome was
detectable in serum for 3 days (dpi 3–5 and dpi 4–6), while
in sheep S05 for 5 days (dpi 4–8) (Fig. 2). In S05 antibodies
were detected 14 days after infection for the ﬁrst time, in
S06 after 21 days and S07 remained below cut-off until
euthanized on dpi 29 (Fig. 3A).
Viral RNA could not be detected in serum in the animals
of group C (Vero) at any time (Fig. 2). Nevertheless, in 6 out
of 12 of these animals, which were euthanized at dpi 27,
SBV-speciﬁc antibodies were found (see Fig. 3B).
Six out of 7 sheep inoculated with infectious serum
(group E and F) showed detectable amounts of viral RNA
from dpi 2 until dpi 5, 6 or 7 (Fig. 2). Antibodies were found
Fig. 2. RT-qPCR results for serum.
Fig. 3. Results of the SBV antibody ELISA of the groups A, B, F, G (3A) and C
(3B). Animals of group E were slaughtered 7 days after inoculation, no
serological tests were performed.
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Table 1
RT-qPCR results for organ samples taken at autopsy.
Sample material A: KC/BHK5 B: KC/BHK/KC/BHK C: Vero E: infectious serum F: infectious serum G: control
S01 S02 S03 S04 S05 S06 S07 S08 S09 S10 S11 S28 S29 S30 S31 S32 S33 S34 S35 S36 S37
7 dpi 10 dpi 44 dpi 44 dpi 29 dpi 29 dpi 29 dpi 4 dpi 4 dpi 4 dpi 4 dpi 7 dpi 7 dpi 7 dpi 7 dpi 29 dpi 29 dpi 29 dpi 29 dpi 29 dpi 29 dpi
Serum – – – – – – – – – – – – – – – – – – – – –
Cerebellum 35.4 29.8 – – – – – – – – – – – – – – – – – – –
Cerebrum – – – – – – 39.0 – – – – – – – – – – – – – –
Medulla – – – – – – – – –
Ovary – – – 43.3
Cumulus cells – – – –
Oocytes – – – –
Follicular ﬂuid – – – –
Uterus – – – – – – – – –
Epididymis – – – –
Testicle – – – – – – – –
Seminal vesicle – – – –
Aorta artery – – – – – – – – – – – – – – – – –
Heart – – – – – – – – – – – – – – – – –
Lung 37.9 41.1 40.7 – – – – – – – – – – – – – – – – – –
Kidney – 38.9 39.1 39.0 – – 36.5 – – – – – – – – – – – – – –
Liver – – – – – – – – – – – – – – – – –
Jejunum incl.
Peyer’s Patches
– – – – – – – – –
Skin – – – – – – – – –
Muscles inoculation site – – – – – – 31.4 – – – – 44.6 – – – – –
Lymph node
inoculation site
– 38.7 – 37.1 – 34.7 – – 34.2 34.4 36.1 – – – – – –
Mandibular lymph node – – – 40.6 – – – – –
Mesenteric lymph node 22.1 22.7 27.5 29.8 41.1 35.8 33.9 – – 41.5 – – –
Spleen 28.5 27.8 27.2 28.9 – – 28.6 – – – – 38.8 31.2 38.4 30.8 33.5 – – – – –
Tonsil – – – 38.8 – – – – –
–, no Cq value after 45 cycles.
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in two sheep between dpi 10 and 14 by ELISA for the ﬁrst
time (Fig. 3A), 4 further animals were euthanized one week
after inoculation, no antibodies were detected (data not
shown). In the remaining sheep (S33) as well as in all in-
contact animals viral RNA was not detectable at any time
(see Fig. 2) and none of them showed any antibody response.
Viral RNA was detected in the spleens of 10 animals, the
mesenteric lymph nodes of 8 sheep, the lymph nodes close
to the inoculation site of 6 animals, the mandibular lymph
node of one sheep, one tonsil sample, in the kidney of 4
sheep, in the ovarian tissue of 1 ewe, the muscle samples
taken at the area of inoculation of 2 sheep, in lung samples
of 3 animals, the cerebellum of two sheep, and in one
cerebrum sample (Table 1).
4. Discussion
In late 2011, SBV was identiﬁed for the ﬁrst time in blood
samples of diseased adult cows by a metagenomic approach.
Thereafter, the virus has been implicated in many cases of
severely malformed bovine, but also ovine offspring (Beer
et al., 2013; Dominguez et al., 2012; Garigliany et al., 2012;
Herder et al., 2012; Lievaart-Peterson et al., 2012). Though
more than 90% of sheep from Dutch herds known to be
infected or suspected to be so are seropositive (Loeffen et al.,
2012), no clinical signs in adult sheep have been reported in
the period of presumed infection. After natural or experi-
mental SBV infection of cattle, affected animals showed
fever, decreased milk production and diarrhoea for a few
days (Hoffmann et al., 2012). In the present study, a short
RNAemia, as previously reported for cattle (Hoffmann et al.,
2012; Wernike et al., 2012), was observed in the sheep
experimentally inoculated in this study, while only one
single sheep out of 13 RNAemic animals showed clinical
signs (diarrhoea) for several days as well. Therefore, our
results in recently published analyses and the study
presented here suggest a rather similar course of SBV-
infection both in sheep and cattle.
RNAemia was not induced by all types of inoculation
materials. Following inoculation with SBV isolated from a
brain of a lamb on Vero cells, RNA was for example not
detectable in serum samples despite a very high cell
culture titre of about 108 TCID50/ml. In contrast, RNAemia
was induced by the virus isolated from the blood of a cow
on KC cells and passaged on BHK-cells. A possible
explanation for the change in virus phenotype, including
a reduced virulence in the natural host, could be a selection
of attenuated variants after passages in cell culture. This
phenomenon has also been described for several other
bunyaviruses (Griot et al., 1993; Lundkvist et al., 1997;
Ogawa et al., 2007). Further explanations are (1) the
different origins of the sample materials from which
viruses were isolated (blood of a diseased adult cow vs.
brain material from a malformed new-born lamb), (2) the
initial switch between cell lines of mammalian and insect
origin or (3) the different route of inoculation (i.m. vs. s.c.).
Nevertheless, differences in virulence of SBV have not been
observed between subcutaneously and intravenous inocu-
lation of cattle with PCR-positive blood (Hoffmann et al.,
2012); intramuscular inoculation of caprine foetuses with
the closely related Akabane virus (AKAV) led to typical
lesions such as encephalomyelitis and polymyositis
(Konno and Nakagawa, 1982). Consequently, it is very
likely that the cell culture adaptation may be responsible
for the absence of RNAemia. However, further sequence
analyses and studies based on reverse genetics are
necessary for clariﬁcation.
Despite the lack of RNAemia in serum samples from all
animals of group C, half of the animals became positive in
the SBV-ELISA. Furthermore, inoculation with virus,
isolated from the blood of a cow on KC cells, did not
result in seroconversion in two sheep. One of them had
already been euthanized after one week, and referring to
similar observations for AKAV, it was killed before a
detectable amount of antibodies could be induced (Inaba
and Matumoto, 1990; Radostits et al., 2007).
One sheep inoculated with infectious serum showed
neither RNAemia nor seroconversion, which could be
caused by failed injection or interpreted as a status of
resistance to SBV infection. A missing RNAemia has also
been seen for Bluetongue virus. Albeit consistently PCR-
negative sheep seroconverted, antibodies were detected
later after inoculation and in lower titres than in RNAemic
animals (Eschbaumer et al., 2009; Wa¨ckerlin et al., 2010).
Whether the same is true for SBV and sheep without
RNAemia develop neutralizing antibodies later after
inoculation requires further investigation.
In conclusion, both infectious serum and low passage cell
culture material is a viable option for an SBV-infection
model. Nevertheless, all materials have to be ﬁrst evaluated
in an in vivo study, and passaging of SBV imposes the risk of a
complete loss of virulence and infectivity in the natural host.
As soon as serum passaged in sheep only becomes available,
this material should be also tested to allow a comparison to
the cattle-derived materials.
Detection of viral RNA in lymph nodes, particularly in
the mesenteric lymph node, and spleen samples taken at
autopsy (up to day 44) indicates an afﬁnity to and possible
persistence in the lymphoreticular system; identical
observations have been reported recently in cattle also
(Wernike et al., 2012, 2013a). In one ewe, viral RNA was
detected in the ovarian tissue taken 7 days after inocula-
tion. To our knowledge, this is the ﬁrst evidence showing
that the virus may be present in the genital tract after
experimental infection. This ﬁnding is in agreement with a
previous report dedicated to Akabane virus in cattle
(Parsonson et al., 1981). However, no RNA was detected
from the male genital tract in contrary to recent ﬁndings
regarding semen in bulls (ProMED-mail, 2012a,b).
Further studies will be necessary to determine the
relevance of these ﬁndings and the role for pathogenesis of
SBV.
In summary, the short RNAemia, the mild or absent
clinical symptoms and the persistence of viral RNA in the
lymphoreticular system shows that SBV infection of adult
sheep is very similar to that of adult cattle.
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4.1.2 Infection of adult, non-pregnant goats  
 
Experimental inoculation of SBV to adult non-pregnant goat was performed in order to 
describe the clinical signs, the kinetics of viremia and seroconversion, and the distribution of 
the virus and the lesions in this species. This study included a follow-up of SBV excretion in 
buck semen. The results are detailed in the following paper, published in BMC Veterinary 
Research.  
 
I was involved in necropsies, sample collection, histological analyses, and RT-qPCR assays. I 
wrote the draft. 
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Abstract
Background: Schmallenberg virus (SBV) is an emerging Orthobunyavirus of ruminant livestock species currently
circulating in Europe. SBV causes a subclinical or mild disease in adult animals but vertical transmission to pregnant
dams may lead to severe malformations in the offspring. Data on the onset of clinical signs, viremia and
seroconversion in experimentally infected adult animals are available for cattle and sheep but are still lacking for
goats.
For a better understanding of the pathogenesis of SBV infection in adult ruminants, we carried out experimental
infections in adult goats. Our specific objectives were: (i) to record clinical signs, viremia and seroconversion; (ii) to
monitor viral excretion in the semen of infected bucks; (iii) to determine in which tissues SBV replication took place
and virus-induced lesions developed.
Results: Four goats and two bucks were inoculated with SBV. Virus inoculation was followed by a short viremic
phase lasting 3 to 4 days and a seroconversion occurring between days 7 and 14 pi in all animals. The inoculated
goats did not display any clinical signs, gross lesions or histological lesions. Viral genomic RNA was found in one
ovary but could not be detected in other organs. SBV RNA was not found in the semen samples collected from
two inoculated bucks.
Conclusions: In the four goats and two bucks, the kinetics of viremia and seroconversion appeared similar to those
previously described for sheep and cattle. Our limited set of data provides no evidence of viral excretion in buck
semen.
Background
In the late summer/autumn 2011, a disease outbreak with
diarrhea, drop of milk production, and fever was reported
in adult cattle in Western Europe. These symptoms
could not be attributed to any known infectious
agent. Metagenomic analyses on blood samples from
affected animals in Germany led to the identification
of a new Orthobunyavirus that was named the
Schmallenberg virus (SBV) [1]. This emerging virus
was later found to induce teratogenesis in pregnant
cattle, sheep, and goats leading to typical malforma-
tions in the offspring [2].
Experimental infections of adult sheep and cattle with
SBV resulted in subclinical infections with a short viremic
phase. Seroconversion in the infected animals occurred
about two weeks post inoculation (pi) [1, 3–5]. To our
knowledge, no report on the pathogenesis of experimental
SBV infections in adult goats has been published.
SBV is transmitted by biting midges (Culicoides spp.).
The possibility of sexual transmission between rumi-
nants has not yet been elucidated [2]. Infectious SBV has
been detected in bovine semen samples from the field
[6–8] and SBV RNA could be detected in semen from
experimentally infected bulls [9]. Whether SBV can be
excreted in buck semen is still unknown.
In this study, we carried out experimental infections of
SBV in adult goats. Our specific objectives were: (i) to
record the development of clinical signs, viremia and
seroconversion in goats; (ii) to monitor the excretion of
SBV in buck semen after inoculation; (iii) to determine
in which tissues SBV replication took place and virus-
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induced lesions developed in adult bucks and non-gravid
goats, with special emphasis on the genital tract.
Methods
All experiments were conducted in accordance with the
guidelines of the Council European Directive (2010/63/
UE). All experimental procedures were approved by the
ethical review board of the Val de Loire (CEEA VdL,
committee number n°19, number 2012-02-11).
Experimental design
Five adult Alpine goats, one adult Saanen buck and one
adult Alpine buck were purchased from local breeders
(INRA Center, Bourges, France) and were housed in the
Biosafety Level 3 and insect-proof animal facilities of the
National Institute of Agricultural Research (INRA),
Research Loire Valley Center (PFIE, Nouzilly, France).
All purchased animals were SBV-negative as determined
by ELISA and RT-qPCR.
Two goats (designated A and B) were inoculated sub-
cutaneously on day 0 with 1 mL of SBV-containing bovine
serum kindly provided by the Friedrich-Loeffler-Institut
(FLI), Germany [3]. Two goats (designated C and D) were
inoculated on day 0 with 1 mL of SBV-containing ovine
whole blood collected at the PFIE during a previous ex-
perimental infection trial [5]. One goat from each group
was killed at day 7 pi and the remaining goats were killed
at day 14 pi. The two bucks (designated E and F) were in-
oculated subcutaneously at day 0 with 1 mL of the FLI
serum and killed at day 28 pi. One goat (designated G)
was inoculated subcutaneously on day 0 with 1 mL of ster-
ile saline solution and served as an in-contact negative
control until it was killed at day 28 pi.
During the course of the trial, all animals were moni-
tored twice daily, and body temperatures were recorded
by telemetric measurement with rumen temperature
sensors (Small Bolus®, Médria, Châteaubourg–France).
After inoculation, whole blood and serum samples were
collected daily during the first week and then at days 14
and 28 pi. Buck semen was collected at day 0 and then
twice a week. At necropsy, all the organs were macro-
scopically evaluated and a panel of tissue samples was
collected for histopathology and RT-qPCR (spleen, pre-
scapular lymph node, skeletal muscle, aorta, liver, kidney,
lung, small intestine, brain, skin, ovary, oviduct, uterus,
testis, and epididymis).
Real-time PCR
Ovaries were dissected and follicular fluid, cumulus cells,
oocytes and interstitial tissue were separated from each
other prior to total RNA extraction. RNA from blood
and tissue samples was extracted using the LSI MagVet™
Universal Isolation kit (Life Technologies SAS, Saint-
Aubin, France) and King Fisher magnetic particle
processor (Thermo Scientific™, Illkirch, France) accord-
ing to the manufacturers’ instructions. RNA from semen
samples was extracted with Trizol ® LS Reagent [6].
The samples were then tested for the presence of SBV
RNA by RT-qPCR as previously described [10]. Quantifi-
cation cycle (Cq) threshold value was 40, with higher
values regarded as negative.
Serology
Serum samples were submitted to SBV specific ELISA test-
ing (ID Screen Schmallenberg virus Indirect®, monocupule,
IDvet) and virus neutralization test (VNT) [11].
Histopathological examination
After fixation in 10 % buffered formalin, tissues were
routinely processed, sliced at 4 μm, stained with
Hematoxylin-Eosin-Saffron (HES) and examined by
light microscopy.
Results
Clinical and post-mortem observations
The goats and bucks did not exhibit any clinical signs.
No fever peak was detected in any of the animals. No
significant gross lesion was found at necropsy.
Real-time PCR
SBV RNA was detected in the blood of all inoculated
animals for 3 to 4 days, starting between day 1 and 3 pi
(Fig. 1). From day 6 pi, SBV RNA became undetectable.
Cq values during RNAemia in all animals ranged from
25 to 39. The intensity of RNAemia differed in 2 of the
4 inoculated goats, with goats A and D showing a max-
imal Cq value of about 25 while goats B and C showed a
maximal Cq value of about 35, independently of the
inoculum (ovine EDTA blood or bovine serum). All
sampled tissues scored negative for SBV by RT-qPCR in
Fig. 1 Detection of SBV RNA in blood by RT-qPCR after SBV inoculation
in goats and bucks. A, B: goats inoculated with SBV-containing bovine
serum; C, D: goats inoculated with SBV-containing ovine blood; E, F:
bucks inoculated with SBV-containing bovine serum
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bucks and goats, except for one ovary in goat C (intersti-
tial ovarian tissue with a non-normalized Cq value of
34). The semen from the bucks remained negative for
SBV from day 0 until the end of the trial, as determined
by RT-qPCR.
Serology
The ELISA results for inoculated animals are shown in
Fig. 2. Goats B and C, killed at day 7 pi, remained sero-
negative. Antibodies to SBV were detected in goats A
and D at 14 pi by ELISA and at day 9 pi by VNT (titers:
128 and 96 respectively). Antibodies to SBV were de-
tected in buck E at day 28 pi by ELISA and at day 14 pi
by VNT (titer: 64). Buck F was found seropositive at day
14 pi by ELISA and VNT (titer: 96). The mock-
inoculated goat remained seronegative until day 28 pi
(as determined by ELISA).
Histopathological examination
No significant lesions was found in any of the animals.
Rare coccidian parasites were seen in the intestine from
goats B, C and G.
Discussion
Our results show that, in goats and bucks, inoculation of
SBV is followed by a short viremic phase lasting 3 to
4 days followed by seroconversion between day 7 and
day 14 pi. Importantly, these clear signs of successful
experimental infection were not accompanied by any
clinical sign, including fever.
These observations are in accordance with data from ex-
perimental infection studies with sheep and cattle inocu-
lated subcutaneously with infectious serum. In sheep,
RNAemia was detected a few days after infection and lasted
for 3 to 7 days, while SBV-specific antibodies appeared be-
tween 7 and 9 days pi (detection by VNT) [12] or between
10 and 14 days pi (detection by ELISA) [5]. Data from this
experiment in goats show a trend towards a higher sensitiv-
ity of VNT compared to ELISA at the beginning of the
seroconversion. Poskin et al. [12] had similar observations
in sheep and suggested that this difference could be due to
the ability of VNT to detect both IgM and IgG, while the
ELISA can only detect IgG. Following experimental infec-
tion, sheep did not show any clinical sign [12] or almost no
sign, with diarrhea being reported in one case [5]. In cattle,
RNAemia could be detected for less than a week after in-
oculation [1, 3, 4] with detection by ELISA of SBV-specific
antibodies two weeks pi [3, 4]. Clinical signs were absent
[3, 4] or limited to fever or diarrhea [1].
In cattle and sheep, after experimental inoculation,
SBV genomic RNA was most consistently found in
lymphoid organs, i.e. spleen and lymph nodes, especially
the mesenteric lymph nodes [3–5, 9, 12]. This was not
the case in any of the four goats and two bucks inocu-
lated in the present study; however we did not collect
the mesenteric lymph nodes. The only organ where SBV
genome was found was one ovary of a single goat. Inter-
estingly, the SBV genome had already been found in the
ovary of one experimentally infected sheep [5], but the
significance of this finding remains unknown. No signifi-
cant gross lesions or histological lesions were found in
our study. Similarly, experimental infections of cattle or
sheep did not result in gross lesions at necropsy [3–5, 12].
So far, in experimentally infected adult ruminants, the
presence of SBV genome in a given organ has not been re-
ported to be associated with any lesion in this organ.
No SBV genome was found between day 0 and day 28
pi (end of the trial) in the semen samples obtained from
the two inoculated bucks. This result differs from the
observations made after experimental infection of two
bulls with SBV-containing cell culture supernatants [9].
Viral genome could be detected in the semen of both
bulls for the first week following inoculation and, in the
case of one bull, as late as at day 19 pi (the trial ended at
day 25 pi). SBV excretion in bovine semen has also been
reported from the field [6–8] but, to our knowledge, this
has never been reported for bucks. However, the small
size of our inoculated group precludes a conclusion re-
garding the excretion of SBV in caprine semen and the
risk of sexual transmission.
The data from this study match those from reports of
natural infection by SBV in domestic ruminants: clinical
signs of infection are either mild or absent in adults.
The most important effects of SBV infection are malfor-
mations in the offspring due to vertical transmission in
pregnant dams [2]. A study of the impact of SBV in
French domestic ruminants showed that only 2 % of the
kids born in goat herds with congenital SBV cases showed
Fig. 2 Detection of SBV specific antibodies by ELISA after SBV
inoculation in goats and bucks. A, B: goats inoculated with
SBV-containing bovine serum; C, D: goats inoculated with SBV-
containing ovine blood; E, F: bucks inoculated with SBV-
containing bovine serum. S/P < 60 %: negative; S/P > 70 %:
positive and S/P between 60 % and 70 %: doubtful
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malformations [13]. The same study reported a potential
effect of SBV infection in the early stages of pregnancy,
based on reports of repeated estrus or early embryonic
loss, especially in small ruminants [13]. The effects of SBV
infection in pregnant goats, however, remain to be
elucidated.
Conclusions
Following experimental infection in goats with SBV, the
kinetics of viremia and seroconversion were found to be
similar to earlier reported kinetics in sheep and cattle.
No clinical signs were associated to infection, in agree-
ment with reports from the field. SBV RNA was found
in one ovary but not in other organs. The SBV genome
was not found in semen from the two inoculated bucks
but this limited set of data does not exclude the risk of
viral transmission by artificial insemination or natural
service.
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4.1.3 Infection of adult goats around the time of insemination and during pregnancy  
 
 
4.1.3.1 Overview of the experimental design 
 
This study includes two protocols, which took place at different time points. One protocol 
(protocol 1) was designed to investigate the effects of SBV inoculation in goats around the 
time of insemination and involved groups A to D’ (protocol 1). The other protocol was 
designed to investigate the effects of SBV inoculation on pregnant goats and involved groups 
E to G (protocol 2). An overview of the experimental design is shown in figure 6.  
 
 
Figure 6. Experimental design. 
Goats were inoculated either subcutaneously (SC) or intravaginally (IVag), with either viral inoculum (SBV) or 
virus-free material (mock). In group D, one half of the group was mock-inoculated at day -7 before insemination 
while the other half was mock-inoculated on day 0. In group G, one half of the group was mock-inoculated at 
day 28 after insemination while the other half was mock-inoculated at day 42.  
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4.1.3.2 Infection around the time of insemination  
 
This part corresponds to the protocol 1. This protocol was designed to investigate the effects 
of SBV inoculation around the time of insemination and involved 5 groups of goats (A to D’). 
 
I was involved in the protocol design. I performed necropsies, sample collection, histological 
analyses, and RT-qPCR assays. I performed data analysis. 
 
4.1.3.2.1 Materials and methods 
 
 Experimental design 
Thirty-four adult Alpine goats were purchased from local breeders (INRA Center, Bourges, 
France) and were housed in the Biosafety Level 3 and insect-proof animal facilities of the 
National Institute of Agricultural Research (INRA), Research Loire Valley Center (PFIE, 
Nouzilly, France). All purchased animals were seronegative for SBV (ELISA), Q fever 
(complement fixation test) and brucellosis (complement fixation test and seroagglutination 
test). They were also Border disease virus and SBV-negative as determined by RT-qPCR. 
Vaginal sponges (Syncro-part 45mg, CEVA) were inserted in the goats’ vagina to 
synchronize estrus. On the day of insemination, each goat was artificially inseminated with 
two semen straws. Pregnant status was assessed at days 35 and 42 after insemination by 
ultrasonography. Three goats were excluded from the study because ultrasonography showed 
they were pseudogestant. Accordingly, the groups detailed below includes only 31 goats. 
 
In groups A (8 goats) and B (7 goats), animals were inoculated subcutaneously with 1mL of 
SBV-containing bovine serum kindly provided by the Friedrich-Loeffler-Institut (FLI), 
Germany (Wernike et al., 2012b), at day 7 before insemination and at the day of insemination, 
respectively. The group D (the control group for A and B) included 5 goats that received 1mL 
of sterile saline solution subcutaneously. In the group C (7 goats) the animals were inoculated 
intravaginally with SBV-spiked semen (made from the FLI serum) at the time of 
insemination. The group D’ (the control group for C) included 4 goats that received SBV-
negative serum (as determined by PCR) intravaginally at the time of insemination. 
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During the course of the trial, all animals were monitored twice daily, and body temperatures 
were recorded by telemetric measurement with rumen temperature sensors (Small Bolus®, 
Médria, Châteaubourg – France). After inoculation, whole blood and serum samples were 
collected daily during the first week and then once a week until the end of the experiment. 
Whole blood samples were then submitted to hematology analysis (full blood count) and to 
RT-qPCR. All the animals were euthanized at day 56 after insemination. 
 
 Luteinizing hormone (LH) and progesterone follow-up 
To follow the LH surge in the goats from the groups A and D, blood samples were collected 
every 4 hours from 22h to 42h after sponge removal, then submitted to ELISA testing for 
quantification of LH levels. To follow the serum progesterone in the goats from the groups A, 
B, C, D and D’, blood samples were collected daily from the day of insemination to day 7 
after insemination then submitted to ELISA testing for quantification of progesterone levels. 
 
 Necropsy, tissue collection and preparation 
At necropsy, all the organs from the goats were macroscopically evaluated and a panel of 
tissue samples was collected for histopathology, virus isolation and RT-qPCR (spleen, 
prescapular lymph node, ovary, oviduct, uterus, and vagina). In the pregnant goats, the fetus 
were examined and measured (crown-rump length) and a panel of tissue samples was 
collected for histopathology and RT-qPCR (brain, vertebrae with spinal cord, skeletal muscle, 
heart, kidney, eye, lung, intestine, liver, thymus, umbilical cord, and mandible from the fetus; 
placentomes, amniotic and allantoic membranes). Amniotic and allantoic fluid were collected 
for RT-qPCR only. One aliquot of each tissue sample was homogenized with 500µl of MEM. 
After a centrifugation (2000g 5min at 4°C), the supernatant was collected and used for RNA 
extraction. 
 
 Serology 
Serum samples were submitted to SBV specific ELISA testing (ID Screen Schmallenberg 
virus Competition Multispecies®, IDvet) according to the manufacturers’ instructions. 
 
 RT-qPCR 
RNA from blood and tissue samples was extracted using the LSI MagVet TM Universal 
Isolation kit (Life Technologies SAS, Saint-Aubin, France) and King Fisher magnetic particle 
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processor (Thermo Scientific™, Illkirch, France) according to the manufacturers’ instructions. 
The samples were then tested for the presence of SBV RNA by RT-qPCR targeting the S 
segment as previously described (Bilk et al., 2012). Quantification cycle (Cq) threshold value 
was 40, with higher values regarded as negative. 
 
 Histology 
After fixation in 10% buffered formalin, tissues were routinely processed, sliced at 4 µm, 
stained with Hematoxylin-Eosin-Saffron (HES) and examined by light microscopy 
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4.1.3.2.2 Results  
 
 Clinical signs, viremia and seroconversion in goats 
No clinical signs were observed. The full blood counts showed slight eosinophilia in groups A 
and D’. One goat from the group A and one goat from the group B had ruminal temperature of 
40°C 1 day post-inoculation (dpi) and from 2 to 3 dpi, respectively; two goats from group C 
had ruminal temperature of 40°C, one at 7 dpi, the other several times at -3, 0, 1 and 6 dpi. No 
fever peak were detected in any of the other goats after inoculation. SBV RNA was detected 
in the blood of all the goats from groups A and B for 4 to 6 dpi, starting between 2 and 4 dpi. 
SBV RNA was detected in the blood of only one goat in group C, starting at 4 dpi and lasting 
4 days; this goat did not show hyperthermia. No SBV RNA was detected in the blood of the 
other goats from group C and in mock-inoculated goats. All the goats with RNAemia were 
found seropositive between days 7 and 14 pi. Antibodies against SBV were not found in the 
other goats. 
 
 Pregnancy outcomes  
The pregnancy outcomes are summarized in table 5. 
Table 5. Pregnancy outcomes per group. 
Group 
Number of pregnant 
goats 
Total number of goats 
Number of 
fetuses* 
A 2 8 2 
B 5 7 10 
C 3 7 5 
D and D' 3 9 5 
*All fetuses were viable, except one fetus in group B and two fetuses in group C that were found dead 
(autolyzed). 
 
 Gross and histological lesions 
No gross or histological lesions were found in fetuses. 
In the adults, abscesses consistent with Corynebacterium pseudotuberculosis infection were 
found in two goats form group A (in mesenteric lymph nodes or mammary gland), two goats 
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from group B (in mesenteric lymph nodes or mammary gland), two goats from group C (lung 
or spleen), one goat from group D (spleen and ovarian ligament) and one goat from group D’ 
(liver). 
Granulomatous lymphadenitis consistent with Mycobacterium avium subsp. paratuberculosis 
infection was found in two goats from group A and one goat from group C, associated with 
cachexia in the latter. Cachexia was also found in one goat from group D without associated 
lesion. 
Amyloidosis was detected in the spleen or lymph nodes of one goat from group A, one goat 
from group B and one goat from group D, often in combination to abscesses or granulomatous 
lymphadenitis. 
Two goats displayed severe chronic mastitis (groups B and C). Slight acute suppurative 
endometritis was detected histologically, but not at gross examination, in one goat from group 
D and one goat from group D’. 
In the ovaries, histological examination revealed lymphoplasmacytic infiltrates in the corpus 
luteum in 3 goats from group B, 2 goats from group C, and one goat from each other group D, 
D’ and A. The severity was minimal, limited to one focus to a few foci with less than 10 
lymphocytes and plasma cells each. 
 
 Virus distribution 
SBV RNA was not detected in any tissue from the goats and the fetuses, including placental 
samples. 
 
 Hormonal modifications after inoculation around the time of insemination 
The rise in LH concentration in serum occurred at different time points after sponge removal 
in each group, with inter-individual variability (Figure 7). 
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Figure 7. Evolution of the LH concentration in goats from groups A and D after sponge removal.  
 
 
 
The rise in progesterone in each group is shown in Figures 8 and 9. In several group included 
in controls, the progesterone dropped after an initial rise. The corresponding goats were not 
pregnant. 
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Figure 8. Evolution of the progesterone concentration (P4, ng/mL) in serum in groups A, B and D. 
AI: artificial insemination. 
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Figure 9. Evolution of the progesterone concentration (P4, ng/mL) in serum in groups C and D’.  
AI: artificial insemination. 
 
In group C, the only goat with SBV viremia (goat 30039C) displayed a progesterone rise 
within normal limits. 
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4.1.3.2.3 Discussion 
 
Most of the goats included in the control group (D) were not in good condition. Some of them 
displayed lesions associated with chronic general disease, as paratuberculosis or amyloidosis. 
The others had inflammatory lesions in the genital tract. All these conditions could have 
impaired their ability to have a normal pregnancy. Indeed, most of them were not pregnant at 
the end of the study. Because of this inadequate control group, comparisons between the 
infected goats and the control goats for hormonal levels and pregnancy outcome seem not 
appropriate. In addition, lesions evocative of chronic general disease or genital tract 
inflammation were also detected in goats from other groups, leading to intra-group 
heterogeneity. It would have been necessary to exclude several goats in order to further 
interpret the results, however the groups are already small. 
 
This study shows that intravaginal inoculation with SBV may lead to a viremia in goats. 
Similarly, experimental intrauterine inoculation with AKAV at the time of insemination 
resulted in viremia in cows. In spite of this viremia, 6/10 cows had a successful pregnancy 
and the newborns did not display lesions. The only lesion in these cows was an infiltration of 
the corpus luteum by lymphocytes and plasma cells (Parsonson et al., 1981a). 
Lymphoplasmacytic infiltrates were also detected in the corpus luteum in the goats in our 
study, yet they were of minimal severity. In addition, they were detected in goats from each 
group: A, B, C, D and D’. They were thus not considered significant. 
 
The only goat that developed viremia following intravaginal insemination was pregnant with 
one fetus. At necropsy, the fetus was found dead (autolyzed). SBV RNA was not detected in 
this fetus, hence a causal link with SBV is unlikely. The cause of this fetal death in not 
known.  
 
In this study, the intravaginal insemination was performed with the same material as for 
artificial insemination. This material could have damaged the vaginal mucosa, causing 
erosions allowing the virus to access more easily to the blood circulation. Natural service may 
not have the same effects. Therefore, we can conclude that in goats, viremia can occur after 
intravaginal exposure to SBV in a context of artificial insemination. 
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4.1.3.3 Infection during pregnancy  
 
This part corresponds to the protocol 2 and is developed in the following draft (in 
preparation). For clarity purpose, the names of the groups have been changed in the paper: 
groups E, F, and G are named G28, G42, and Control, respectively. 
 
I was involved in the protocol design. I performed necropsies, sample collection, histological 
and immunohistological analyses, and RT-qPCR assays. I performed data analysis. I wrote the 
draft. 
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Abstract  23 
Schmallenberg virus is an emerging virus responsible for congenital malformations in the 24 
offspring of domestic ruminants. Infection of pregnant animals may also cause early 25 
embryonal losses. To determine the susceptibility of the goat in early gestation to 26 
Schmallenberg virus, we inoculated the virus to pregnant goats at days 28 and 42 of gestation 27 
and followed the goats until day 55 of gestation. Viremia occurred in all the goats without 28 
clinical signs. Embryonic and early fetal deaths were observed in several goats infected at 28 29 
or 42 days of gestation and were associated with viral genome detection in the 30 
embryos/fetuses. Among the surviving fetuses, two displayed lesions in the central nervous 31 
system (porencephaly) associated with the detection of viral genome and antigens. All the 32 
fetuses from goats infected at day 42 of gestation, and the majority of fetuses from goats 33 
infected at day 28 of gestation, contained viral genome. Viral genome was widely distributed 34 
in these fetuses and their placenta and infectious virus could be isolated from several organs 35 
and placentomes from living fetuses. These results show that the pregnant goat is susceptible 36 
to Schmallenberg virus infection between 28 and 42 days of gestation. The outcomes of the 37 
infection at this stage of gestation, as determined at day 55 of gestation, include embryonic or 38 
fetal deaths, living fetuses with central nervous system lesions, and living fetuses without 39 
detectable lesions. 40 
 41 
Keywords (indexing terms):  Goat, Reproduction, Schmallenberg virus, Orthobunyavirus, 42 
Experimental infection 43 
 44 
 45 
 46 
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Introduction  47 
Schmallenberg virus (SBV) emerged in summer and autumn 2011 in Western Europe 48 
associated to an outbreak of diarrhea, drop of milk production, and fever in adult cattle. 49 
Metagenomic analyses on blood samples from affected animals living near the city of 50 
Schmallenberg, in Germany, led to the identification of this new Orthobunyavirus, within the 51 
family Bunyaviridae (1). SBV was later found to induce congenital malformations in 52 
newborns in the offspring of cattle, sheep, and goats: arthrogryposis with muscular 53 
hypoplasia, malformations of the central nervous system (CNS), and vertebral malformations 54 
were the most common (2,3). In non-pregnant adult ruminants, however, clinical signs are in 55 
general mild to absent (4). 56 
As determined by phylogenetic analyses, SBV belongs to the Simbu serogroup within the 57 
genus Orthobunyavirus. Several viruses among this serogroup, namely Akabane virus 58 
(AKAV), Aino virus, and Shamonda virus, can cause diseases in domestic ruminants (1). 59 
AKAV has been extensively studied for more than 25 years. It is responsible for abortions, 60 
stillbirths, premature births and congenital malformations in newborns while it elicits only 61 
subclinical or asymptomatic disease in non-pregnant adult animals. Pregnant ewes and goats 62 
are most susceptible between 28 and 56 days of gestation; infection at this stage leads to 63 
arthrogryposis and/or CNS malformations in the offspring (5). 64 
After a study in the highest goat-specialized region of France, goats have been suggested to be 65 
less susceptible to SBV infection than sheep and cattle (6). Another study on the impact of 66 
SBV in France in 2012-2013 revealed that 8% of lambs, 3% of the calves, and 2% of kids 67 
born in SBV-infected herds showed congenital malformations, with farmers reporting early 68 
embryonal losses in females from the 3 species (7). The window of susceptibility of the 69 
pregnant goats to SBV remains unknown. 70 
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In this study, we carried out experimental infections of SBV in pregnant goats at early stages 71 
of gestation, 28 and 42 days after insemination. Our specific objectives were: (i) to assess 72 
whether the embryo or fetus is susceptible to SBV when pregnant goats are inoculated at 28 73 
and 42 days of gestation; (ii) to describe the pregnancy outcomes and the lesions in growing 74 
fetuses; (iii) to determine the tissues and cells targeted by SBV in the fetus, in cases of 75 
successful transplacental SBV transmission. 76 
 77 
 78 
 79 
 80 
 81 
 82 
 83 
 84 
 85 
 86 
 87 
 88 
 89 
 90 
 91 
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Materials and methods 92 
All experimental procedures were approved by the ethics committee of the Val de Loire 93 
(CEEA VdL, committee number n°19, number 00770.02) 94 
 95 
Animals  96 
13 adult Alpine goats and 16 adult Saanen goats were purchased from local breeders (INRA 97 
Center, Bourges, France) and were housed in the Biosafety Level 3 and insect-proof animal 98 
facilities of the National Institute of Agricultural Research (INRA), Research Loire Valley 99 
Center (PFIE, Nouzilly, France). All purchased animals were seronegative for SBV (ELISA), 100 
Q fever (complement fixation test) and brucellosis (complement fixation test and 101 
seroagglutination test). They were also Border disease virus and SBV-negative as determined 102 
by RT-qPCR. 103 
 104 
Experimental design 105 
Vaginal sponges (Syncro-part 45mg, CEVA) were inserted in the goats’ vagina to 106 
synchronize estrus. On the day of insemination, each goat was artificially inseminated with 107 
two semen straws. Pregnant status was assessed at days 35 and 42 after insemination by 108 
ultrasonography. The goats that were not pregnant at day 42 post insemination (15/29) were 109 
excluded from the study. The numbers of animals per group indicated below do not include 110 
these animals. 111 
The protocol involved 3 groups: one group inoculated at day 28 post insemination (G28; 5 112 
goats), one group inoculated at day 42 post insemination (G42; 5 goats) and a control group (4 113 
goats). The goats from the group G28 and from the group G42 were inoculated 114 
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subcutaneously with 1mL of SBV-containing bovine serum kindly provided by the Friedrich-115 
Loeffler-Institut (FLI), Germany (8). The control group received 1mL of sterile saline 116 
solution subcutaneously at day 28 (2 animals) and day 42 (2 animals) post insemination. 117 
During the course of the trial, all animals were monitored twice daily, and body temperatures 118 
were recorded by telemetric measurement with rumen temperature sensors (Small Bolus®, 119 
Médria, Châteaubourg – France). After inoculation, whole blood and serum samples were 120 
collected daily during the first week and then once a week until the end of the experiment. 121 
The whole blood samples were then submitted to hematology analysis (full blood count) and 122 
to RT-qPCR. The animals were euthanized at day 53, 54 or 55 after insemination. 123 
 124 
Necropsy, tissue collection and preparation 125 
At necropsy, all the organs from the goats were macroscopically evaluated and a panel of 126 
tissue samples was collected for histopathology and RT-qPCR (spleen, prescapular lymph 127 
node, ovary, oviduct, uterus, and vagina). In the pregnant goats, the fetus were examined and 128 
measured (crown-rump length) and a panel of tissue samples was collected for histopathology 129 
and RT-qPCR (brain, spinal cord within vertebrae, skeletal muscle from the hindlimb (thigh), 130 
heart, kidney, eye, lung, intestine, liver, thymus, umbilical cord, and mandible from the fetus; 131 
placentomes, amniotic and allantoic membranes). Fetal umbilical blood and amniotic and 132 
allantoic fluid were collected for RT-qPCR only. One aliquot of each tissue sample was 133 
homogenized with 500µl of MEM. After centrifugation (2000g 5min at 4°C), the supernatant 134 
was collected and used as inoculum or for RNA extraction. 135 
 136 
 137 
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Serology 138 
Serum samples were submitted to SBV specific ELISA testing (ID Screen Schmallenberg 139 
virus Competition Multispecies®, IDvet) according to the manufacturers’ instructions. 140 
 141 
RT-qPCR 142 
RNA from blood, fetal fluids and tissue samples was extracted using the LSI MagVet TM 143 
Universal Isolation kit (Life Technologies SAS, Saint-Aubin, France) and King Fisher 144 
magnetic particle processor (Thermo Scientific™, Illkirch, France) according to the 145 
manufacturers’ instructions. The samples were then tested for the presence of SBV RNA by 146 
RT-qPCR targeting the S segment, as previously described (9). Quantification cycle (Cq) 147 
threshold value was 40, with higher values regarded as negative. 148 
 149 
Viral isolation 150 
A subset of samples was submitted to viral isolation by two passages on Vero cells (African 151 
green monkey kidney epithelial cells). The same subset was later passaged twice on CPT-Tert 152 
cells (10). Briefly, fresh cell monolayers of Vero or CPT-Tert were prepared as follows: 20 153 
000 Vero (or CPT-Tert) cells per well were added in 96 wells microtiter plates with 200μL of 154 
MEM (GIBCO) containing 10% fetal calf serum and 1% sodium pyruvate per well (for CPT-155 
Tert cells: 200µL of Iscove’s Modified Dulbecco’s Medium (IMDM, GIBCO) containing 156 
10% fetal calf serum, 1% sodium pyruvate and 1% non-essential amino acids). The cells were 157 
incubated 1 day at 37°C and then supernatants were discarded and monolayers washed with 158 
200µL of MEM. Fifty µl of inoculum (tissue or fluid) was added per well and incubated 1h at 159 
room temperature. The inoculum was discarded and 200µL of MEM containing 5% fetal calf 160 
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serum and 1% sodium pyruvate were added per well (for CPT-Tert cells: 200 µL of IMDM 161 
containing 10% fetal calf serum, 1% sodium pyruvate and 1% non-essential amino acids). The 162 
plates were incubated 1week at 37°C and frozen at -80°C until a second passage on fresh 163 
monolayer cells was carried out. Fifty µL of each first passage supernatant was then used as 164 
inoculum, and after 1h of contact with the cells, it was removed and 200µL of medium was 165 
added. The plates were incubated 1week at 37°C and frozen at -80°C until needed for RT-166 
qPCR analyses. A result was considered as positive in a well only if cell lysis was associated 167 
with evidence of viral genome replication by RT-qPCR. 168 
 169 
Histology, immunohistochemistry and image analysis 170 
After fixation in 10% buffered formalin, tissues were routinely processed, sliced at 4 µm, 171 
stained with hematoxylin-eosin-saffron (HES) or Kluver-Barrera (brain and spinal cord only) 172 
and examined by light microscopy. Immunohistochemistry was performed using a DXT 173 
automat (Ventana Medical Systems; Roche Diagnostics) with streptavidin-biotin-peroxidase 174 
complex method with DAB as a substrate and hematoxylin counterstaining. The primary 175 
antibodies used are listed in Table 1. 176 
 177 
 178 
 179 
 180 
 181 
 182 
 183 
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Table 1. Primary antibodies used for immunohistochemistry. 184 
Antibody Provider/manufacturer Species Dilution 
SBV Massimo Palmarini and Mariana 
Varela, University of Glasgow, UK* 
Rabbit polyclonal 1/3000 
Activated caspase 3 Cell Signaling Technology, Danvers, 
Massachusetts, USA 
Rabbit polyclonal 1/200 
Ki67 (MIB-1) DAKO, Glostrup, Denmark Mouse monoclonal 1/50 
CD3 (A0452) DAKO, Glostrup, Denmark  Rabbit polyclonal 1/200 
CD79 (HM57) AbD Serotec, Kidlington, UK Mouse monoclonal 1/1000 
*Reference: (11) 185 
Positivity for activated caspase 3 (Casp3) and positivity for Ki 67 in samples of fetal muscle 186 
were evaluated by computer-assisted image analysis. Pictures were taken by an ImagerZ1 187 
Zeiss microscope and an AxioCam HRc Zeiss camera. Casp3-positive cells were manually 188 
counted on each slide and expressed per area (Zen pro digital imaging for light microscopy, 189 
Carl Zeiss S.A.S., Le Pecq, France). Quantitative analysis of Ki67 was performed on five 190 
representative images 40x per slide; for each image the ratio between the area occupied by 191 
positive nuclei and the total area occupied by nuclei was calculated (AxioVision 4.6.3 Zeiss 192 
software measurement tool Carl Zeiss S.A.S., Le Pecq, France).  193 
 194 
Statistical analyses 195 
A logistic model was used to compare the fetal mortality between groups. Because several 196 
fetuses could be carried by the same goat, this model was fitted using generalized estimating 197 
equations, the goat ID being used as a grouping factor.  198 
Two linear models were fitted using generalized estimating equations (i) to compare the fetal 199 
length between groups (because several fetuses could be carried by the same goat, the goat ID 200 
was used as a grouping factor), and taking into account the ‘dead or alive’ status of the fetus; 201 
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(ii) to compare the Ki67 ratio in fetal muscle between groups (repeated measures were 202 
performed for the same fetus, the fetus ID was thus uses as a grouping factor).  203 
A general linear model was used to analyze data about the diameter of placentomes. The 204 
independent variable was the maximal diameter of the placentomes (one diameter in cm per 205 
goat), and explanatory variables were the group (infected –G28 or G42, or control), the breed 206 
(Alpine or Saanen), the age of the goat (in years, treated as a categorical variable), and the 207 
number of fetuses carried by the goat (treated as a categorical variable). An univariate 208 
analysis was performed to select the explanatory variables associated to the maximal diameter 209 
of the placentomes, with a p-value <0.20. A multivariate model was then fitted including the 210 
explanatory variables thus selected. The absence of collinearity between explicative variables 211 
was verified based on the variance inflation factor.   212 
P-values <0.05 were considered significant throughout the analysis. Statistical analyses were 213 
conducted using R software (R Foundation for Statistical Computing, Vienna, Austria, 214 
http://www.R-project.org/) with Car (12) and Geepack packages (13). 215 
  216 
 217 
 218 
 219 
 220 
 221 
 222 
 223 
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 224 
Results 225 
Clinical signs, viremia and seroconversion in goats 226 
No clinical signs were observed. No fever peak were detected in any of the goats. Full blood 227 
counts were similar for the SBV- and the mock-inoculated goats all along the study. The SBV 228 
RNA was detected in the blood of all the goats from groups G28 and G42 for 4 to 6 days, 229 
starting between 2 and 4 days post-inoculation (dpi). One goat from group G28 showed 230 
intermittent viremia with SBV RNA found again at 15 dpi. No SBV RNA was detected in the 231 
blood of mock-inoculated goats. All the goats with RNA-emia were found seropositive 232 
between 7 and 14 dpi. Antibodies against SBV were not found in the serum of mock-233 
inoculated goats. 234 
 235 
Pregnancy outcomes  236 
Pregnancy outcomes are showed in Table 2. Prolificacy was 2.2 fetuses per goat in groups 237 
G28 and G42 and 2.5 fetuses per goat in the control group. However, 5/11 fetuses in group 238 
G28 as well as in group G42 were autolyzed; this indicates they were already dead before 239 
euthanasia. Fetal death was more likely to occur in group G28 or in group G42 than in control 240 
(P<0.0001). In case of twin pregnancy, fetal death was observed either in both fetuses or only 241 
in one of them, or in none of them. In case of triplet pregnancy, one or two fetuses were found 242 
dead. 243 
 244 
 245 
 246 
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 247 
Table 2. Pregnancy outcomes. 248 
Group 
No. of fetal 
death  
Total no. of 
fetuses 
No. of pregnant 
goats 
Prolificacy (no. of 
fetuses per goat) 
No. of goats 
carrying at least 1 
dead fetus 
G28 5a 11 5 2.2 3 
G42 5b 11 5 2.2 3 
Control 0a,b 10 4 2.5 0 
a and b: P<0.05 249 
 250 
Gross and histological lesions 251 
At necropsy, we found an abscess in one mesenteric lymph node in 2 goats from G28 and an 252 
abscess in the spleen in 2 goats from G42; histologically, they were consistent with abscesses 253 
due to Corynebacterium pseudotuberculosis. Diffuse, chronic lymphoplasmacytic mastitis 254 
and focal, chronic suppurative bronchopneumonia were also found in a goat from G28 and a 255 
goat from G42, respectively. These lesions were most likely of bacterial origin. No gross or 256 
histological lesions were seen in any of the control goats. 257 
In the placenta, we observed a unique allantoic sac including all the fetuses in most of the 258 
cases of twin or triplet pregnancy (total fusion). In 6 goats (2 goats in each group) the placenta 259 
contained 2 allantoic sacs, one per uterine horn, including one (no fusion) or two fetuses 260 
(partial fusion). In every placenta, the placentomes displayed multiple small foci of 261 
hemorrhages: placental hematomas (normal in this species). For a given goat, the placentomes 262 
were of varying size: the smallest placentomes ranged from 0.5 to 1 cm in diameter while the 263 
largest placentomes ranged from 1 to 4 cm in diameter. The maximal diameter was measured 264 
for 4 goats in each group (all selected goats had at least one living fetus except one goat from 265 
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group G42 with 2 dead fetuses Univariate analysis allowed selecting age and breed as 266 
explanatory variables. Multivariate analysis showed a significant difference in the maximal 267 
diameter of placentomes between infected (G28 and G42) and control goats (lower diameter 268 
in infected goats, Figure 1) on the one hand, and between Alpine and Saanen goats on the 269 
other hand (higher diameter in Saanen goats). The goats included in the analysis were all 270 
carrying at least one living fetus except one goat from G42, thus fetal mortality alone cannot 271 
explain the smaller maximal diameter of placentomes in the infected goats. Histologically, 272 
foci of degeneration and necrosis of the placentomes, involving both fetal and maternal parts 273 
on approximately 5 to 10% of the surface, were seen only in 2 goats from G42, one carrying 2 274 
living fetuses and the other one carrying 2 dead fetuses. 275 
The fetuses from G28 and G42 did not display gross abnormalities except autolytic changes in 276 
some of them (fetal death) and wide variation in crown-rump length, ranging from 3 to 8.8 cm 277 
in G28 and from 7.5 to 9 cm in G42 (Figure 2 A and B). No gross lesions were observed in 278 
fetuses from control goats; their length ranged from 8 to 9.2 cm. The crown-rump length was 279 
significantly lower in fetuses from G28 than in those from control goats, but there was no 280 
significant difference between the length of fetuses from G42 and the length of fetuses from 281 
control goats (Figure 2 A). However, when we added the ‘dead or alive’ status of the fetuses 282 
as an explanatory variable, the difference between the length of fetuses from G28 and from 283 
controls was not significant anymore. Thus, the difference relied more on the ‘dead or alive’ 284 
status than on the group. 285 
Histological lesions were found in the cerebrum of 2 fetuses, one from G28 and one from 286 
G42, both with an ‘alive’ status before euthanasia. In the neopallium, bilaterally around the 287 
lateral ventricles, there was a circumferential loss of cells within the periventricular layer with 288 
cavitation: porencephaly (Figure 3 A, B and C). The cavitation was twice wider in the fetus 289 
from G28 than in the one from G42, in transverse brain sections from the same level. In both 290 
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cases, porencephaly was associated with multiple foci of hemorrhage with 291 
erythrophagocytosis by macrophage-like cells, and with hyperplasia of small caliber, venule-292 
like vessels. In addition, the wall of these vessels was thickened and irregular, made of 293 
hypertrophic endothelial cells with prominent nuclei (Figure 3 D). The other fetuses did not 294 
show any brain lesions. No lesions were found in the spinal cord of any fetus; the ventral 295 
horns already displayed a few well-differentiated neurons. Skeletal muscle was similar in 296 
control fetuses and in fetuses from G28 and G42 (Figure 4 A). We did not find any lesions in 297 
the other fetal organs, except in the umbilical cord of the fetus from G28 with porencephaly. 298 
In this fetus, both umbilical arteries showed a focal, superficial infiltration of their wall by 299 
round cells (figure 5 A). This infiltrate was located below a focus of endothelial loss, partially 300 
covered by an aggregate of fetal blood cells enmeshed in small amounts of fibrin 301 
(thrombosis). Among the round cells infiltrating the wall were a few CD3-positive cells: T 302 
lymphocytes (figure 5 D). No cells were CD79-positive. Overall, the lesions were consistent 303 
with chronic, bilateral, focal umbilical arteritis with thrombosis. 304 
 305 
SBV distribution in goats and fetuses 306 
Distribution of SBV RNA and SBV antigens in the organs from inoculated goats and their 307 
fetuses is shown in figure 3. SBV RNA and SBV antigens were not found in the goats and 308 
fetuses from the control group. 309 
SBV RNA was detected in 3/5 goats from G28 and 5/5 goats from G42. It was detected more 310 
constantly in the placentome than in the proper goat tissues in both groups. The placentome 311 
was also the tissue where the highest RNA quantity was detected, in G42 only, with Cq values 312 
ranging from 20 to 25, while in the other tissues, and in placentomes from the G28 goats, the  313 
Cq ranged from 25 to 38 (non-normalized data from samples of the same volume). For the 314 
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two goats from G28 with one allantoic sac per uterine horn, the placentomes from the right 315 
side were RT-qPCR negative whereas those from the left side were positive. By 316 
immunohistochemistry, SBV antigen was found in the placentomes of 1 goat from G28 and 4 317 
goats from G42, being located in the cytoplasm of giant syncytial cells on the maternal side as 318 
well as in the cytoplasm of binucleate trophoblastic cells on the fetal side (Figure 6). SBV was 319 
successfully isolated in Vero cells (but not in CPT-Tert cells) from a placentome from a G42 320 
goat, but not from another one from a G28 goat. 321 
SBV RNA was found in 6/11 fetuses from G28, including all the fetuses found dead in this 322 
group and one fetus found alive - the one with porencephaly. For two goats from G28 with 323 
triplet pregnancy but separate right and left allantoic sacs, SBV RNA was found in the two 324 
fetus from the left horn but not in the one from the right one. The results obtained in 325 
placentomes from these goats paralleled those found in fetuses, with SBV RNA being found 326 
in the left horn but not in the right horn. The fetuses from the two G28 goats that were devoid 327 
of SBV RNA in their organs did not contain SBV RNA either. All the fetuses from G42 328 
contained SBV RNA, whatever their ‘alive or dead’ status. For any fetus with a positive 329 
result, all the sampled organs, the umbilical blood and the amniotic and allantoic fluids and 330 
membranes contained SBV RNA, with few exceptions (one G28 fetus with a negative 331 
amniotic fluid, one G42 fetus with a negative umbilical blood and one G42 fetus with 332 
negative results in the eye, mandible, and amniotic membrane). The Cq values were similar in 333 
G28 fetuses and in G42 fetuses for a given organ, with the lowest values found in muscle, 334 
kidney, heart, eye, liver, spinal cord, brain, intestine, lung and mandible (Cq values ranging 335 
from 15 to 25), especially for muscle, kidney and heart (Cq values: 14-20). 336 
In fetuses, SBV antigens were found in several organs. In the cerebrum, it was found in 337 
association with histological lesions of porencephaly (one G28 fetus and one G42 fetus); the 338 
antigen was in the cytoplasm of progenitor cells located in the periventricular layer (Figure 3 339 
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F). In three G42 fetuses (including the one with cerebral porencephaly), SBV antigens were 340 
also found in the cerebellum, without histological lesions; there were foci of 10 to 50 positive 341 
cells in the external granular layer with rare positive cells in the underlying layers. In the 342 
thoracic and lumbar parts of the spinal cord from one G28 fetus (the one with porencephaly) 343 
and two G42 fetuses, rare positive cells were observed in the ventral horn; they were located 344 
around neurons and morphologically consistent with astrocytes. SBV antigens were detected 345 
in the cytoplasm of cells in the kidney, heart and skeletal muscle of one G28 fetus and almost 346 
all G42 fetuses. In the kidney, the positive cells were at the periphery of the cortex, appearing 347 
as groups of adjacent cells in rudimentary glomeruli and tubules as well as scattered 348 
undifferentiated cells under the renal capsule (Figure 6 H). In the heart and skeletal muscle, 349 
multifocal adjacent cells were positive: mostly secondary myotubes with rare primary 350 
myotubes in the skeletal muscle (Figure 4 B), and cardiomyocytes in the heart (Figure 6 F). 351 
The mandible of one G28 fetus and three G42 fetuses showed SBV antigens in the cytoplasm 352 
of scattered chondrocytes (Figure 6 D). SBV antigens were also detected in the wall of one 353 
umbilical artery from the G28 fetus that displayed bilateral umbilical arteritis; the positive 354 
cells were parallel spindle cells consistent with smooth muscle cells (figure 5 C). SBV 355 
antigens were not found in any fetal eye stricto sensu, however a few myotubes in the 356 
surrounding eyelids were positive.  357 
SBV viral isolation was successful in Vero cells (but not in CPT-Tert cells) using 358 
homogenates from the following fetal organs: the intestine and the eye in one G28 fetus and 359 
the eye, the lung and the umbilical cord in one G42 fetus. Viral isolation was unsuccessful in 360 
all the other sampled tissues. 361 
 362 
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Table 3. Distribution of SBV RNA and SBV antigens in the organs of SBV-inoculated goats 363 
and their fetuses. For a given organ, the number of animals with positive results is detailed for 364 
each technique, followed by the total number of tested animals in brackets. 365 
   Group 
 Organ Technique G28 G42 
Fetuses and their 
amniotic and 
allantoic sacs 
Brain RT-qPCR 6 (11) 11 (11) 
  IHC 1 (2) 3 (8) 
 
Spinal cord within 
vertebrae 
RT-qPCR 1 (5) 11 (11) 
  IHC 1 (7) 3 (7) 
 Skeletal muscle RT-qPCR 1 (5) 11 (11) 
  IHC 1 (2) 6 (7) 
 Kidney RT-qPCR 1 (6) 11 (11) 
  IHC 1 (3) 7 (7) 
 Heart RT-qPCR 1 (5) 11 (11) 
  IHC 1 (3) 7 (7) 
 Mandible RT-qPCR 1 (6) 10 (11) 
  IHC 1 (2) 3 (6) 
 Eye RT-qPCR 1 (5) 10 (11) 
  IHC 0 (2) 0 (7) 
 Thymus RT-qPCR 1 (5) 11 (11) 
 Liver RT-qPCR 3 (8) 11 (11) 
 Intestine with meconium RT-qPCR 1 (6) 11 (11) 
 Lung RT-qPCR 1 (6) 11 (11) 
 Umbilical cord RT-qPCR 4 (8) 11 (11) 
 Umbilical blood RT-qPCR 2 (6) 9 (10) 
 Amniotic membrane RT-qPCR 7 (10) 10 (11) 
 Amniotic fluid RT-qPCR 6 (11) 11 (11) 
 Allantoic membrane* RT-qPCR 4 (7) 7 (7) 
 Allantoic fluid* RT-qPCR 4 (7) 6 (6) 
     
Goats and 
placentomes 
Mesenteric lymph node RT-qPCR 2 (4) 5 (5) 
 Spleen RT-qPCR 0 (4) 4 (5) 
 Ovary RT-qPCR 2 (5) 1 (5) 
 Oviduct RT-qPCR 3 (5) 4 (5) 
 Uterus RT-qPCR 3 (5) 4 (5) 
 Placentome RT-qPCR 3 (4) 5 (5) 
  IHC 1 (4) 4 (5) 
IHC: immunohistochemistry. * The allantoic sacs were totally fused in most cases of twin or triplet pregnancy 366 
except in 4 goats whose placenta displayed 1 allantoic sac per horn. 367 
 368 
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Apoptosis and cell proliferation in fetal muscle 369 
To screen for apoptosis in the fetal muscle, the density of activated caspase 3-positive cells 370 
per surface area was measured in muscle from three SBV-positive fetuses (as determined by 371 
RT-qPCR), including the two fetuses with porencephaly, and from two control fetuses. 372 
Muscle from the SBV-positive fetuses and from control fetuses displayed, on average, 4.5 and 373 
1.7 positive cells per mm2 (standard deviation 3.2 and 0.6), respectively. The difference in 374 
density was not significant between the SBV-positive fetuses and the control fetuses. 375 
Nevertheless, a trend towards higher densities of positive cells (6.1 to 6.5 cells per mm2) was 376 
observed in the muscle from the two SBV-positive fetuses with porencephaly in comparison 377 
to the muscle from control fetuses. 378 
To assess cell proliferation in the fetal muscle, the Ki67 ratio, defined as the ratio between the 379 
area occupied by positive nuclei and the total area occupied by nuclei, was assessed in the 380 
muscle of 3 SBV-positive fetuses and 4 control fetuses. The Ki67 ratio was significantly 381 
higher in SBV-positive fetuses than in control fetuses (figure 7). 382 
 383 
 384 
 385 
 386 
 387 
 388 
 389 
 390 
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 391 
Discussion  392 
Our results indicate that the vertical transmission of SBV from a pregnant goat to its fetus(es) 393 
can occur between 28 and 42 days of gestation. In ruminants, fetal-maternal exchange occurs 394 
in specialized structures in the placenta: the placentomes. In sheep, SBV has been shown to 395 
cross the placenta after inoculation at day 38 or at day 45 of gestation, with SBV RNA 396 
detection in the placentomes and some fetuses at 7 dpi (14). In this study, placentomes from 397 
all the G42 goats contained viral genome and, for at least one of them, infectious virus, at 12 398 
dpi (end of the trial) while placentomes from the majority of the G28 goats contained viral 399 
genome at 26 dpi (end of the trial). However, in the G28 goats with fetuses in separate left 400 
and right allantoic sacs, SBV genome was only found on the placentomes and the associated 401 
fetuses from one side and not from the other. Thus, either the virus may not diffuse 402 
homogeneously within the maternal uterus or, in some cases, its diffusion may be stopped 403 
locally at the level of the placentomes.  404 
Following placental crossing, SBV disseminated widely in the goat fetus. SBV genome was 405 
found in blood, CNS, muscle, cartilage, lung, meconium, umbilical cord, and in fetal 406 
membranes and fluids: this is in line with the organs that have been found positive in newborn 407 
or stillborn ruminants in the field (9,15,16). In addition, SBV genome was found in the 408 
thymus and the liver of many infected fetuses in this study; thus, SBV can disseminate in 409 
these organs at least transiently. We also found infectious virus in the eye; however, 410 
considering the immunohistochemistry results, the muscular part of the eyelids seems to be 411 
the site of viral replication while the globe itself may not.  412 
As determined by immunohistochemistry, the target cells of SBV in the goat fetuses were (i) 413 
progenitor cells: on the one hand, in the brain: periventricular layer cells in the cerebrum and 414 
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external granular layer cells in the cerebellum (17); on the other hand, in the kidney: 415 
subcapsular undifferentiated cells (ii) cells engaged in their differentiation process in muscle: 416 
secondary myotubes (18), in the kidney: cells from rudimentary glomeruli and tubules, and in 417 
the heart: growing cardiomyocytes (iii) well-differentiated cells in the mandible: 418 
chondrocytes. It has been previously shown that the neurons from the CNS are target cells for 419 
SBV in young ruminants (11,19) and in mice (11). After their experimental inoculation of 420 
AKAV during early pregnancy in the ewe, Parsonson et al. (20) also found viral antigens in 421 
the brain, especially in the cerebrum but they did not mention a target zone or cell.  422 
In the goat fetuses, the infection by SBV was associated with 3 different outcomes, which 423 
could occur within the same litter. The infected fetuses were either dead (10/17, 5 from G28 424 
and 5 from G42), or alive with lesions (2/17, 1 from G28 and 1 from G42: 2 fetuses with 425 
porencephaly), or alive without lesions (5/17, G42 only). In the latter case, we can 426 
hypothesize either that the lesions were not yet developed at 12 dpi, or that the infection 427 
would have been cleared later in gestation. 428 
Fetal death was often associated with reduced fetal length. If we consider there was no growth 429 
retardation associated with fetal death, the smallest fetuses died around 38 to 40 days of 430 
gestation (end of the embryonic period) in G28 and around 49-52 days of gestation in G42 431 
(21). Thus, embryonic or fetal death could occur as soon as 10 dpi, i.e. around a week after 432 
viremia in the pregnant goat. Embryonic or early fetal death can easily be overlooked by the 433 
farmers and could have been underestimated in the field. Indeed, evidence of embryonal or 434 
early fetal loss in the field in association with SBV infection in goats has only been reported 435 
in the literature in 2013 for German herds (22) and in 2014 for French herds (7), one and two 436 
years, respectively, after the emergence of the virus in Europe. As hyperthermia was absent in 437 
the SBV-inoculated goats, its causal role in embryonic or fetal death is unlikely. Embryonic 438 
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or early fetal death can also occur because of placental failure or because of disruption of the 439 
expression of developmental genes. 440 
Our findings of reduced maximal diameters of placentomes in infected goats and of 441 
degenerative changes observed in placentomes from 2 goats from G42 in association with 442 
abundant SBV antigens, suggest that SBV could reduce the efficiency of the feto-maternal 443 
exchange. This hypothesis deserves to be further explored for example through an evaluation 444 
of the proportion of apoptotic cells and evaluation of blood vessels density and caliber in 445 
placentomes. The umbilical arteritis with partial thrombosis observed in one (viable) fetus in 446 
association with SBV antigen may be incidental or may represent another way for the virus to 447 
lead to fetal ischemia by disruption of the fetal blood circulation. The expression of fetal 448 
genes was not evaluated in this study but a recent report showed that SBV down-regulate in 449 
vitro the expression of a transcription factor involved in embryonic development (23). The 450 
ability of SBV to influence the expression of key-genes for embryonic and fetal development 451 
remains to be determined. 452 
Lesions were found in the CNS of only two out of 17 infected fetuses. This low frequency 453 
was expected as reports from the field in France state that only 2% of the goat kids born in 454 
SBV-infected herds display congenital malformations (7). The 2 fetuses displayed 455 
porencephaly in the neopallium. Porencephaly is one of the frequent lesions associated with 456 
SBV transplacental infection in newborn or stillborn domestic ruminants (24,3,25–27). 457 
However, the porencephaly lesions we observed at 2 months of gestation may have later 458 
evolved into hydrocephaly or even hydranencephaly, which are also typical lesions found in 459 
SBV-infected young ruminants (2,3,26,27).  Indeed, the cavitation and loss of cells in the goat 460 
fetuses were within the periventricular zone that contains bipotential progenitor cells (17). 461 
These cells give rise to neuronal progenitor cells and glial progenitor cells. The latter are 462 
precursors to astrocytes and oligodendrocytes but also to the radial glial cells, temporary cells 463 
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that guide the young neurons during their migration in the cortex in midpregnancy (17). Cell 464 
death in any of these precursors could thus result in hypoplasia of the neopallium, with 465 
resulting hydranencephaly (26) or hydrocephalus ex vacuo (3), depending on the severity of 466 
cell loss. SBV could elicit cell death in the CNS directly or indirectly through ischemia. On 467 
the one hand, SBV is able to trigger apoptosis in vitro in CPT-Tert cells and in vivo in the 468 
brain of mice (28), suggesting cell loss may rely upon direct viral effects in the brain. 469 
Supporting this hypothesis is the detection of SBV antigens-positive cells around the areas of 470 
cavitation in the fetuses from the present study. On the other hand, evidence of blood vessel 471 
damage was noticed in the fetuses’ brains in this study, appearing as acute hemorrhages in the 472 
areas of cavitation, as well as in the CNS of neonates in another study, appearing as chronic 473 
hemorrhages often associated with tissue destruction (25). Although we did not noticed 474 
vasculitis or viral antigen in small-caliber blood vessels in the brain of the goat fetuses, the 475 
ability of SBV to elicit brain ischemia by blood vessel damage cannot be excluded; it may 476 
have occurred at an earlier time point during the course of infection. The blood vessels 477 
associated to porencephaly in fetal brains were hyperplastic with marked hypertrophy of the 478 
endothelial cells. It may be a non-specific reactive change secondary to cell loss. This 479 
vascular proliferation has also been described in the brain of goat fetuses about 10 days after 480 
inoculation of AKAV (29). In these fetuses infected by AKAV, muscular degeneration and 481 
necrosis have also been reported and may determine in part the muscular hypoplasia seen in 482 
the newborns (29). In the present study, no histological lesions were seen in skeletal muscle 483 
despite evidence of SBV infection; we cannot exclude they would have occurred later in 484 
gestation. We found a trend in increased apoptosis in muscle from infected fetuses bearing 485 
porencephaly than in muscle from infected fetuses without lesions or control fetuses. 486 
Unexpectedly, the rate of cell proliferation was higher in muscle from the infected fetus than 487 
in muscle from control fetuses. This proliferation could be either a reactive event secondary to 488 
23 
 
previous cell loss or, less likely, a direct effect of the virus. Overall, these results support only 489 
weakly the hypothesis of a direct destructive action of SBV on fetal muscle. Muscle 490 
hypoplasia in newborns may also result from SBV-determined neuronal loss in the spinal cord 491 
(26,30). An alternative mechanism would be the disruption of muscle cell differentiation by 492 
the virus. 493 
 494 
Conclusion 495 
Vertical transmission of SBV through the placenta can occur between 28 and 42 days of 496 
gestation in pregnant goats. The virus is widely distributed in infected fetuses. Following 497 
SBV infection between 28 and 42 days of gestation, embryonic or fetal death can occur and, 498 
in the surviving fetuses, CNS lesions may develop. Embryonic or early fetal death due to SBV 499 
infection in goats may have been overlooked during the first year of SBV spread in Europe 500 
and could have led to an underestimation of the impact of the virus on goat farming. 501 
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 612 
 613 
Figure 1. Box-plot showing the maximal diameter of the placentomes from pregnant goats in 614 
the control group (control) and in the SBV-inoculated group (SBV) including both G28 and 615 
G42. *P < 0.05. 616 
 617 
 618 
 619 
 620 
 621 
 622 
 623 
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 624 
 625 
Figure 2. Crown-rump length of the goat fetuses. (A) Box-plot: length of fetuses from the 626 
control goats (control), from the G28 and the G42 goats. (B) Detailed length per fetus in each 627 
group. Symbols filled in black correspond to dead fetuses, whereas unfilled symbols 628 
correspond to living fetuses. Within each group, fetuses from the same mother have the same 629 
symbol (filled or unfilled depending on their status). 630 
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 637 
Figure 3. Lesions and SBV antigen localization in the brain of goat fetuses. (A) Brain, 638 
cerebrum, goat fetus from G28. Cavitation in the periventricular layer: porencephaly (arrows). 639 
CP: choroid plexus. LV: lateral ventricle. HES, bar=500 µm. (B) Brain, cerebrum, goat fetus 640 
from G28. Porencephaly in the periventricular layer with hemorrhage (arrow). LV: lateral 641 
ventricle. HES, bar=50 µm. (C) Brain, cerebrum, goat fetus from G42. Porencephaly in the 642 
periventricular layer. LV: lateral ventricle. HES, bar=50 µm. (D) Brain, cerebrum, goat fetus 643 
from G28. Porencephaly in the periventricular layer. The endothelial cells lining the venules 644 
are hypertrophic (arrow). Kluver-Barrera stain, bar=20 µm. (E) Brain, cerebrum, control 645 
fetus. A normal venule (arrow) in the periventricular layer. Kluver-Barrera stain, bar=20 µm. 646 
(F) Brain, cerebrum, goat fetus from G28. SBV-positive cells around the cavitation in the 647 
periventricular layer. LV: lateral ventricle. IHC SBV, bar=20 µm.  648 
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 662 
Figure 4. Skeletal muscle of a SBV-infected fetus. (A) Skeletal muscle, goat fetus from G28. 663 
A large primary myotube is in the center, surrounded by smaller secondary myotubes. HES, 664 
bar=20 µm. (B) Skeletal muscle, goat fetus from G28. Several secondary myotubes are SBV-665 
positive (cytoplasmic staining). IHC SBV, bar=20 µm. (C) Skeletal muscle, goat fetus from 666 
G28. Many nuclei of myotubes are Ki67-positive. IHC Ki67, bar=20 µm. (D) Skeletal muscle, 667 
goat fetus from G28. A few myotubes show activated caspase 3 positivity in their cytoplasm. 668 
IHC activated caspase 3, bar=20 µm.  669 
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 687 
Figure 5. Lesions and SBV antigen localization in the umbilical cord from one SBV-infected 688 
fetus. (A) Umbilical cord, umbilical artery, goat fetus from G28. The wall is focally infiltrated 689 
by round cells (white arrow); a thrombus partially fills the lumen. L: lumen of the umbilical 690 
artery. HES stain, bar=50 µm. (B) Umbilical cord, umbilical artery, control goat fetus. The 691 
wall is made of smooth muscle cells and is devoid of round cells. L: lumen of the umbilical 692 
artery. HES stain, bar=50 µm. (C) Umbilical cord, same umbilical artery as in A. SBV-693 
positive spindle cells in the wall of the artery, morphologically consistent with smooth muscle 694 
cells. IHC SBV, bar=50 µm. (D) Umbilical cord, detail of the wall of the umbilical artery 695 
shown in A. On the right, the wall is infiltrated by round cells, some of which are CD3-696 
positive. IHC CD3, bar=20 µm. 697 
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Figure 6. Placentome, kidney, heart and mandible from SBV-infected goat fetuses: 715 
histological aspect and SBV antigen localization. (A) Placentome, goat and fetus from G42.  716 
Focal disjunction of maternal septum and fetal villus close to a placental hemorrhage, with 717 
erythrophagocytic trophoblast (arrow) on the fetal villus. F: fetal villus. M: maternal septum. 718 
Arrowhead: giant syncytial cell. HES stain, bar=20 µm. (B) Placentome, goat and fetus from 719 
G42.  A syncytial giant cell on the maternal side and a trophoblastic binucleate cell on the 720 
fetal side (arrow) are SBV-positive. F: fetal villus. M: maternal septum. IHC SBV, bar=20 721 
µm. (C) Mandible, cartilage, goat fetus from G28. The cartilage is made of chondrocytes 722 
(arrow) and extracellular matrix. HES stain, bar=20 µm. (D) Mandible, cartilage, goat fetus 723 
from G28. Several chondrocytes are SBV-positive. IHC SBV bar=20 µm. (E) Heart, 724 
myocardium, goat fetus from G28. The myocardium is made of cardiomyocytes interspersed 725 
with blood capillaries. HES stain, bar=20 µm. (F) Heart, myocardium, goat fetus from G28. 726 
Several cardiomyocytes are SBV-positive. IHC SBV, bar=20 µm. (G) Kidney, periphery of 727 
the cortex, goat fetus from G28. A rudimentary glomerulus (arrow and a rudimentary tubule 728 
(arrowhead) are developing in the cortex. C: capsule. HES stain, bar=20 µm. (H) Kidney, 729 
periphery of the cortex, goat fetus from G28. SBV-positive cells appear as groups of adjacent 730 
cells in rudimentary glomeruli and tubules as well as scattered undifferentiated cells under the 731 
renal capsule. IHC SBV, bar=20 µm. C: capsule. 732 
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 737 
Figure 7. Ki67 ratio in the thigh muscles from fetuses from the control group (control) and 738 
from fetuses from the SBV-infected group (SBV) including G28 and G42. *P < 0.05. 739 
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Highlights  748 
 Goats were inoculated with Schmallenberg virus at 28 and 42 days of gestation. 749 
 Most of the fetuses were transplacentally infected. 750 
 Embryonic and fetal deaths were observed. 751 
 In some of the surviving fetuses, lesions developed in the central nervous system. 752 
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4.2 Circulation in wild and exotic ruminants 
 
4.2.1 Free-ranging wild ruminants in France 
 
A serologic study was performed to evaluate the spread of SBV in red deer populations in 
France in 2011-2012. The results are described in the following paper, published in Emerging 
Infectious Diseases (Laloy et al., 2014). 
 
I participated in data selection and analysis. I wrote the draft. 
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Eve Laloy,1 Emmanuel Bréard, Corinne Sailleau, 
Cyril Viarouge, Alexandra Desprat,  
Stéphan Zientara, François Klein, Jean Hars,  
and Sophie Rossi1
Schmallenberg	virus	infection	is	emerging	in	European	
domestic	and	wild	ruminants.	We	investigated	the	serologic	
status	of	 9	 red	deer	 populations	 to	describe	 virus	 spread	
from	September	2010	through	March	2012	among	wildlife	in	
France.	Deer	in	7	populations	exhibited	seropositivity,	with	
an	average	seroprevalence	of	20%.
In summer and fall 2011, an unidentified disease was re-ported in dairy cattle in Germany and the Netherlands, 
causing decreased milk production, fever, and diarrhea 
(1,2). The virus associated with these clinical signs was 
identified as a new member of the genus Orthobunya-
virus of the Simbu serogroup and named Schmallenberg 
virus (SBV) (2). This virus was later associated with abor-
tions and congenital malformations in calves, lambs, and 
kids in several European countries (3). Serologic testing 
among wild cervids in Belgium revealed antibodies against 
Schmallenberg virus in roe deer (Capreolus capreolus) and 
red deer (Cervus elaphus) (4). Seroprevalence was already 
high (27% on average) in wild cervids in October 2011 
in Belgium, suggesting that the virus began circulating 
months earlier (before August 2011). It has recently been 
shown that SBV had already circulated in Culicoides vec-
tors in Belgium during August and September 2011 (5). Al-
though SBV has been closely monitored among domestic 
ruminants in France, suggesting that clinical cases and anti-
bodies appeared almost at the same time during 2011–2012 
(6), little is known about the geographic spread of SBV in 
wildlife. To correct this lack of data, we conducted a sero-
logic study using serum specimens collected from red deer 
in different regions in France.
The Study
Blood samples from 502 red deer, which had been ei-
ther killed by gunshot or captured, were collected within 
9 French departments (administrative units) during 1 or 2 
sampling seasons (i.e., during September 2010–January 
2011 and September 2011–March 2012). The serum speci-
mens were first screened by using an SBV indirect ELISA 
(i-ELISA) that was previously validated for the serum 
specimens from cattle, sheep, and goats (ELISA ID Screen 
Schmallenberg Virus Indirect, Bicupule; ID Vet, Montpel-
lier, France) (7). The results were expressed as S/P values 
using the cutoff recommended for domestic species (S/P = 
[optical density sample (S)/optical density positive control 
(P)] × 100); S/P<60%, negative; S/P>70%, positive; and 
S/P 60–70%, doubtful result). Serum specimens were also 
tested with a new competitive ELISA (c-ELISA; ELISA ID 
Screen Schmallenberg Virus Competitive; ID Vet). Posi-
tive results by c-ELISA corresponded to a percentage of 
inhibition (PI) <50, doubtful result if 40>PI≤50, and nega-
tive when PI >50. The antigen used in both c-ELISA and 
i-ELISA is the same N recombinant protein. A subset of 
samples were also subjected to a seroneutralization test 
(SNT) as described (7).
Of 502 serum specimens, 492 could be tested by us-
ing i-ELISA and 486 by using c-ELISA. The 2 ELISA 
methods exhibited a 92% match (449/486). Because our 
samples (taken from dead animals in nonsterile condi-
tions) generated bacterial contamination or cytotoxicity, 
conclusive SNT results were available from 114 animals 
only: 64 samples with positive or doubtful i-ELISA re-
sults and 50 samples (S/P>20) with negative i-ELISA 
results. A large part of the serum specimens that were 
positive or doubtful by ELISA methods were also posi-
tive for SBV by SNT, suggesting a good specificity of 
both methods, though slightly better for c-ELISA than 
for i-ELISA (Table 1). Many serum specimens that test-
ed negative by i-ELISA or c-ELISA (all collected dur-
ing 2011–2012) were positive by SNT (Table 1). Even 
though the c-ELISA kit appeared slightly more sensitive 
than the i-ELISA kit, these results suggest that SNT is the 
most sensitive technique for detecting antibodies against 
SBV in a recently infected population of red deer. These 
results are consistent with the fact that SNT and c-ELISA 
are able to detect IgG and IgM, whereas i-ELISA detects 
only IgG that appears after the IgM adaptive response (E. 
Breard, pers. comm.). Considering the performance of se-
rologic methods in that study, seroprevalence was finally 
estimated as the proportion of positive or doubtful serum 
specimens by using the c-ELISA kit.
The number of samples collected in each department, 
the proportion of positive specimens, and the date of first 
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observation of seropositive result are indicated in Table 2. 
The 56 serum specimens collected during September 2010–
February 2011 in northeastern and southwestern France 
(Bas-Rhin and Pyrenees-Atlantiques departments) were 
negative by both ELISAs. From September 2011 through 
March 2012, a total of 7 of 9 departments exhibited at least 
1 seropositive specimen by c-ELISA. Among these 7 de-
partments, the average seroprevalence was 20% (95% CI 
16%–24%), with significant variations between the 7 de-
partments exhibiting seropositive results (8%–49%) (χ2 = 
67.4, df = 6, p<0.001). Seroprevalence was not influenced 
by the animal’s age, suggesting an equal exposure of fawns 
born in 2011 and older animals (χ2 = 0.16, df = 2, p = 0.92). 
It is thus likely that SBV had not spread to France before 
red deer in France gave birth to young in spring 2011 (mid-
May to early June) (8). Seroprevalence varied significantly 
with the period (χ2 = 25.0, df = 2, p<0.001). On average, se-
roprevalence was higher in December 2011–January 2012 
(31%; 95% CI 25%–37%]) compared with September–No-
vember 2011 (7%; 95% CI 3%–12%) or February–March 
2011 (14%; 95% CI 7%–22%).
These results suggest that SBV was actively circu-
lating during fall 2011 until mid-November or early De-
cember. In agreement with the findings of Linden et al. 
for Belgium (4), we consider that the mild temperature 
observed in France in fall 2011 may have favored a late 
activity of vectors (9). The date of first occurrence of 
seropositive red deer and the seroprevalence observed in 
each department (Table 2) were not strictly dependent 
on the distance from the Meurthe-et-Moselle department 
where the first domestic case (congenital form) had been 
confirmed on January 25, 2012 (10) (Figure). This result 
possibly arose because of uncontrolled variations in the 
sampling dates of red deer between the 9 departments 
and still unknown factors associated with SBV spread. 
Nevertheless, most of the departments that exhibited se-
ropositive red deer from September 2011 to March 2012 
had also reported clinical cases in domestic flocks during 
January–March 2012 (Figure).
In southwestern France (near the Pyrénées Mountains), 
a red deer seropositive for SBV was observed in the Hautes-
Pyrénées department, whereas congenital clinical cases of 
SBV infection in domestic livestock (congenital malforma-
tions on kids) had been reported by March 30, 2012, in the 
neighboring Pyrénées-Atlantiques department (E. Bréard, 
pers. comm.) (Figure). These results suggest similar spread 
of SBV among red deer and domestic livestock during fall 
2011 at the department level. In 2012, no evidence of abor-
tions or malformations was reported in red deer or other na-
tive wildlife ruminant species within the populations moni-
tored by wildlife biologists or zoo veterinarians in France 
(S. Rossi, A. Decors, A. Lécu, pers. comm.). However, spe-
cific studies exploring the effect of SBV on the reproductive 
success of wild species are still lacking.
Conclusions
This study provides a preliminary view of SBV spread 
among wild cervids in France during 2010–2012. Our 
data suggest that SBV spread quickly from northeastern 
to southwestern France (≈800 km) between October and 
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Table	1.	Serologic	results	for	red	deer	serum	samples	tested	for	Schmallenberg	virus	with	SNT,	i-ELISA,	and	c-ELISA* 
ELISA	method	 
SNT	method 
SNT	positive,	n	=	97  SNT	negative,	n	=	17 
Positive	or	doubtful Negative  Positive	or	doubtful Negative 
i-ELISA 57 40  7 10 
c-ELISA 67 30  6 11 
i-ELISA	and	c-ELISA 49 22  6 9 
*SNT,	seroneutralization	test;	i-ELISA,	indirect	ELISA;	c-ELISA,	competitive	ELISA. 
 
 
Table	2.	Results	of	c-ELISA	and	indication	of	first	seropositive	result	for	Schmallenberg	virus	in	red	deer, by	department,	France,	
2010–2012* 
Department 
Average	distance	to	
Meurthe-et-Moselle	
department,	km† 
No.	positive	samples/ 
no.	tested	in	2010–2011	
(95%	CI,	%) 
2011–2012 
First	positive	
result,	2011 
No.	positive	
samples/no.	tested 
Mean	prevalence,	%	
(95%	CI) 
Moselle 46  4/26	 15	(2–29)‡ Nov	5 
Haute-Marne 102  26/53	 49	(36–63)‡ Nov	12 
Bas-Rhin 103 0/41	(<7)§ 8/53	 15	(6–25)‡ Oct	25 
Côte d’Or 184  11/37	 30	(15–45)‡ Dec 3 
Oise 282  26/69	 38	(26–49)‡ Dec	19 
Loir-et-Cher 375  11/132	  8	(4–13)‡ Nov	25 
Hautes-Pyrénées	 789	 0/14	(<19)§ 1/12	  8	(0–30)‡ Dec	10 
Corsica 749  0/23	  0	(<12)§  
Pyrénées	Atlantiques  815  0/26	 0	(<11)§  
*c-ELISA,	competitive	ELISA. 
†Department where first domestic clinical cases were reported, January 25, 2012. 
‡95% CIs were estimated by assessing a binomial distribution of seroprevalence. 
§Upper	value	of	the	95%	CI	was	estimated	according	a	hypergeometric	distribution	of	the	risk	to	detect	at	least	1	positive	result	(p	=	1–exp(Ln(0,05)/N),	
with	N	being	the	sample	size). 
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December 2011. Our data also show the match of SBV 
spread among red deer and domestic flocks at the level of 
the department and highlight the perspective that red deer 
can be a sentinel of SBV spread for livestock. We also pin-
pointed the relevance of new competition ELISA for im-
proving SBV surveillance in wildlife species, even though 
SNT remained the most reliable assay for SBV antibody 
detection in red deer. Further studies that encompass sever-
al years and include a larger number of species and locali-
ties would help provide a more complete picture of virus 
spread and risk factors in wildlife (11).
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4.2.2 Wild and exotic ruminants kept in zoos in France and the Netherlands 
 
 
This study was carried out to look for evidence of SBV infection in captive wild and exotic 
ruminants, in France and in the Netherlands. Retrospective analysis of medical records were 
performed to search clinical signs evocative of SBV infection. 
The results are presented in the following draft, submitted for publication in Emerging 
Infectious Diseases. 
 
I performed RT-qPCR, ELISA and viral neutralization assays. I was involved in data selection 
and analysis. I wrote the draft. 
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Text 23 
Schmallenberg virus (SBV), a new Orthobunyavirus of the Bunyaviridae family, emerged in 24 
August 2011 in north-western Europe (1) and spread to most parts of Europe via Culicoides 25 
vectors (2). Most infections are asymptomatic in adult ruminants, yet fever, milk drop and 26 
diarrhea have been reported (1). SBV is responsible for congenital malformations in newborn 27 
calves, lambs and goat kids. It has also been associated with abortions (3). The virus affects 28 
domestic livestock, but antibodies against SBV have also been found in free-ranging wild 29 
ruminants in several European countries (3–5,7) and in wild and exotic ruminants kept in 30 
captivity in the United Kingdom and in Austria (3,4). This study was carried on to investigate 31 
the exposure to SBV of wild and exotic ruminants kept in one zoological park in France and 32 
one in the Netherlands. 33 
The investigation was carried out on 42 serum samples (39 animals) collected between 2011 34 
and 2014 in the SafariPark Beekse Bergen (SPBB,  Hilvarenbeek, the Netherlands) and on 16 35 
serum samples (14 animals) collected between 2013 and 2015 in the Ménagerie du Jardin des 36 
Plantes, Muséum National d'Histoire Naturelle (MJP, Paris, France). 37 
First, the presence of SBV-specific antibodies in the samples was determined by ELISA 38 
(ELISA ID Screen® SBV Competition, ID Vet, France) and by virus neutralization test 39 
(VNT) according to a protocol previously described (6). The two methods gave identical 40 
results except for five samples found negative by ELISA and positive by VNT. VNT has 41 
proved more sensitive than ELISA for detecting antibodies against SBV in red deer (7). 42 
Antibodies against SBV were found in 30/53 animals by VNT: 11/14 animals from MJP and 43 
19/39 animals from SPBB (Table). Positive results were found in samples collected every 44 
year from 2011 to 2015; the earliest positive result was found in a sample collected in 45 
September 2011 (SPBB). Several seropositive ruminants from MJP were either born in Paris 46 
3 
 
or transferred to Paris from some other European park before 2010, which suggests that they 47 
were exposed to SBV in Paris. SBV antibodies were found in 3 consecutive samples collected 48 
in October 2011, September 2012 and March 2013 from a sable antelope in SPBB 49 
(Hippotragus niger niger) but also in 3 consecutive samples collected in October 2013, 50 
February 2014 and September 2014 in a bharal (Pseudois nayaur) from MJP. These data 51 
indicate that SBV antibodies can persist for one year or more in these two species.  52 
SBV-specific RT-qPCR targeting the S segment (8) of the virus was then performed on every 53 
sample. One sample from a SBV seronegative wildebeest (Connochaetes taurinus taurinus) 54 
collected in September 2011 in SPBB was found positive (Cq = 30). Several in-house 55 
conventional RT-PCR targeting the S, L, and M segments were then performed on this sample 56 
and allowed us to retrieve a 2,866 bp partial sequence from the M segment and a 1,374 bp 57 
partial sequence from the L segment (deposited in GenBank under the accession numbers 58 
KR828816 and KR828815, respectively). Genetic analyses based on BLAST revealed that the 59 
L and M partial sequences had 100 and 99.79% identity, respectively, with SBV sequences 60 
from cows.  61 
IFNAR-/- mice have been reported to be susceptible to SBV infection (9). To test the presence 62 
of infectious SBV in the wildebeest sample, we inoculated subcutaneously three adult IFNAR 63 
-/- mice with 100µL of serum per mouse. The mice showed no clinical signs and no SBV 64 
genome could be amplified from their blood at days 4 and 11 after inoculation (by RT-qPCR). 65 
No SBV antibodies were found by ELISA and VNT in their sera at day 21 after inoculation. 66 
The meaning of these negative isolation results remains unclear. It may be that initially viable 67 
virus disappeared due to poor storage conditions (-20°C for 3 years). 68 
According to the medical records of SPBB no clinical signs possibly related to an SBV 69 
infection were observed in the ruminants during the period studied. Abortions were reported 70 
4 
 
in MJP in two bharals in 2011 and 2012 and in one West Caucasian tur (Capra caucasica 71 
caucasica) in 2013. No correlation can be drawn between these abortions and the SBV 72 
serological results since the sampling did not take place immediately afterwards. 73 
Unfortunately, no material from aborted fetuses was tested by SBV RT-qPCR. 74 
This study demonstrates the circulation of SBV in 18 wild and exotic ruminant species kept in 75 
captivity in the Netherlands and in France between 2011 and 2015. Exposure to the virus may 76 
occur even in an urban area (such as Paris center). For the first time, we report evidence of 77 
SBV viremia in a blue wildebeest which was seronegative by ELISA and VNT when the 78 
serum was collected. SBV RNA has previously been found in an elk (5) but the duration of 79 
viremia was not determined. Further investigations are required to determine whether SBV is 80 
responsible for congenital malformations or abortions in zoo ruminants. 81 
 82 
Acknowledgments 83 
This study was supported and financed by the Muséum National d’Histoire Naturelle (grant 84 
identification: ATM - Collections vivantes 2014 & 2015). We are grateful to Dylan Duby and 85 
Claire Réjaud. We thank Manjula Deville and Marc Chodkiewicz for editing of the 86 
manuscript. 87 
 88 
References 89 
1.  Hoffmann B, Scheuch M, Höper D, Jungblut R, Holsteg M, Schirrmeier H, et al. Novel 90 
Orthobunyavirus in Cattle, Europe, 2011. Emerg Infect Dis. 2012;18(3):469‑72.  91 
2.  Wernike K, Conraths F, Zanella G, Granzow H, Gache K, Schirrmeier H, et al. 92 
Schmallenberg virus-two years of experiences. Prev Vet Med. 2014;116(4):423‑34.  93 
5 
 
3.  Steinrigl A, Schiefer P, Schleicher C, Peinhopf W, Wodak E, Bagó Z, et al. Rapid spread 94 
and association of Schmallenberg virus with ruminant abortions and foetal death in 95 
Austria in 2012/2013. Prev Vet Med. 2014;116(4):350‑9.  96 
4.  EFSA (European Food Safety Authority), 2014. Schmallenberg virus: State of the Art. 97 
EFSA journal 2014; 12(5):3681, 54 pp. [cited 2015 May 17]. 98 
http://www.efsa.europa.eu/en/efsajournal/pub/3681.htm 99 
5.  Larska M, Krzysiak M, Smreczak M, Polak MP, Zmudziński JF. First detection of 100 
Schmallenberg virus in elk (Alces alces) indicating infection of wildlife in Białowieża 101 
National Park in Poland. Vet J. 2013;198(1):279‑81.  102 
6.  Bréard E, Lara E, Comtet L, Viarouge C, Doceul V, Desprat A, et al. Validation of a 103 
commercially available indirect ELISA using a nucleocapside recombinant protein for 104 
detection of Schmallenberg virus antibodies. PloS One. 2013;8(1):e53446.  105 
7.     Laloy E, Bréard E, Sailleau C, Viarouge C, Desprat A, Zientara S, et al. Schmallenberg 106 
virus infection among red deer, France, 2010-2012. Emerg Infect Dis. 2014;20(1):131-4. 107 
8.  Bilk S, Schulze C, Fischer M, Beer M, Hlinak A, Hoffmann B. Organ distribution of 108 
Schmallenberg virus RNA in malformed newborns. Vet Microbiol. 2012;159(1-2):236‑8.  109 
9.  Wernike K, Breithaupt A, Keller M, Hoffmann B, Beer M, Eschbaumer M. 110 
Schmallenberg Virus Infection of Adult Type I Interferon Receptor Knock-Out Mice. 111 
PloS One. 2012;7(7):e40380.  112 
 113 
 114 
 115 
 116 
6 
 
Table: Number of animals seropositive to Schmallenberg virus as determined by virus 117 
neutralization test, among exotic and wild ruminants from two zoological parks, 118 
between 2011 and 2015 119 
Species 
Number of seropositive 
animals (total) 
Blue wildebeest (Connochaetes taurinus taurinus) * 3 (5) § 
Springbok (Antidorcas Marsupialis) * 3 (5) § 
Sable antelope (Hippotragus niger niger) * 3 (3) § 
Waterbuck (Kobus ellipsiprymnus ellipsiprymnus) * 1 (4) § 
Nyala (Tragelaphus angasii) * 1 (2) § 
Père David's deer (Elaphurus davidianus) * 1 (1) 
Gemsbok (Oryx gazella gazella) * 1 (1) 
African buffalo (Syncerus caffer caffer) * 1 (1) § 
Persian fallow deer (Dama mesopotamica) * 1 (1) § 
Vietnamese sika deer (Cervus nippon pseudaxis) * 1 (1) 
Blackbuck (Antilope cervicapra) * 0 (6) 
Axis deer (Cervus axis) * 0 (2) 
Red forest duiker (Cephalophus natalensis) * 0 (1) 
Common eland (Taurotragus oryx) * 0 (1) 
Watussi (Bos taurus taurus watussi) * 0 (1) 
Yak (Bos grunniens grunniens) ‡ 4 (5) 
West caucasian tur (Capra caucasica caucasica) † 2 (2) § 
Bharal (Pseudois nayaur) † 2 (3) § 
Markhor (Capra falconeri) † 2 (3) § 
Arkal urial sheep (Ovis aries arkal) † 1 (1) § 
Rocky mountain goat (Oreamnus americanus) † 1 (1) § 
Vigogna (Vicugna vicugna) † 1 (1) § 
Gaur (Bos gaurus) † 1 (1) 
Pygmy goat (Capra aegagrus hircus) † 0 (1) 
 120 
* Animals from the SafariPark Beekse Bergen (Hilvarenbeek - the Netherlands); samples 121 
collected between 2011 and 2014 122 
† Animals from the Ménagerie du Jardin des Plantes (Muséum National d'Histoire Naturelle, 123 
Paris - France); samples collected between 2013 and 2015 124 
‡ Animals from both zoological parks 125 
§ Antibodies against Schmallenberg virus described for the first time in this species 126 
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5 DISCUSSION 
 
5.1 Pathogenesis of the infection with SBV: hypotheses drawn from 
experimental infection in domestic ruminants 
 
5.1.1 Pathogenesis of the infection in males and non-pregnant females 
 
5.1.1.1 Characteristics of the inoculation: route and inoculum 
 
In vivo studies with SBV have been performed by several teams on different species, namely 
cattle, sheep and goat. A major challenge was to standardize the model for each species. 
Standardization is necessary to compare results coming from different studies, otherwise the 
interpretation is limited.  
 
The SBV inoculum must contain a critical dose to produce a homogeneous response in adult 
sheep (Poskin et al., 2014b) and cattle (Wernike et al., 2012b). A SBV-containing serum 
passaged in cattle, containing 2.0 x 10
3
 TCID50/mL (TCID50: 50% tissue culture infectious 
dose), was inoculated (1mL per animal) undiluted, at 1/10, 1/100, and 1/1000 dilutions in 
cattle (Wernike et al., 2012b) and sheep (Poskin et al., 2014b). RNAemia was detected in all 
the animals inoculated with undiluted and 1/10 diluted serum, and in all the cows inoculated 
with 1/100 diluted serum. However, only 1/3 sheep showed RNAemia at this dilution. After 
inoculation with 1/1000 diluted serum, RNAemia was detected in only one cow and not in 
any sheep (Poskin et al., 2014b; Wernike et al., 2012b). Therefore, to have a homogeneous 
response in a group of animals, the critical dose per animal for this inoculum would be 20 
TCID50 for cattle and 200 TCID50 for sheep. 
 
In addition, the origin of the SBV inoculum has to be properly chosen to produce a reliable 
induction of viremia in adult cattle: virus-containing serum passaged in cattle is suitable but 
cell culture-grown virus does not seem appropriate (Wernike et al., 2012b). In sheep, the 
experiments included in this manuscript (part 4.1.1.) did not reveal differences in the kinetics 
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of viremia after inoculation with infected serum passaged in cattle or inoculation with virus 
grown on KC and BHK cells. However, sheep inoculated with virus grown on Vero cells did 
not show RNAemia (Wernike et al., 2013d). This discrepancy can be explained by selection 
of attenuated variants after passages in Vero cells, while the alternation between KC and BHK 
cells may help to maintain genome stability (Wernike et al., 2012b). Alternative explanations 
include the different origin of the initial samples from which SBV was isolated, on the one 
hand, and the different route of inoculation (subcutaneous for infectious serum and KC/BHK 
cell culture-grown virus, intramuscular for Vero cell culture-grown virus), on the other hand 
(Wernike et al., 2013d).  
In the experiments presented in part 4.1.2., adult non-pregnant goats were inoculated with the 
virus-containing serum passaged in cattle that had been used successfully in cattle (Wernike et 
al., 2012b) and sheep (Wernike et al., 2013d). The inoculation was followed by RNAemia in 
all the infected goats. This inoculum was later used successfully for the inoculation of 
pregnant goats. A few adult non-pregnant goats were inoculated with whole blood sampled 
from a sheep inoculated with this serum (i.e. after a passage in sheep). Although the number 
of inoculated animals was small and did not allow for statistical testing, the RNAemia was 
similar to the one detected in the goats inoculated with the initial serum. 
 
Several routes of inoculation with SBV have been experimentally tested. Cattle have been 
submitted to oral, subcutaneous, and intravenous inoculations. Only the subcutaneous and 
intravenous inoculations led to SBV infection in the animals (Hoffmann et al., 2012b; 
Wernike et al., 2013a). In sheep, intradermal and subcutaneous inoculations were followed by 
RNAemia while intranasal inoculation failed to generate RNAemia (Martinelle et al., 2015). 
Intradermal inoculation is similar to the natural route of infection by Culicoides species, 
however subcutaneous inoculation is easier to perform (Martinelle et al., 2015). Accordingly, 
subcutaneous inoculation was performed in adult non-pregnant goats as well as in adult 
pregnant goats (cf. experiments 4.1.2 and 4.1.3.3), resulting in successful RNAemia in all the 
inoculated animals.  
 
Once the inoculum (infected serum passaged in cattle) and the route (subcutaneous) had been 
validated in goats, the intravaginal route was tested in comparison to the standard route 
(subcutaneous). Intravaginal inoculation and subcutaneous inoculation resulted in viremia in 
1/7 goats and 8/8 goats respectively (cf. experiments 4.1.3.2). Thus, intravaginal inoculation 
can lead to viremia in goats, yet this route may be less effective than the subcutaneous one. 
76 
 
The circumstances of the intravaginal inoculation, i.e. at the same time that artificial 
insemination, may have helped the virus to reach the blood circulation via small erosions of 
the mucosa. Therefore, our results suggest intravaginal transmission may occur in goats in a 
context of artificial insemination. 
 
 
 
5.1.1.2 Hematolymphopoietic organs and organs of the genital tract: are they 
target-organs for SBV? 
 
After experimental infection of adult ruminants, SBV RNA has been found mainly in the 
hematolymphopoietic organs: in the mesenteric, superficial cervical and mandibular lymph 
nodes, the spleen and tonsils in sheep (Martinelle et al., 2015; Poskin et al., 2014b; Wernike et 
al., 2013d); in the mesenteric, mandibular and inguinal lymph nodes, the Peyer’s patches (an 
intestinal component of the gut-associated lymphoid tissue) and tonsils in cattle (Van Der 
Poel et al., 2013; Wernike et al., 2012b, 2013a). Surprisingly, in non-pregnant goats, SBV 
RNA was not detected in the spleen and in the prescapular lymph nodes (close to the site of 
inoculation). Unfortunately, the mesenteric lymph nodes were not sampled (cf. experiments 
4.1.2). In pregnant goats, SBV RNA was frequently found in the mesenteric lymph nodes (cf. 
experiments 4.1.3.3). 
In sheep, SBV RNA was detected in the mesenteric lymph node and the spleen up to 44 dpi, 
indicating SBV may have an affinity for these organs (Wernike et al., 2013d). Whether 
hematolymphopoietic organs could be a persistence site for SBV remains to be elucidated. 
Viral isolation was unsuccessful in the RT-qPCR positive mesenteric and inguinal lymph 
nodes from two experimentally infected bulls (Van Der Poel et al., 2013). In other studies, 
viral isolation has not been performed on the hematolymphopoietic organs, hence whether 
they contain infectious virus is still unknown. The SBV-containing cells in these organs have 
not been determined either.  
 
In cattle, infectious SBV has been detected in semen samples from two experimentally 
infected bulls, yet SBV RNA was not detected in the genital tract (prostate, testis, 
bulbourethral gland, and epididymis) of these bulls at 24 dpi (Van Der Poel et al., 2013). 
After experimental infection of bucks and rams, SBV RNA was not detected in the genital 
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tract (epididymis, testis, and seminal vesicle) either (Wernike et al., 2013d) (cf experiments 
4.1.2). Buck semen was collected from 0 to 28 dpi but remained negative by SBV RT-qPCR. 
One major limitation of these studies is that they have been performed on small numbers of 
animals. 
Infectious SBV has been detected in a few bovine semen samples from the field (Hoffmann et 
al., 2013; Ponsart et al., 2014; Schulz et al., 2014). Viral RNA was detected in every semen 
sample for 3 months after natural infection in one bull (Ponsart et al., 2014), while viral RNA 
excretion in semen was intermittent in two bulls (Hoffmann et al., 2013). Viral RNA could be 
detected in both the seminal cell fraction and in the seminal plasma from several bulls, with 
lower Cq (thus higher copy numbers) in the former (Hoffmann et al., 2013). Altogether, these 
data from the field are suggestive of a persistence of SBV in these bulls, either in cells from 
the genital tract, or in cells from another organ with frequent diffusion or cell-associated 
migration to the genital tract. 
 
As to the female genital tract, SBV RNA has been found in the ovary from both a single goat 
(cf. experiment 4.1.2) and a single ewe 7 days after experimental inoculation (Wernike et al., 
2013d). In both animals, viral RNA was detected in the ovarian interstitial tissue but not in the 
follicular fluid, cumulus cells, and oocytes (Wernike et al., 2013d). Unfortunately, viral 
isolation from these organs was not performed. The significance of these findings remains to 
be determined. 
 
Other organs have been shown to contain SBV RNA after experimental inoculation in sheep,: 
muscle (inoculation site, up to 29 dpi), cerebellum (up to 10 dpi), cerebrum (up to 29 dpi), 
lung (up to 44 dpi), and kidney (up to 44 dpi) in one or two animals each (Martinelle et al., 
2015; Poskin et al., 2014b; Wernike et al., 2013d). No lesions and clinical signs were 
associated to these findings. Viral isolation was not performed in these organs. Whether SBV 
could persist in these organs is still unknown. 
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5.1.1.3 Summary 
 
Taking into account the data gathered from the field and from experimental infections, a 
hypothetical pathogenesis of SBV in adult non-pregnant ruminants is proposed in Figure 10. 
 
 
 
Figure 10. Hypothetical pathogenesis after SBV infection in adult non-pregnant ruminants.  
The excretion of SBV in semen has been shown in cattle only. 
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5.1.2 Pathogenesis of the infection in pregnant females 
 
As shown for goats, SBV infection in pregnant females can lead to several outcomes for the 
offspring. The pathogenesis of these outcomes will be discussed at the animal level and the 
tissue level.  
 
5.1.2.1 Window of susceptibility 
 
The window of susceptibility of the growing embryo or fetus in pregnant goats is at least 
between 28 and 42 dg (cf. experiments in part 4.1.3.3). In cattle, a field study has shown this 
window to be at least between 60 and 144 dg, in association with the birth of malformed or 
dead calves (Wernike et al., 2014c). 
It is likely the vertical transmission of SBV to the embryo could not occur before the 
placentomes are mature, i.e. before 20 dg in sheep and goats and before 32 dg in cattle 
(Dantzer and Leiser, 2006). 
As earlier mentioned in this manuscript (part 2.3.3.1.1), the end of the window of 
susceptibility may rely upon the stage of maturation of the target organs, on the one hand, and 
the competency of the immune system, on the other hand.  
In the brain, one of the major target organs, we have shown that SBV replicates mainly in the 
undifferentiated cells of the periventricular zone and in the cerebellar granular cell layer in 56 
dg-old goat fetuses (cf. experiments in part 4.1.3.3). Later in pregnancy, this pool of 
undifferentiated cells, which may be the most SBV-susceptible cells, will slowly decrease. In 
addition, the more advanced the pregnancy is, the more mature the blood-brain barrier is. In 
sheep, the blood-brain barrier begins to mature between 50 and 60 dg (Evans et al., 1974). 
From 60 dg on, this barrier may limit the distribution of SBV to the brain (Varela et al., 
2013). 
The development of the immune system has been more studied in the ovine fetus than in the 
goat fetus. In the ovine fetus, cell-mediated immunity as well as humoral immunity develop 
as soon as 70 dg, exemplified by the ability of the fetus to reject allografts and to produce 
specific antibodies at this time (Sammin et al., 2009). Development of specific immunity with 
immune memory in ovine neonates following oral DNA vaccination at 120 dg shows that the 
ovine fetus is immunocompetent at 120 dg (Gerdts et al., 2002). Therefore, from 70 dg on, 
SBV distribution is probably restricted by the action of the immune system. Nevertheless, the 
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immune system may also worsen SBV-induced lesions, as described earlier in the SBV-
infected goat fetus with umbilical arteritis. 
 
5.1.2.2 The placentome: site of crossing, site of persistence? 
 
Our results have shown a tropism of SBV for the goat placentome, with infection of 
trophoblastic binucleate cells and giant syncytial cells (cf. experiments in part 4.1.3.3). The 
SBV tropism for trophoblastic cells has also been shown in vitro, with infection of ovine 
trophoblastic cell (oTr-1) culture (Varela et al., 2013).  
The placentome is the gateway for the virus to invade the fetus. However, after inoculation of 
SBV at 28 dg to goats with twin or triplet pregnancy, 28 days later some fetuses and their fetal 
membranes were spared while the other(s) were infected (cf. experiments in part 4.1.3.3). 
Diffusion of the virus at 28 dg was thus not homogeneous in the uterus and then in 
placentomes; alternatively, the virus was blocked in the maternal side of some placentomes. 
The way the virus crosses the placental barrier, from the maternal blood to the fetal blood, is 
not known. Like many bacteria responsible for placentitis in sheep, the virus may cross in the 
hemophagous areas, i.e. the areas of hemorrhage in the ruminants’ placentomes (Sammin et 
al., 2009). As the fetal trophoblast exerts a phagocytic activity on the red blood cells in these 
areas, it could be speculated that the trophoblast would phagocyte viral particles at the same 
time. Nevertheless, SBV do not seem associated with blood cells as the SBV-associated 
viremia is very short (Hoffmann et al., 2012b, 2013). 
 
Placentomes from experimentally infected pregnant goats can contain infectious SBV or at 
least, SBV antigen and RNA, until 28 dpi (cf. experiments in part 4.1.3.3). After experimental 
infection of pregnant ewes with AKAV, infectious virus was detected until 60 dpi in the 
placentomes, suggesting the placentomes may be a site of viral persistence (Parsonson et al., 
1981c). Indeed, the placenta is a site where the maternal immune response is limited. In 
sheep, ovine trophoblasts and feto-maternal syncytia do not express MHC class I molecules 
(Sammin et al., 2009). This means that intracellular infection of the trophoblasts and syncytia 
with a pathogen would not trigger recognition and killing by cytotoxic T lymphocytes. 
Besides, in sheep the trophoblast secretes interferon tau and the endometrial glands secretes 
serpins; these proteins inhibit in vitro activation of lymphocytes (Sammin et al., 2009). Ovine 
uterine serpins also inhibits natural killer cell function (Padua and Hansen, 2010). Thus, the 
placenta may represent a protected niche for SBV replication and persistence.  
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5.1.2.3 Pathogenesis of embryonic/fetal death 
 
SBV infection has been associated with embryonic loss, abortion and stillbirth. Embryonic or 
fetal death can result either from anomalies in the environment (the mother, the placenta) or 
from anomalies in the embryo or fetus itself.  
 
First, the embryo is susceptible to variation in temperature and can die because of 
hyperthermia. In experimentally SBV-infected goats, some dead kids were suspected to be 
dead at the end of the embryonic period, yet no hyperthermia was detected (cf. experiments in 
part 4.1.3.3). This mechanism was unlikely the cause of the embryonic death in this 
experiment. 
 
Second, an infection of the placenta may lead to embryonic or fetal death through several 
mechanisms. In case of a true placentitis, the feto-maternal exchange has a reduced efficiency, 
the placental endocrine function may be disrupted, and the local immunomodulation may be 
lost with resultant immune expulsion (Sammin et al., 2009). In SBV infection in pregnant 
goats, no placentitis could be detected but SBV was replicating in the trophoblastic cells and 
the giant syncytial cells (cf. experiments in part 4.1.3.3). The placental endocrine function 
was not evaluated, thus the hypothesis of a disruption by SBV was not explored. However, 
our results suggest SBV may impair the feto-maternal exchange. Indeed, the maximal 
diameter of placentomes was reduced in infected goats. The goats included in the analysis 
were all carrying at least one live fetus except one goat from G42, thus fetal mortality alone 
cannot explain the smaller maximal diameter of placentomes in the infected goats. Therefore, 
SBV infection may have an effect on placentomes development, either by inhibiting their 
growth or by triggering partial degeneration and loss. Moreover, degenerative changes were 
found in placentomes from 2 goats from G42 in association with abundant SBV antigens (cf. 
experiments in part 4.1.3.3). Similarly, after experimental infection of pregnant ewes with 
AKAV, degeneration and necrosis was noticed in the fetal villi in placentomes, with AKAV 
antigen positivity in the areas of necrosis (Parsonson et al., 1988). Altogether, these results 
suggest an ability of both viruses to damage placentomes. With severe damage, embryonic or 
fetal mortality could result by ischemia. 
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Finally, embryonic or fetal death can occur secondary to down-regulation of the expression of 
genes related to embryonic or fetal development, alone or in combination with associated up-
regulation of genes related to pro-inflammatory response (Sanad et al., 2015). 
 
5.1.2.4 Pathogenesis of lesions in fetuses and newborns 
 
SBV infection can result in a wide range of lesions in fetuses and newborns. The most 
affected organs or systems are the CNS, the skeletal muscle, and the axial skeleton. 
  
5.1.2.4.1 In the CNS  
 
In two goat fetuses whose mothers were experimentally infected at 28 dg and 42 dg, 
porencephaly was found at 55 dg in the cerebrum, associated with SBV antigen in 
surrounding cells (cf. experiments in part 4.1.3.3). The cell loss was located in the 
periventricular zone, which contains bipotential progenitor cells (Fred Sinowatz, 2010a). 
Importantly, these cells give rise to neuronal progenitor cells and glial progenitor cells. The 
latter are precursors not only to astrocytes and oligodendrocytes but also to the radial glial 
cells, which are temporary cells that guide the young neurons during their migration in the 
cortex in midpregnancy (Fred Sinowatz, 2010a). Therefore, cell loss this area could have 
evolved later into hydrocephalus ex vacuo or hydranencephaly.  
 
Cell loss could have resulted either from a direct SBV-driven cytopathic effect, or from 
ischemia. The association of SBV antigen with the lesions in goat fetuses is in favor of the 
former mechanism (cf. experiments in part 4.1.3.3). After infection of pregnant sheep by 
AKAV, no vascular lesions were found in lambs, suggesting that the direct destruction of 
undifferentiated neural cells was a major event in the pathogenesis (Narita et al., 1979). In the 
goat fetuses with porencephaly, the brain blood vessels did not show damage or inflammation, 
yet acute hemorrhages were detected in the areas of cell loss (cf. experiments in part 4.1.3.3). 
Hemosiderosis has been found in the brain of SBV RNA positive neonatal ruminants, 
indicating chronic hemorrhages (Herder et al., 2013). In addition, after intracerebral 
inoculation in mice, acute hemorrhage was detected at 48h post-infection, earlier than 
malacia, which occurred at 72h post-infection (Varela et al., 2013). These data support 
vascular disruption as a cause of porencephaly (Herder et al., 2013). However, no vascular 
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necrosis and thrombosis has been reported up to now in the brain of SBV-infected fetuses. In 
addition, cell tropism of SBV in ruminants includes both neurons (Hahn et al., 2013; 
Peperkamp et al., 2012; Varela et al., 2013) and, at least in vitro, endothelial cells (Barry et 
al., 2014; Varela et al., 2013). Therefore, both cytopathic effect and ischemia have to be 
considered as possible mechanism of SBV-induced cell loss in the fetal brain.  
 
The range of CNS lesions associated with SBV in the field includes inflammation, appearing 
as lymphohistiocytic meningoencephalitis (Herder et al., 2013). If malformations of the CNS 
were detected in all cases of lymphohistiocytic meningoencephalitis in neonatal ruminants 
from one study, inflammation was present only in a minority of neonates displaying 
malformations in the CNS (Herder et al., 2013). Viral antigen was often associated with the 
inflammation; this can be interpreted as a close interaction between SBV expression and the 
local immune response (Herder et al., 2013). Another interpretation could be that detection of 
both viral antigen and inflammation indicates an infection in late stages of pregnancy, before 
viral clearance and after maturation of the immune system. Accordingly, Peperkamp et al. 
hypothesize that an infection early in gestation would result in severe dysplastic lesions and 
viral clearance at the time of parturition, whereas a late gestational SBV infection would 
result in encephalomyelitis with detectable viral RNA and antigen (Peperkamp et al., 2014). 
 
5.1.2.4.2 In the skeletal muscle 
 
In SBV-infected goat fetuses at 55 dg, no histological lesions were seen in skeletal muscle 
despite SBV RNA and antigen were abundant in this tissue (cf. experiments in part 4.1.3.3). 
We hypothesize the lesions could be not yet developed at this stage but SBV could already 
have an effect on apoptosis and cell cycle in myotubes. There was a trend in greater apoptosis 
in muscle from infected fetuses bearing porencephaly than in muscle from infected fetuses 
without lesions or control fetuses. Unexpectedly, the rate of cell proliferation was higher in 
muscle from the infected fetus than in muscle from control fetuses (cf. experiments in part 
4.1.3.3). This proliferation could be either a reactive event secondary to previous cell loss or, 
less likely, a direct effect of the virus. Overall, these results support only weakly the 
hypothesis of a direct destructive action of SBV on fetal muscle.  
 
In SBV-infected newborn calves, a correlation has be shown between the degree of overall 
body deformity and a progressively greater reduction in the diameter of the spinal cord, on the 
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one hand, and with fewer spinal neurons, on the other hand. This suggests arthrogryposis 
could result directly from denervation atrophy of skeletal muscle (Bayrou et al., 2014). In 
SBV-infected goat fetuses, neuron loss in the ventral horn of the spinal cord was not detected 
(cf. experiments in part 4.1.3.3). Nevertheless, morphometry would be more accurate than 
conventional histological examination in the evaluation of neuron density. 
 
An alternative mechanism would be the disruption of muscle cell differentiation by the virus. 
Indeed, in SBV RNA-positive neonates, the hypoplastic skeletal muscle is made of small 
myofibers that sometimes lack cross striations (Seehusen et al., 2014). To explore this 
possibility, the expression of myogenic regulator factors (Fred Sinowatz, 2010b) in the fetal 
muscle could be compared between SBV-infected and control fetuses. In vitro work with 
primary bovine fibroblasts has shown SBV is able to downregulate a transcription factor 
involved in embryonic development (Blomström et al., 2015), paving the way for further 
research in this area. 
 
5.1.2.4.3 In other organs 
 
One SBV-infected goat fetus displayed a bilateral umbilical arteritis with thrombosis and 
SBV antigen in spindle cells in the wall (cf. experiments in part 4.1.3.3). This finding was 
unexpected as SBV-associated lesions in the umbilical cord have not been reported to our 
knowledge. This arteritis may be an incidental finding; alternatively, it may represent a way 
for the virus to lead to fetal ischemia by disruption of the fetal blood circulation. A tropism 
for the arterial wall has been described for CVV, which antigen has been detected in the 
media of the aorta in ovine fetuses inoculated experimentally at 35 dg. However, presence of 
CVV antigen was not associated with histological lesions from 7 to 28 dpi (Hoffmann et al., 
2012a). A tropism of SBV for ovine endothelial cells has been shown in vitro (Barry et al., 
2014; Varela et al., 2013), but SBV antigen was not detected in endothelial cells in infected 
goat fetuses (cf. experiments in part 4.1.3.3). Whether SBV infection of endothelial cells in 
the fetus would result in vascular lesions remains to be demonstrated. 
 
SBV antigen and RNA were detected in the mandible and vertebrae of SBV-infected goat 
fetus at 55 dg (cf. experiments in part 4.1.3.3). At this stage, these bones are made of a 
hyaline cartilaginous model that will become bone later by endochondral ossification (Fred 
Sinowatz, 2010b). SBV antigen was found in the cytoplasm of well-differentiated 
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chondrocytes, yet no lesions were detected in the cartilage. SBV could elicit malformations in 
the axial skeleton by damaging the cartilaginous model of future bones, or by disrupting the 
expression of key genes for bone development. The former hypothesis requires sequential 
analyses on bone at different stages of fetal development in goats. The latter hypothesis can 
be explored through transcriptomic analyses in the fetal bone, with a focus on Notch and Wnt 
pathways, major pathways for development of the axial skeleton (Dittmer and Thompson, 
2015), and on the transcription factors Cbfa1 and Indian hedgehog that are involved in the late 
steps of endochondral ossification (Fred Sinowatz, 2010b). 
 
In SBV-infected goat fetuses, SBV RNA was detected in several other organs that seldom 
display lesions in newborns after in utero SBV infection in the field (Table 6). No gross or 
histological lesions were found in these organs in goat fetuses (cf. experiments in part 
4.1.3.3). Therefore, a causal link between presence of SBV RNA and lesions in the 
corresponding organ in neonates is far from being established. Table 6 gives, by organ, earlier 
reported lesions associated with SBV infection in the literature, and, when possible, 
arguments for and against a causal link between SBV RNA presence and lesion formation. 
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Table 6. In a subset of organs containing SBV RNA without associated lesions in experimentally infected goat 
fetuses: lesions found in SBV-infected neonates in the field, arguments for and against a causal link between 
SBV RNA presence and lesion formation. 
Organ 
Lesions in SBV-infected 
neonates in the field 
FOR 
a causal link 
AGAINST 
a causal link 
Kidney 
Unilateral hydronephrosis 
in a sheep (Herder et al., 
2012) 
CVV infection in ovine 
fetuses: focal necrosis in 
tubular epithelial cells of 
the renal cortex 
(Hoffmann et al., 2012a) 
Renal necrosis was minimal and 
found in 1 fetus only (Hoffmann et al., 
2012a) 
Eye 
Bilateral cataract in a sheep 
(Herder et al., 2012) 
 
In SBV-infected goat fetuses, antigen 
in the eyelid but not in the globe itself 
Lung 
Lung hypoplasia in a goat 
(Herder et al., 2012); 
lymphocytic interstitial 
pneumonia in calves 
(Bayrou et al., 2014) 
Lung hypoplasia in 
lambs after AKAV 
infection (Parsonson et 
al., 1981b) 
 
Lymphocytic interstitial pneumonia 
detected in control calves (Bayrou et 
al., 2014) 
Heart 
Cardiac ventricular septal 
defect in a sheep (Herder et 
al., 2012) 
 
CVV infection in ovine fetuses: CVV 
antigen in cardiomyocytes without 
lesions (Hoffmann et al., 2012a) 
Digestive 
tube 
Colonic atresia in a sheep 
(Herder et al., 2012) 
 
SBV RNA detected in meconium 
swabs of 6/9 clinically healthy calves 
(Wernike et al., 2014c) 
Liver 
Chronic lymphohistiocytic 
hepatitis in calves 
(Seehusen et al., 2014) 
 
Chronic lymphohistiocytic hepatitis 
also found in age-matched control 
calves (Seehusen et al., 2014) 
Lymphoid 
organs 
Lymphoid depletion in 
lymph node, thymus, and 
spleen in lambs and calves 
(Herder et al., 2012; 
Seehusen et al., 2014). 
Lymphoid depletion in 
the thymus in lambs 
after AKAV infection 
(Parsonson et al., 1977). 
Lymphoid depletion also found in 
age-matched control lambs (Seehusen 
et al., 2014). 
 
The arguments for a causal link, presented in Table 6, are weak as they are few and they do 
not refer to SBV but to other viruses from the genus Orthobunyavirus. There are more 
arguments against a causal link between SBV RNA and lesion development in these organs. 
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5.1.2.5 Summary 
 
After SBV crosses the placenta, embryonic or fetal death may occur. If the fetus survives, 
lesions may develop in utero in the CNS, the skeletal muscle and the axial skeleton. The third 
outcome after fetal infection by SBV is in utero development without lesions, followed by 
birth of a normal neonate. Indeed, SBV RNA has been detected in meconium swabs of 6/9 
clinically healthy calves with high SBV-antibody titers before colostrum intake (Wernike et 
al., 2014c). The authors speculate that both the antibody response and the detection of SBV 
RNA may be the consequence of extensive SBV-replication, which only seldom lead to 
abortion, malformation or stillbirth (Wernike et al., 2014c).  
 
Considering SBV infection can result in the birth of healthy neonates, then arises the question 
of immunotolerance. Immunotolerance with persistence of the virus has been described for 
Bovine viral diarrhea virus (BVDV) in calves. The persistently infected animals are a hidden 
source of infection and are a major concern for disease control. Persistence of the virus in 
newborn calves occurs if the infection takes place between 40 and 125 dg with a 
noncytopathogenic strain of BVDV (Brodersen, 2014). Despite SBV infection of pregnant 
cows before 90 dg, in the field, high titers of precolostral SBV-specific antibodies have been 
detected in their calves, indicating immunotolerance was not induced (Wernike et al., 2014c). 
 
After experimental infection of pregnant goats at 42 dg, we reported SBV RNA-positive 
fetuses that were alive and devoid of lesions at 12 dpi (cf. experiments in part 4.1.3.3). The 
slaughter time point may have been too early to detect all the SBV-induced lesions; 
alternatively, the virus could have been cleared later without damaging the fetuses. The latter 
hypothesis is suggested by the virus clearance occurring between 7 and 28 dpi after CVV 
infection at 35 dg in ovine fetuses (Hoffmann et al., 2012a). CVV clearance may result from 
the ability of the ovine fetus to develop both an innate immune response and an adaptive 
immune response early in gestation, i.e. before 70 dg (Rodrigues Hoffmann et al., 2013). 
 
To conclude this part about the pathogenesis of lesions after SBV infection in pregnant 
females, a diagram recapitulating the three outcomes after SBV infection of pregnant goats is 
proposed in Figure 11. 
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Figure 11. Outcomes and pathogenesis after SBV infection in adult pregnant goat.  
From data shown in part 4.1.3.3. 
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5.2 Rapid and broad dissemination of the virus among wild and exotic 
ruminants 
 
5.2.1 A quick spread in many species and in various ecosystems 
 
In Europe, SBV disseminated quickly in domestic ruminants (Afonso et al., 2014; Steinrigl et 
al., 2014), with a higher rate of spread in comparison to BTV-8 (Sedda and Rogers, 2013). 
The spread was rapid in wild ruminants as well. Indeed, the results presented in part 4.2.1 
revealed a high speed of spread in red deer populations in France and similar results were 
earlier described for red deer and roe deer in Belgium (Linden et al., 2012).  
Models of SBV spread in Europe and in the United Kingdom have been developed and 
indicate midge dispersal was the main transmission route of SBV (Gubbins et al., 2014a, 
2014b; Sedda and Rogers, 2013), through downwind movements or a combination of 
downwind and random movements (Sedda and Rogers, 2013). However, average wind speed 
in Europe during SBV spread and during BTV-8 spread was similar, between 3 and 5 m/s 
(Sedda and Rogers, 2013). Additional factors may explain the faster spread of SBV in 
comparison to BTV. 
First, in Northwestern Europe, the area of virus circulation from summer 2011 to April 2012 
corresponds to an area affected by drought between March and May 2011. This match 
suggests drought could have enhanced the spread and circulation of SBV, although the 
biological mechanism is unknown (Calzolari and Albieri, 2013). Second, in comparison to 
BTV, in spite of a shorter viremia in the host, SBV has been predicted to have a higher 
probability of transmission from host to vector, a shorter latent period in the vector, a lower 
threshold temperature for replication and a faster replication when temperature is above the 
threshold (Gubbins et al., 2014a). All these characteristics may explain why SBV has spread 
faster than BTV-8. Nevertheless, these predictions were made via computer-assisted 
modelling and have to be verified biologically. 
Finally, data from the field suggest competence of midges for SBV may be higher than for 
BTV (Rossi et al., 2015). SBV virus has been detected in relatively high number of midges 
(Elbers et al., 2013a; De Regge et al., 2012), even in small pools of midges while BTV 
detection in similar pools was rarer (Veronesi et al., 2013). This high proportion of SBV-
infected midges may have enhanced virus spread in Europe. 
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In addition to a high speed of spread, SBV has circulated in numerous species of wild and 
exotic ruminants. The results presented in part 4.2.2 revealed for the first time evidence of 
SBV infection in 13 species. Combined to the 28 species of wild and exotic ruminants earlier 
reported to be receptive (cf. chapter 2), then SBV has circulated in at least 41 species of non-
domestic ruminant in Europe, demonstrating a wide range of receptive hosts. 
In France, SBV spread to a larger range of hosts in free-ranging wild ruminants than BTV did. 
Antibodies against SBV were found in roe deer, mouflon, chamois, and ibex while antibodies 
against BTV were absent or found in a low proportion of animals in these species (Rossi et 
al., 2014, 2015). This difference in host range may rely upon a higher number of hosts 
receptive to SBV but also upon a difference in the species of vectors able to transmit each 
virus to wild ruminants (Rossi et al., 2015). 
 
SBV circulated in a wide range of species but also in a wide range of ecosystems.  
The results from part 4.2.1 revealed that ruminants have been exposed to SBV in the 
Ménagerie du Jardin des Plantes, a zoological park in the city center of Paris, suggesting the 
vectors of SBV can live, or at least survive, in urban areas. The zoological park environment 
may have allowed Culicoides spp. to live in this area, given that high quantities of Culicoides 
midges have already been described in Chester zoo in England (Vilar et al., 2011). Moreover, 
C. obsoletus, C. scoticus, C. chiopterus and C. punctatus can choose opportunistically their 
bloodmeal host, feeding on common wood pigeon if need be (Lassen et al., 2011). 
Wild ruminants have also been exposed to SBV in mountainous areas. In Austria, Italy and 
Spain, antibodies to SBV have been detected in chamois, which lives in high alpine areas 
(Chiari et al., 2014; Fernández-Aguilar et al., 2014; Schiefer et al., 2013). As suggested by 
Schiefer et al., exposure to SBV has occurred through vectors that either were natural 
inhabitants of alpine sites or disseminated there (Schiefer et al., 2013). In several wild species 
in France, although SBV seroprevalence was found to be on average higher at low altitude 
than at high altitude, seroprevalence up to 70% was detected in Alpine ibex in one area above 
1500m (Rossi et al., 2015). In comparison to SBV, BTV seroprevalence at this altitude was 
lower (Rossi et al., 2014, 2015). 
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5.2.2 Wild ruminants: do they play a role in SBV dissemination in domestic ruminants? 
 
The role of wild species in the dissemination of SBV is still unknown. We can speculate they 
could participate to SBV overwintering, as maintenance hosts of SBV. SBV viremia is short-
lasting in domestic ruminants and in the llama and the alpaca, however it has not been 
characterized in the other wild and exotic ruminants. As red deer populations are abundant in 
Europe, they might be a reservoir of SBV if long-lasting or recurrent viremia occurs in this 
species. Experimental infection may be useful to describe viremia in red deer. 
 
Conversely, wild ruminants may be only spillover hosts of SBV. SBV has spread in wild 
ruminants and domestic livestock at the same time during fall 2011 in France (part 4.2.1). 
However, a delay of one year has been recorded between the domestic cases and a high 
seroprevalence in wild ruminants living in mountainous areas in France and Italy (Chiari et 
al., 2014; Rossi et al., 2015). This delay may be due to different vector species for SBV 
between mountain wild ruminants and domestic ruminants, or to exposure of mountain 
ruminants after a spillover from domestic ruminants (Rossi et al., 2015). Furthermore, the 
domestic ruminant density has been shown to influence positively the SBV infection in wild 
ruminants in Poland. In addition, SBV seroprevalence was lower in wild ruminants than in 
domestic ruminants in Poland in 2013. These data from Poland are consistent with SBV 
infection in wild ruminants occurring secondary to spillover from domestic ruminants (Larska 
et al., 2014). 
 
In summary, evidence from the field are not consistent with a major role of wild ruminants in 
SBV dissemination. However, there is a need to characterize SBV viremia in wild ruminants 
to evaluate the risk they can pose to domestic ruminants (Tarlinton et al., 2013). 
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5.3 Consequences in the field: impact and preventive measures 
 
5.3.1 Domestic ruminants 
 
Sexual transmission of SBV has not been proven as yet. Evidence of SBV excretion in semen 
come from studies in cattle (Hoffmann et al., 2013; Van Der Poel et al., 2013; Ponsart et al., 
2014; Schulz et al., 2014) whereas SBV viremia after intravaginal inoculation during artificial 
insemination was demonstrated in goats (part 4.1.3.2). Whether cows can be infected by 
vaginal route remains to be determined; if so, the consequences on pregnancy should be 
evaluated. SBV excretion was not detected after experimental SBV infection in bucks (part 
4.1.2), however only very few bucks were included in the study. Additional testing of semen 
batches is needed to assess whether bucks can excrete SBV in the semen. To protect SBV-
naïve females, vaccination before mating or artificial insemination is advised. 
 
Evidence of embryonal or early fetal loss in the field in association with SBV infection in 
goats has only been reported in the literature in 2013 for German herds (Helmer et al., 2013) 
and in 2014 for French herds (Dominguez et al., 2014), one and two years, respectively, after 
the emergence of the virus in Europe. 
Embryonic or early fetal death in domestic ruminants could have been underestimated in the 
field. First, they can easily be overlooked by the farmers, limiting the number of reports. 
Second, at the European scale, data about reproduction in livestock, for example the number 
of abortions and of return to service per herd is not easily available (Afonso et al., 2014). 
Therefore, the estimation of the impact of SBV on early pregnancy was limited in Europe. 
 
In France, the spread of SBV has influenced the clinical surveillance system of bovine 
brucellosis, a system based on abortion notification. Indeed, the spread of SBV was associated 
with an increase in the numbers of farmers that had notified abortion in 2012 and 2013. This 
increase may result from an increase in abortion occurrence due to SBV and/or from the 
farmers’ increased propensity in notifying abortions in this period (Bronner et al., 2015). The 
increase in notifying farmers was thus not easy to interpret. In France, a syndromic 
surveillance could be useful to improve the monitoring of abortions in cattle (Bronner et al., 
2015).  
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Syndromic surveillance can be defined as “the routine monitoring of one or several indicators 
for the early detection of adverse health events” (Madouasse et al., 2013). Milk yield in cattle 
has been tested as an indicator for the emergence of vector borne disease, yet the system 
described by the authors had to be improved due to low specificity (Madouasse et al., 2013). 
Indicators of fertility and prolificacy in livestock deserve to be monitored. 
 
The window of susceptibility of pregnant goats to SBV infection is at least between 28 and 42 
dg (part 4.1.3.3). Preventive measures should be applied to prevent SBV infection in naïve 
female goats before mating or artificial insemination. They include protection against midges, 
and acquisition of an adaptive immunity against SBV, as detailed in part 2.5.2. However, 
commercialized vaccines have not yet been tested in goats.  
 
 
5.3.2 Wild and exotic ruminants 
 
As yet, SBV impact for free-ranging wild ruminants is unknown. One suspected case in roe 
deer kids in France has been evoked (Rossi et al., 2015), yet no malformations have been 
reported in red deer from the populations studied in part 4.2.1, in 2012. No gross lesions 
evocative of SBV infection and no SBV RNA were found in 27 fetuses and newborns from 
red deer in Belgium at the beginning of the SBV epizootic (Linden et al., 2012) and in 7 
chamois fetuses in Spain in 2013 (Fernández-Aguilar et al., 2014). Obviously, it is more 
difficult to detect malformed newborns in the wild than in farms. 
Considering SBV infects wild ruminants and might elicit clinical disease, its impact would 
depend on the breeding period of each species. In roe deer, mating occurs in in July or 
August, with embryonic diapause a few days after. Pregnancy starts again with implantation 
in December and birth in May or June (Aitken, 1974). Thus, the period at risk is early 
embryonal life, before embryonic diapause, when the midges are active. In red deer, mating 
occurs in October or December and births take place in May or July (Guinness et al., 1971). 
During the first months of pregnancy, red deer females are unlikely to be exposed to midges, 
except when the weather favors midges’ activity beyond October. 
 
In contrast to red deer and roe deer, which are not endangered species, several ruminant 
species kept in zoos are threatened by extinction. Among them are three species that has been 
found seropositive for SBV (cf. part 4.2.2). 
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The Pere David’s deer (Elaphurus davidianus) is extinct in the wild but has been rescued 
through breeding in captivity. This species is native from China (Zhigang and Harris, 2008). 
The breading season takes place in summer (Asher et al., 1988), then births occur 270-300 
days later (Zhigang and Harris, 2008). Females can be exposed to SBV via midges during the 
first half of pregnancy. 
The Mesopotamian Fallow deer (Dama mesopotamica) is found in Iran and has been 
reintroduced in Israel. With less than 250 mature individuals in Iran, this species is considered 
as endangered (Rabiei and Saltz, 2013). Mating takes place in August and early September, 
then calving occurs at the end of March to early April (Rabiei and Saltz, 2013). The period 
over which females can be exposed to midges overlaps with pregnancy. 
The West Caucasian Tur (Capra caucasica) is found in the western part of the Great 
Caucasus Mountains in Georgia and Russia. The total population was estimated at 5,000-
6,000 animals in 2004 and has been decreasing, thus this species is considered as endangered 
(Weinberg, 2008). In this species, the rut lasts from mid-November until the beginning of 
January; births occurs from May to July (Weinberg, 2008). Exposure to SBV could occur 
during the second half of pregnancy. 
 
Vaccination, unless mandatory, is not widely used in zoological parks. It could interfere with 
control of the serological status when the animal comes to a new park. As animal exchange is 
frequent, facultative vaccination is seldom performed (Norin Chai, personal communication). 
Until SBV is proven to put zoo animals at risk, prevention of SBV infection will not be 
developed in zoological parks. Nevertheless, serological testing in the dams and submission 
of samples from aborted, stillborn or malformed newborn animals for SBV RT-qPCR testing 
is advised. 
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6 FUTURE DIRECTIONS 
 
6.1 Pathogenesis of the infection in goats 
 
The work presented in this thesis has led to hypotheses on the pathogenesis of the infection in 
pregnant goats. To elucidate further the way SBV induces malformations and death in the 
offspring, the following studies could be performed: 
 
 Immunohistochemistry and morphometry on tissue slices 
To identify more precisely target cells in CNS, IHC should be performed on fetal tissues to 
see if the affected cells are bipotential progenitor cells only or if there are already 
differentiating into neurons or glial cells. To assess ventral horn neuron density in spinal cord 
with accuracy, morphometry should be performed on fetal tissues.  
To look for an effect of SBV on the vascularization in placentomes, the capillary area density 
and capillarity cross sectional area could be measured in caruncles and cotyledons from 
infected animals and controls. It could be interesting to combine this morphometry study with 
a comparison of copy numbers of VEGF mRNA in placentomes between infected animals and 
controls. 
 
 Transcript analysis or proteomics on fetal tissues to look for difference in the 
expression of developmental and immune genes 
As to developmental genes, the expression of myogenic regulator factors (Fred Sinowatz, 
2010b) in the fetal muscle could be compared between SBV-infected and control fetuses. The 
influence of SBV on bone development could be explored through transcriptomic analyses in 
the fetal bone, with a focus on Notch and Wnt pathways, major pathways for development of 
the axial skeleton (Dittmer and Thompson, 2015), and on the transcription factors Cbfa1 and 
Indian hedgehog that are involved in the late steps of endochondral ossification (Fred 
Sinowatz, 2010b). 
Whether the goat fetuses infected by SBV are able to mount an innate immunity early in 
gestation is not known. The ability to develop innate immunity earlier than 70 dg has been 
showed for ovine fetuses inoculated experimentally with Cache valley virus at 35 dg 
(Rodrigues Hoffmann et al., 2013). The samples obtained from SBV-infected and control goat 
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fetuses could be submitted to RT-qPCR targeting transcripts of genes involved in the innate 
immunity, for example: IFN-α, IFN-β, TNF-α, IL-1; and, considering the response against a 
single stranded RNA virus: TLR7 and TLR8. Besides, mucosal chemokine CCL25, expressed 
early in gestation in the thymus of ovine fetuses, is supposed to have an important role in 
colonization of the thymus by lymphocytes (Meurens et al., 2007). As SBV infection has been 
associated with lymphocyte depletion in the thymus in some affected newborns (Herder et al., 
2012; Seehusen et al., 2014), we may hypothesize that SBV disrupt colonization of the 
thymus via CCL25 shutdown. It could be interesting to compare the copy number of CCL25 
mRNA in the thymus from our infected goat fetuses and the control goat fetuses. 
 
The purpose of pathogenesis studies is to elucidate the mechanisms leading to diseases. In the 
end, they can bring a basis for prevention and treatment. Vaccines are now available to protect 
ruminants against SBV infection. However, they have not been tested on goats. A first step 
would be testing on adult non-pregnant goats. Furthermore, the safety of SBV vaccines has 
not been tested on pregnant females; this would be useful to evaluate for live virus vaccines 
that will be produced in the future, as they might have a teratogenic effect if inoculated 
accidentally in pregnant animals (Tarlinton et al., 2012). A second step would include vaccine 
administration to pregnant cows, ewes, and goats, followed by SBV challenge and survey of 
the pregnancy outcome.  
 
6.2 SBV circulation in wild and exotic ruminants 
 
The role of wild ruminants in dissemination of SBV remains unclear. Among wild ruminants, 
red deer populations are very abundant in Europe. In order to elucidate if red deer could play 
a role in dissemination of SBV, experimental infection on red deer could be performed to 
describe the duration of SBV viremia in this species. In addition, to explore the possibility of 
maintenance of SBV in wildlife, SBV RNA could be sought by RT-qPCR on serum samples 
from free-ranging wild ruminants that are stored in several laboratories in France. 
The effects of SBV on reproduction of wild and exotic ruminants kept in zoos have not been 
characterized. Staff in zoological parks may be asked to send samples from stillborn or 
aborted fetuses for SBV-specific PCR testing. 
Finally, the origin of SBV has not been elucidated. Serological testing could be performed 
outside of Europe, on local species of ruminants, to look for antibodies against SBV. 
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7 CONCLUSION  
 
SBV was identified and isolated only a few months after description of the corresponding 
clinical signs in cattle, whereas AKAV-associated lesions in calves were described 18 years 
before the virus was isolated and the causal link between AKAV and the lesions was made 
(Wilks, 2014). The emergence of SBV has been associated from the beginning with 
transparency in reporting, generous exchanges of reagents and collaborative research between 
the European countries (Wilks, 2014).  
 
In the scope of the European research program on SBV in the pathogenesis and epidemiology 
areas, the works included in this thesis provided new data about SBV infection in livestock 
and wild and exotic ruminants. We participated in the description of the kinetics of viremia 
and seroconversion after experimental SBV infection in sheep and goats. We demonstrated 
goats can be infected by SBV via vaginal route. We showed fetal deaths or central nervous 
system lesions can occur in goat fetuses after SBV infection between 28 and 42 days of 
gestation. We described for the first time evidence of susceptibility to SBV in several species 
of wild and exotic ruminants kept in zoos. 
In 2013, the within-herd SBV seroprevalence in cows in Sweden and Belgium, as well as in 
goats in France, was heterogeneous with low values in some herds, indicating that SBV-naïve 
animals remained two years after the epizootics (Chenais et al., 2013; Méroc et al., 2013). 
Thus, recurrence of SBV could be expected in 2014; it did happen in Germany, with acute 
disease in adult cattle and increased frequency of malformations in the offspring (Wernike et 
al., 2015). This scenario may repeat over time, given the animals left naïve after one vector 
season will allow recurrence of the infection the next vector season. Depending on the 
duration of the immunity, clinical expression of the disease will appear as sporadic outbreaks, 
or further epizootics if immunity at population level declines (Dominguez et al., 2014). 
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 Schmallenberg 
Virus Infection in 
Dogs, France, 2012
To the Editor: In 2011, Schmal-
lenberg virus (SBV) emerged in Eu-
rope (1); the virus spread into France 
in January 2012 (2). During January–
March 2012, a total of >1,000 cases 
were reported in France, mainly in 
stillborn and newborn lambs with con-
genital malformations. 
In March 2012, neurologic disor-
ders were detected in five 15-day-old 
puppies (Belgian shepherd) from a 
dog breeding kennel in northwestern 
France (Orne). We report data sug-
gesting that these puppies were infect-
ed with SBV.
In June 2012, the kennel veteri-
narian contacted a veterinary school 
(Unité de Médecine de l’Elevage et du 
Sport Breeding and Sport Medicine 
Unit, Maisons-Alfort, France) after 
neurologic signs of ataxia, exotropia, a 
1896 Emerging Infectious Diseases • www.cdc.gov/eid • Vol. 19, No. 11, November 2013
Figure. Phylogenetic tree, 
based on a 330-bp amplicon of 
the Seoul virus (SEOV) RNA-
dependent RNA polymerase 
gene, depicted in FigTree 1.4.0 
(www.molecularevolution.
org/software/phylogenetics/
figtree). The tree was generated 
by using the uncorrelated 
lognormal distribution relaxed 
molecular clock model and 
SRD06 substitution model in 
BEAST1.74 (7). SEOV strain 
name/GenBank accession 
no/country: The location is 
shown in taxa. The posterior 
number is shown for each 
branch. Clades A and D were 
established as  described (2) 
Scale bar represents number 
of nucleotide changes per site.
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head tilt, and stunted growth were ob-
served in a litter of 5 puppies. Four of 
the puppies had died at 5–6 weeks of 
age. The veterinarian collected blood 
samples from the surviving puppy at 3 
months of age, and the puppy was eu-
thanized for necropsy. Severe torticol-
lis was observed during the necropsy, 
but no other macroscopic signs were 
detected. The brain, including the cer-
ebellum; a part of the spine; and ce-
rebrospinal fluid (CSF) were collected 
for further investigation. Specific 
PCR analyses for canine coronavirus, 
Neospora caninum, Toxoplasma gon-
dii, and canine minute virus were per-
formed on CSF; all test results were 
negative. The brain tissue was fixed in 
formalin and processed for histologic 
examination. Features of degenerative 
encephalopathy, including neuronal 
vacuolation, neuropil vacuolation, and 
minimal gliosis, were observed. 
Because some clinical signs were 
evocative of SBV infection and the 
puppy was born in an area where the 
virus was circulating actively in cattle 
and sheep, veterinarians decided to in-
vestigate SBV as a possible etiology. 
Serum samples from the 3-month-old 
puppy and the dam were tested by vi-
rus neutralization test (VNT), accord-
ing to the protocol used for ruminant 
serum. The results were negative for 
the puppy but positive (titer 128) for 
the mother. Specific competitive SBV 
ELISA (IDVet, Montpellier, France) 
against the SBV N protein showed 
similar results.
Real-time reverse transcription 
PCR (RT-PCR) was performed (3) 
to detect the presence of the SBV ge-
nome in the cerebellum. Because the 
sample was paraffin-embedded, RNA 
was extracted from 5-µm sections, as 
described (4). All of the extracted cer-
ebellum sections had positive test re-
sults (cycle threshold range 33-36); the 
extraction and PCR controls all showed 
negative results. To confirm these posi-
tive results, conventional RT-PCR was 
used to amplify a 573-nt sequence of 
the SBV S segment. The amplification 
product was sequenced, and a BLAST 
analysis was performed (www.ncbi.
nlm.nih.gov/BLAST). An identity of 
100% was obtained with the SBV small 
gene segment from a ruminant (Gen-
Bank accession no. KC108860). An 
immunohistochemical assay was also 
performed; the result was negative. 
The remaining 7 female dogs in 
the breeding kennel were tested for 
SBV in October 2012; 1 showed posi-
tive test results by VNT (titer 256), 
which confirmed that SBV was cir-
culating in the kennel. This positive 
dam had a litter of puppies in Decem-
ber 2012, but no signs developed, and 
the puppies were not tested. In March 
2013, repeat testing was done on se-
rum samples from the 2 dogs that had 
shown positive results. Results for 
both animals were positive by VNT 
(titers 32 for the dam and 128 for the 
other dog) and ELISA.
Taken together, specific SBV an-
tibodies in the mother and the SBV ge-
nome in her puppy suggest that these 
dogs experienced SBV infection. The 
absence of detectable SBV antibod-
ies in the puppy in this investigation 
suggests that transplacental infection 
occurred before the onset of fetal im-
mune competence. Maternal infec-
tion probably occurred in January or 
February 2012; entomologic monitor-
ing conducted in France showed the 
presence of Culicoides spp. midges, 
a vector of SBV, during this period in 
northwestern France. In addition, be-
cause the puppies were born in March 
2012 and SBV antibodies were still 
detectable in the mother in March 
2013, the duration of SBV antibodies 
in dogs appears to be >1 year. In cattle 
and sheep, the SBV genome persists in 
an infected fetus and is detectable af-
ter birth by real-time RT-PCR, despite 
gestation length (5,6).
Few reports on orthobunyavirus 
infections in dogs are available. Two 
serologic studies from the United 
States (7) and Mexico (8) found anti-
bodies against La Crosse virus, South 
River virus, and Jamestown Canyon 
virus in dogs. Two other reports de-
scribed cases in which La Crosse virus 
was detected in canine littermates who 
had clinical encephalitis (9) or neuro-
logic disorders (10).
It is unclear if the apparent SBV 
infection we detected in these dogs 
was an isolated event or if other cases 
occurred elsewhere but were not de-
tected because they were not investi-
gated. Further serologic and clinical 
surveys are needed to estimate SBV 
prevalence in dogs and the virus’ in-
volvement in the occurrence of neuro-
logic signs in puppies.
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Geographic  
Co-distribution of 
Influenza Virus  
Subtypes H7N9  
and H5N1 in  
Humans, China
To the Editor: Human infection 
with a novel low pathogenicity influ-
enza A(H7N9) virus in eastern China 
has recently raised global public 
health concerns (1). The geographic 
sources of infection have yet to be 
fully clarified, and confirmed human 
cases from 1 province have not been 
linked to those from other provinc-
es. While some studies have identi-
fied epidemiologic characteristics 
of subtype H7N9 cases and clinical 
differences between these cases and 
cases of highly pathogenic influenza 
A(H5N1), another avian influenza af-
fecting parts of China (2–4), the spa-
tial epidemiology of human infection 
with influenza subtypes H7N9 and 
H5N1 in China has yet to be elucidat-
ed. To test the hypothesis of co-dis-
tribution of high-risk clusters of both 
types of infection, we used all avail-
able data on human cases in mainland 
China and investigated the geospatial 
epidemiologic features.
Data on individual confirmed hu-
man cases of influenza (H7N9) from 
February 19, 2013, through May 17, 
2013, and of influenza (H5N1) from 
October 14, 2005, through May 17, 
2013, were collected from the Chi-
nese Center for Disease Control and 
Prevention. The definitions of these 
cases have been described (3,5). A to-
tal of 129 confirmed cases of influen-
za (H7N9) (male:female ratio 2.39:1) 
and 40 confirmed cases of influenza 
(H5N1) (male:female ratio 0.90:1) 
were included in the analysis. The 
median age of persons with influenza 
(H7N9) was higher than for persons 
with influenza (H5N1) (58 years vs. 
27 years; z = −7.73; p<0.01). Most 
(75.0%) persons with influenza 
(H5N1) had direct contact (e.g., oc-
cupational contact) with poultry 
(including dead and live birds) or 
their excrement and urine, whereas 
most (64.3%) persons with influenza 
(H7N9) had only indirect exposure to 
live poultry, mainly during visits to 
live poultry markets.
Reported cases of influenza 
(H5N1) were distributed over 40 
townships in 16 provinces, where-
as cases of influenza (H7N9) were 
relatively more concentrated, in 108 
townships but only 10 provinces (Fig-
ure). To identify a spatial overlap be-
tween the primary cluster of influenza 
(H7N9) cases, detected in April 2013 
(relative risk [RR] 78.40; p<0.01), 
and the earliest space-time cluster of 
influenza (H5N1) cases, detected dur-
ing November 2005–February 2006 
(RR 65.27; p<0.01), we used spatio-
temporal scan statistics with a maxi-
mum spatial cluster size of 5% of the 
population at risk in the spatial win-
dow and a maximum temporal cluster 
size of 25% of the study period in the 
temporal window (6) (Figure). The 
results suggest that the overlap is not 
perfect and is concentrated around an 
area southeast of Taihu Lake (south of 
Jiangsu Province), bordering the prov-
inces of Anhui and Zhejiang. Smaller 
clusters of influenza (H7N9) cases 
were identified in the boundary of Ji-
angsu and Anhui Province (8 cases; 
RR 64.86; p<0.01) and Jiangxi Prov-
ince (Nanchang County and Qing-
shanhu District) (4 cases; RR 105.67; 
p<0.01). A small cluster of influenza 
(H5N1) cases was detected during 
2012–2013 along the boundaries of 
Guanshanhu, Yunyan, and Nanming 
Counties in Guizhou Province (3 cas-
es; RR 496.60; p<0.01). 
In addition, family clustering, 
defined as >2 family members with 
laboratory-confirmed cases, was 
found for influenza (H7N9) cases 
during March–April 2013 in Shang-
hai and Jiangsu Provinces and for 
influenza (H5N1) cases during De-
cember 2007 in Jiangsu Province. 
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- Court résumé de la thèse  
Le virus Schmallenberg (SBV) affecte les ruminants domestiques. Il est responsable de signes 
cliniques discrets chez les adultes et de malformations congénitales chez les nouveau-nés. Ces 
travaux apportent de nouvelles données sur la pathogenèse de l’infection à SBV chez les ruminants 
domestiques, en particulier chez la chèvre. La sensibilité de plusieurs espèces de ruminants sauvages 
vis-à-vis du virus est démontrée.  
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